Pyridazine derivative and composition containing same

Abstract

The present invention provides: a compound that has an excellent control effect against weed and that is represented by formula (I) [in the formula, R1 represents an isopropyl group or the like, R2 represents a C1-C8 chain hydrocarbon group or the like, R3 represents a phenyl group or the like, X1 and X2 are the same or different from each other and each represent an oxygen atom or the like, Y1 represents OR15 or the like, Z1 and Z2 are the same or different from each other and each represent an oxygen atom or the like, and R15 represents a C1-C10 chain hydrocarbon group or the like that is optionally substituted with one or more halogen atoms]; or a salt thereof.

Description

Pyridazine derivatives and compositions containing the same

[0001] This patent application claims priority under the Paris Convention to and the benefit of Japanese Patent Application No. 2024-084647 (filed May 24, 2024), the entire contents of which are incorporated herein by reference. The present invention relates to pyridazine derivatives and herbicidal compositions containing the same.

[0002] Various compounds have been investigated and put to practical use for the purpose of weed control, and it is known that certain compounds have the effect of inducing male sterility (see, for example, Patent Document 1).

[0003] U.S. Pat. No. 4,345,934

[0004] An object of the present invention is to provide a compound having excellent weed control activity.

[0005] The present inventors have conducted research to find a compound having excellent weed control activity, and as a result have found that a compound represented by the following formula (I) has excellent weed control activity. That is, the present invention is as follows: [1] Formula (I) [In the formula, R 1 is the group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 1 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 2 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR16 , S(O) m R 17 , or NR 18 R 19 represents R 2 is the group G 3 a C1-C8 chain hydrocarbon group optionally substituted with one or more substituents selected from the group G 4 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , C (= Z 1 ) R 11 , C (= Z 1 ) OR 12 , C (= Z 1 ) NR 11 R 12 , S(O) p R 13 , or NR 11 R 14 represents R 3 is the group G 5 a phenyl group optionally substituted with one or more substituents selected from the following: 5 a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from the group G 5 or a group represented by any one of the following formulae: (● indicates the bonding site with the nitrogen atom) G 7a , G 7b and G 7c The combination of 7a is C=O or CR 26a R 27a and G 7b is C=O or CR 26b R 27b and G 7c is C=O or CR 26c R 27c A combination where 7a is C=O or CR 26a R 27a and G 7b is C=O or CR 26b R 27b and G 7c is NR 28c, an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7a is C=O or CR 26a R 27a and G 7b is NR 28b , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7c is C=O or CR 26c R 27c A combination where 7a is NR 28a , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7b is C=O or CR 26b R 27b and G 7c is C=O or CR 26c R 27c or a combination in which 7a is NR 28a , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7b is C=O or CR 26b R 27b and G 7c is NR 28c , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2; 7d , G 7e , G 7f and G 7g The combination of 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7gis NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is NR 28f , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is NR 28e , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is NR 28e , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7f is C=O or CR 26f R 27f and G 7g is NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7eis C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, or 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7e is C=O or CR 26e R 27e and G 7f is NR 28f , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7g is C=O or CR 26g R 27g A combination where X 1 and X 2 are the same or different and represent an oxygen atom or a sulfur atom; Y 1 is OR 15 or SR 15 represents Z 1 and Z 2 are the same or different and represent an oxygen atom or a sulfur atom; m, p, and q each independently represent 0, 1, or 2; R 10 , R 13 and R 23 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a group G 6 R represents a phenyl group which may be substituted with one or more substituents selected from the group consisting of 11 and R 21 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a group G 6 R represents a phenyl group which may be substituted with one or more substituents selected from the group consisting of: 12 , R 16 , R 19 , R 20 and R 22are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 14 , R 17 , R 18 and R 24 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, R 15 represents a C1-C10 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a group G 6 R represents a benzyl group optionally substituted with one or more substituents selected from the group consisting of 25 is the group G 56 R represents a C1-C6 alkyl group optionally substituted with one or more substituents selected from 26a , R 26b , R 26c , R 26d , R 26e , R 26f , R 26g , R 27a , R 27b , R 27c , R 27d , R 27e , R 27f , and R 27g are the same or different and represent a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 28a , R 28b , R 28c , R 28d , R 28e , R 28f , and R 28g are the same or different and represent a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a (C1-C3 alkyl)carbonyl group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 29a , R 29b , R 29c , R 29d , R 29e, and R 29f are the same or different and represent a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 57 is the group G 571 a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a C1-C6 alkyl group, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 58 is the group G 571 Group G represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. 1 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 2 Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 3 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 4Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 5 :Group G 54 a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group G 52 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of OR 20 Group, OR 25 Group, C (=Z 2 ) R 21 , C (= Z 2 ) OR 22 , C (= Z 2 ) NR 21 R 22 , C(R 57 ) = N-OR 58 , S(O) q R 23 , N.R. 20 R 24 , group G 52 a phenyl group optionally substituted with one or more substituents selected from the group G 52 a 3- to 10-membered heterocyclic group optionally substituted with one or more substituents selected from the group consisting of a nitro group, a halogen atom, SF ５ Group G consisting of a cyano group and a phenyl group. 6 Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a mercapto group. 52: a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms Group G consists of a methyl group, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group. 54: a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms, a Group G consists of a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, and a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group. 56 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, C(R 561 ) = N-OR 562 , a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, and an SF5 group.561 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, an aromatic heterocyclic group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 562 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. 571 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, a 5- or 6-membered heterocyclic group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C [1] A compound represented by the formula (I) or a salt thereof, wherein R is a C1-C6 alkylamino)carbonyl group, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group. 3 But the group G 5 a phenyl group optionally substituted with one or more substituents selected from the group G 5 a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from the group G 5 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, OR 20Group, C (=Z 2 ) R 21 , C (= Z 2 ) OR 22 , C (= Z 2 ) NR 21 R 22 , S(O) q R 23 , N.R. 20 R 24 [3] The compound or salt thereof according to [1], wherein X is a group consisting of a nitro group, a halogen atom, and a cyano group. 1 and X 2 [4] The compound or salt thereof according to [1] or [2], wherein Y is an oxygen atom. 1 is OR 15 [5] The compound or salt thereof according to any one of [1] to [3], wherein R is a group. 2 But the group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group G 4 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , or S(O) p R 13 and R 10 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, and R 13 [6] The compound or salt thereof according to any one of [1] to [4], wherein R is a C1-C3 alkyl group optionally substituted with one or more halogen atoms. 2 [7] The compound or salt thereof according to [5], wherein R is a C1-C3 alkyl group optionally substituted with one or more halogen atoms. 1 But the group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, R 19 is a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom; 11 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; 21 [8] R is a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group. 1 But the group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11an ethyl group substituted with one or more substituents selected from the group G 11 an n-propyl group substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 The compound or salt thereof according to [7], wherein the heterocyclic group is a 3- to 6-membered saturated heterocyclic group optionally substituted with one or more substituents selected from the following (the heteroatom constituting the 3- to 6-membered saturated heterocyclic group is an oxygen atom): 11 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; 21 [9] R is a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group. 1

[10] The compound or salt thereof according to [8], wherein R is an isopropyl group or a sec-butyl group. 3 But the group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5

[11] The compound or salt thereof according to any one of [1] to [9], wherein R is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following: 3 But the group G 5 a phenyl group substituted with 1 to 3 substituents selected from the group G 5

[12] The compound or salt thereof according to any one of [1] to [9], wherein R is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following: 3 But the group G5

[13] The compound or salt thereof according to any one of [1] to [9], wherein R is a phenyl group optionally substituted with 1 to 3 substituents selected from the following: 3 But the group G 5

[14] The compound or salt thereof according to any one of [1] to [9], wherein R is a phenyl group substituted with 1 to 3 substituents selected from the following: 3 But the group G 5

[15] The compound or salt thereof according to

[13] , wherein R is a phenyl group substituted with 1 to 2 substituents selected from the following: 3 is a phenyl group substituted with 1 to 2 substituents selected from the group consisting of a cyano group, a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof. 3 But the group G 5

[17] The compound or salt thereof according to any one of [1] to [9], wherein R is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 2 substituents selected from the following: 3 is a 5-membered aromatic heterocyclic group optionally substituted with 1 to 2 substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof. 3 is a 6-membered aromatic heterocyclic group optionally substituted with one substituent selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof. 3 is a group represented by any one of the following formulas, or a salt thereof, according to any one of [1] or [3] to [9].

[20] R 3 is a group represented by any one of the following formulas:

[21] R 3 is a group represented by the following formula:

[22] R 3is a group represented by the following formula:

[23] R 3 But the group G ５

[24] The compound or salt thereof according to any one of [1] or [3] to [9], wherein R is an aromatic fused heterocyclic group optionally substituted with one or more substituents selected from the following: 3 is an 8- to 10-membered aromatic fused heterocyclic group optionally substituted by 1 to 2 substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group.

[25] A herbicidal composition comprising the compound or salt thereof according to any one of [1] to

[24] and an inert carrier.

[26] A method for controlling weeds, comprising applying the compound or salt thereof according to any one of [1] to

[24] to weeds or soil in which weeds grow.

[27] Use of the compound or salt thereof according to any one of [1] to

[24] for controlling weeds.

[28] A composition comprising one or more components selected from the group consisting of Group (d) and Group (f), and the compound or salt thereof according to any one of [1] to

[24] : Group (d): a phytotoxicity-safeting component; Group (f): a herbicidal active component.

[0006] The present invention makes it possible to control weeds.

[0007] The substituents of the present invention will be explained. A halogen atom refers to a fluorine atom, chlorine atom, bromine atom, or iodine atom. When a substituent is substituted with two or more halogen atoms or substituents, these halogen atoms or substituents may be the same or different. In this specification, the expression "optionally substituted with one or more substituents selected from group X" means that when two or more substituents selected from group X are present, these substituents may be the same or different. In this specification, the expression "CX-CY" means that the number of carbon atoms is X to Y. For example, the expression "C1-C8" means that the number of carbon atoms is 1 to 8. The chain hydrocarbon group represents an alkyl group, an alkenyl group, or an alkynyl group. Examples of alkyl groups include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1-ethylpropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, a hexyl group, and an octyl group. Examples of alkenyl groups include vinyl, 1-propenyl, 2-propenyl, 1-methyl-1-propenyl, 1-methyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1-ethyl-2-propenyl, 3-butenyl, 4-pentenyl, 5-hexenyl, and 7-octenyl. Examples of alkynyl groups include ethynyl, 1-propynyl, 2-propynyl, 1-methyl-2-propynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 2-butynyl, 4-pentynyl, 5-hexynyl, and 7-octynyl. Examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, hexyloxy, and octyloxy groups. Examples of alkylsulfanyl groups include methylsulfanyl, ethylsulfanyl, propylsulfanyl, and isopropylsulfanyl groups. Examples of alkylsulfinyl groups include methylsulfinyl, ethylsulfinyl, propylsulfinyl, and isopropylsulfinyl groups.Examples of alkylsulfonyl groups include methylsulfonyl groups, ethylsulfonyl groups, propylsulfonyl groups, and isopropylsulfonyl groups.

[0008] Alicyclic hydrocarbon groups include, for example, cycloalkyl groups and cycloalkenyl groups. Cycloalkyl groups include, for example, cyclopropyl groups, cyclobutyl groups, cyclopentyl groups, cyclohexyl groups, and cyclooctyl groups. Cycloalkenyl groups include, for example, cyclopentenyl groups, cyclohexenyl groups, and cyclooctenyl groups.

[0009] Examples of the 5- to 6-membered aromatic heterocyclic group include a pyrrolyl group, a furyl group, a thienyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, and a tetrazinyl group. Examples of the 3- to 8-membered non-aromatic heterocyclic group (wherein the heteroatom constituting the 3- to 8-membered non-aromatic heterocyclic group is an oxygen atom or a sulfur atom) include an oxiranyl group, a thiiranyl group, an oxetanyl group, a thietanyl group, a dihydrofuranyl group, a tetrahydrofuranyl group, a tetrahydrothienyl group, a pyranyl group, a dihydropyranyl group, a tetrahydropyranyl group, a tetrahydrothiopyranyl group, an oxepanyl group, a thiepanyl group, an oxocanyl group, a thiocanyl group, a dioxolyl group, a dioxolanyl group, and a dioxanyl group. Examples of the aromatic fused heterocyclic group include an 8- to 10-membered aromatic fused heterocyclic group. Examples of the aromatic fused heterocycle include an indolyl group, an isoindolyl group, an indolinyl group, an indolizinyl group, a benzimidazolyl group, a quinolyl group, an isoquinolyl group, an indazolyl group, a benzotriazolyl group, an imidazopyridyl group, a pyrazolopyridyl group, a benzoxazolyl group, a benzoxadiazolyl group, a benzothiazolyl group, a benzothiadiazolyl group, an imidazothiadiazolyl group, a benzofuryl group, and a benzothienyl group.Examples of the 3- to 10-membered heterocyclic group include a pyrrolyl group, a furyl group, a thienyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, a tetrazinyl group, a quinolyl group, an aziridinyl group, an oxiranyl group, a thiiranyl group, an azetidinyl group, an oxetanyl group, a thietanyl group, a pyrrolidinyl group, a tetrahydrofuranyl group, a tetrahydrothiazolyl ... tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl group, a tetrahydrothiazolyl enyl group, pyrazolinyl group, pyrazolidinyl group, imidazolinyl group, imidazolidinyl group, oxazolinyl group, thiazolinyl group, oxazolidinyl group, thiazolidinyl group, isoxazolinyl group, isoxazolidinyl group, isothiazolinyl group, isothiazolidinyl group, dioxolanyl group, dioxanyl group, piperidyl group, piperazinyl group, morpholinyl group, thiomorpholinyl group, pyranyl group, dihydropyranyl group, tetrahydropyranyl group, tetrahydrothiopyranyl group, azepanyl group, oxepanyl group, and thiepanyl group.

[0010] The compound of the present invention may exist in one or more stereoisomers. Examples of stereoisomers include enantiomers, diastereomers, atropisomers, and geometric isomers. The compound of the present invention includes each stereoisomer and a mixture of stereoisomers in any ratio.

[0011] The compound of the present invention may form a base addition salt such as an isopropylamine salt, a dimethylamine salt, a sodium salt, or a potassium salt when mixed with a base such as isopropylamine, dimethylamine, sodium carbonate, or potassium carbonate. The compound of the present invention may form an acid addition salt such as a hydrochloride, a sulfate, a nitrate, a phosphate, an acetate, or a benzoate when mixed with an acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, or benzoic acid. The compound of the present invention may exist as a zwitterion. Furthermore, the compound of the present invention may form an N-oxide structure in which at least one nitrogen atom contained in the compound represented by formula (I) is substituted with an oxo group.

[0012] The following compounds are examples of the compound N of the present invention: [Aspect 1] In the compound of the present invention, X 1 is an oxygen atom. [Embodiment 2] In the compound of the present invention, X 1 is an oxygen atom, and R 15 is a hydrogen atom. [Embodiment 3] In the compound of the present invention, X 1 is an oxygen atom, and R 15 is a C1-C10 chain hydrocarbon group. [Embodiment 4] In the compound of the present invention, X 1 is an oxygen atom, and R 15 is a C3-C6 alicyclic hydrocarbon group. 1 is an oxygen atom, and R 15 is group G 6 A compound of the present invention, wherein X is a benzyl group optionally substituted with one or more substituents selected from the group consisting of: 1 is an oxygen atom, and R 15 [Embodiment 7] In the compound of the present invention, X is a benzyl group. 2 is an oxygen atom. [Embodiment 8] In the compound of the present invention, Y 1 is OR 15 [Embodiment 9] In the compound of the present invention, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Embodiment 11] In the compound of the present invention, R 2 is group G 3 a C1-C4 chain hydrocarbon group optionally substituted with one or more substituents selected from group G 4 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , C (= Z 1 ) R11 , C (= Z 1 ) OR 12 , C (= Z 1 ) NR 11 R 12 Group, S(O) p R 13 , or NR 10 R 14 [Embodiment 12] In the compound of the present invention, R 2 is group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group G 4 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , or S(O) p R 13 [Embodiment 13] In the compound of the present invention, R 2 is group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group consisting of OR 10 , or S(O) p R 13 and R 10 and R 13 are the same or different and are C1-C3 alkyl groups optionally substituted with one or more halogen atoms. 2 is group G 3 A compound of the present invention, wherein R is a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group consisting of: 2 is an isopropyl group, an ethyl group, or a methyl group. 2 is an isopropyl group. [Embodiment 17] In the compound of the present invention, R 2 is an ethyl group. [Embodiment 18] In the compound of the present invention, R 2 is a methyl group. [Embodiment 19] In the compound of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G1 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 2 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 20] In the compound of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 21] In the compound of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a butyl group optionally substituted with one or more substituents selected from the group G 1 an ethyl group substituted with one or more substituents selected from the group G 1an n-propyl group substituted with one or more substituents selected from the group G 2 A compound of the present invention, wherein R is a C3-C6 cycloalkyl optionally substituted with one or more substituents selected from the following: 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a butyl group optionally substituted with one or more substituents selected from the group G 1 an ethyl group substituted with one or more substituents selected from the group G 1 [Embodiment 23] A compound of the present invention, wherein R is an n-propyl group or a C3-C6 cycloalkyl group substituted with one or more substituents selected from the following: 1 is group G 1 an isopropyl group optionally substituted with one substituent selected from the group G 1 a butyl group optionally substituted with one substituent selected from the group G 1 an ethyl group substituted with one substituent selected from the group G 1 [Embodiment 24] A compound of the present invention, wherein R is an n-propyl group or a C3-C6 cycloalkyl group substituted with one substituent selected from the group consisting of: 1 is group G 1 an isopropyl group optionally substituted with one substituent selected from the group G 1 A compound of the present invention, wherein R is a butyl group optionally substituted with one substituent selected from the group consisting of C5-C6 cycloalkyl groups. 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 11 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 21 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 26] In the compound of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 11 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 27] In the compound of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 28] In the compound of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11 an ethyl group substituted with one or more substituents selected from the group G 11 an n-propyl group substituted with one or more substituents selected from the group G 21 [Embodiment 29] A compound of the present invention, wherein R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11 an ethyl group substituted with one or more substituents selected from the group G 11 [Embodiment 30] A compound of the present invention, wherein R 1 is group G 11 an isopropyl group optionally substituted with one substituent selected from the group G 11 a butyl group optionally substituted with one substituent selected from the group G 11 an ethyl group substituted with one substituent selected from the group G 11 [Embodiment 31] A compound of the present invention, wherein R is an n-propyl group or a C3-C6 cycloalkyl group substituted with one substituent selected from the group consisting of: 1 is group G 11an isopropyl group optionally substituted with one substituent selected from the group G 11 A compound of the present invention, wherein R is a butyl group optionally substituted with one substituent selected from the group consisting of C5-C6 cycloalkyl groups. 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 21 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 Compounds in Group G 12 A group consisting of a cyano group, a methoxy group, a methylthio group, a methylsulfinyl group, and a methylsulfonyl group. [Embodiment 33] In the compound of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 34] In the compound of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Embodiment 35] In the compound of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a butyl group optionally substituted with one or more substituents selected from the group G 12 an ethyl group substituted with one or more substituents selected from the group G 12 an n-propyl group substituted with one or more substituents selected from the group G 2 A compound of the present invention, wherein R is a C3-C6 cycloalkyl optionally substituted with one or more substituents selected from the following: 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12a butyl group optionally substituted with one or more substituents selected from the group G 12 an ethyl group substituted with one or more substituents selected from the group G 12 [Embodiment 37] A compound of the present invention, wherein R is an n-propyl group or a C3-C6 cycloalkyl group substituted with one or more substituents selected from the following: 1 is group G 12 an isopropyl group optionally substituted with one substituent selected from the group G 12 a butyl group optionally substituted with one substituent selected from the group G 12 an ethyl group substituted with one substituent selected from the group G 12 [Embodiment 38] A compound of the present invention, wherein R is an n-propyl group or a C3-C6 cycloalkyl group substituted with one substituent selected from the group consisting of: 1 is group G 12 an isopropyl group optionally substituted with one substituent selected from the group G 12 A compound of the present invention, wherein R is a butyl group optionally substituted with one substituent selected from the group consisting of C5-C6 cycloalkyl groups. 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 1 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 2a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 11 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is a group to which R is bonded at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. 1is an isopropyl group, a tert-butyl group, or a sec-butyl group. 1 is an isopropyl group or a tert-butyl group. 1 is an isopropyl group. [Embodiment 50] In the compound of the present invention, R 1 is a tert-butyl group. [Embodiment 51] In the compound of the present invention, R 1 is a cyclopentyl group. [Embodiment 52] In the compound of the present invention, R 1 is a cyclohexyl group. [Embodiment 53] In the compound of the present invention, R 1 is OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. 1 is OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group or a C3-C6 cycloalkyl group, and R 19 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a hydrogen atom. 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5A compound of the present invention, wherein R is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following: 3 is group G 51 Group G: Compounds each of which is a phenyl group optionally substituted with one or two substituents selected from the following: 51 A group consisting of a halogen atom, a methyl group, a trifluoromethyl group, a methoxy group, a trifluoromethoxy group, and a difluoromethoxy group. 3 is a phenyl group optionally substituted with one or more halogen atoms. 3 is a phenyl group optionally substituted with one or two halogen atoms. 3 is group G 51 A compound of the present invention, wherein R is a 6-membered aromatic heterocyclic group optionally substituted with 1 to 2 substituents selected from the group consisting of: 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. 3 is group G 82 Group G: Compounds each of which is a phenyl group optionally substituted with one or two substituents selected from the following: 82 : a group consisting of a halogen atom, a methyl group, a difluoromethyl group, a trifluoromethyl group, an ethyl group, a cyclopropyl group, a methoxy group, a trifluoromethoxy group, and a difluoromethoxy group. 3 is group G 82 A compound of the present invention, wherein R is a phenyl group optionally substituted with one of the following substituents: 3 is a phenyl group optionally substituted with a difluoromethyl group. 3 is a phenyl group optionally substituted with a trifluoromethyl group. 3 is a phenyl group optionally substituted with a cyclopropyl group. 3is a phenyl group optionally substituted with one trifluoromethoxy group. 3 is a pyridyl group optionally substituted with a difluoromethoxy group. 3 is a pyridyl group optionally substituted with a difluoromethyl group of 1. [Embodiment 69] In the compound of the present invention, R 3 is a pyridyl group optionally substituted with a trifluoromethyl group of 1. [Embodiment 70] In the compound of the present invention, R 3 is a pyridyl group optionally substituted with a cyclopropyl group. 3 is a pyridyl group optionally substituted with a trifluoromethoxy group. 3 is a pyridyl group optionally substituted with a difluoromethoxy group. 3 is group G 82 [Embodiment 74] In the compound of the present invention, R 3 is group G 82 A compound of the present invention, wherein R is a 6-membered aromatic heterocyclic group optionally substituted with one substituent selected from the group consisting of: 3 is group G 82 [Embodiment 76] In the compound of the present invention, R 3 is group G 82 [Embodiment 77] In the compound of the present invention, R 3 is group G 82 [Embodiment 78] A compound of the present invention, wherein R is a pyrazolyl group optionally substituted with one or two substituents selected from the following: 3 is group G 82 [Embodiment 79] In the compound of the present invention, R is a triazolyl group optionally substituted with one or two substituents selected from the following: 3is a 5-membered aromatic heterocyclic group optionally substituted with one halogen atom. 3 is a group represented by any of the following formulas: [Embodiment 81] In the compound of the present invention, R 3 is a group represented by any of the following formulas: [Embodiment 82] In the compound of the present invention, R 3 is a group represented by any of the following formulas: [Embodiment 83] In the compound of the present invention, R 3 is a group represented by the following formula: [Embodiment 84] In the compound of the present invention, R 3 is group G 5 [Embodiment 85] A compound of the present invention, wherein R is an aromatic fused heterocyclic group optionally substituted with one or two substituents selected from the following: 3 is group G 5 A compound of the present invention, wherein R is an aromatic fused heterocyclic group optionally substituted with one substituent selected from the group consisting of: 3 is group G 82 A compound of the present invention, wherein R is an aromatic fused heterocyclic group optionally substituted with one or two substituents selected from the following: 3 is group G 82 [Embodiment 88] In the compound of the present invention, R 3 is group G 82 A compound of the present invention, wherein R is a 9-membered aromatic fused heterocyclic group optionally substituted with one or two substituents selected from the following: 3 is group G 82 A compound of the present invention, wherein R is a 10-membered aromatic fused heterocyclic group optionally substituted with one or two substituents selected from the following: 3 is a group represented by any of the following formulas: R 30a , R 30b , R 30c , R 30d , R 30e , R 30f, and R 30g are the same or different and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or an SCF3 group. 3 is a group represented by any of the following formulas: [Embodiment 92] In the compound of the present invention, R 3 is a group represented by any of the following formulas: R 30d , R 30e , R 30f , and R 30g are the same or different and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or an SCF3 group. 3 is a group represented by any of the following formulas: [Embodiment 94] In the compound of the present invention, R 3 is a group represented by any of the following formulas: R 30a , R 30b , R 30c and R 30d are the same or different and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or an SCF group; R 31 represents a hydrogen atom, a methyl group, a difluoromethyl group, a trifluoromethyl group, an ethyl group, a difluoroethyl group, a cyclopropyl group, or an isopropyl group. 3 is a group represented by any of the following formulas: R 30d and R 30e are the same or different and each represents a halogen atom, a cyano group, a methyl group, a difluoromethyl group, a trifluoromethyl group, a cyclopropyl group, a difluoromethoxy group, a trifluoromethoxy group, or an SCF3 group.3 is a group represented by any of the following formulas:

[0013] [Aspect C1] In the compound of the present invention, R 2 is group G 3 a C1-C4 chain hydrocarbon group optionally substituted with one or more substituents selected from group G 4 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , C (= Z 1 ) R 11 , C (= Z 1 ) OR 12 , C (= Z 1 ) NR 11 R 12 Group, S(O) p R 13 , or NR 10 R 14 [Aspect C2] In the compound of the present invention, R 2 is group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group G 4 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , or S(O) p R 13 [Aspect C3] In the compound of the present invention, R 2 is group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group consisting of OR 10 , or S(O) p R 13 and R 10 and R 13 are the same or different and are C1-C3 alkyl groups optionally substituted with one or more halogen atoms. [Aspect C4] In the compound of the present invention, R 2 is group G 3 [Aspect C5] In the compound of the present invention, R 2is an isopropyl group, an ethyl group, or a methyl group. [Aspect C6] In the compound of the present invention, R 2 is an isopropyl group. [Aspect C7] In the compound of the present invention, R 2 is an ethyl group. [Aspect C8] In the compound of the present invention, R 2 is a methyl group. [Aspect C9] In the compound of the present invention, R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C10] In the compound of the present invention, R 3 is group G 51 [Aspect C11] In the compound of the present invention, R 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C12] In the compound of the present invention, R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C13] In the compound of the present invention, R 3 is group G 51 [Aspect C14] In the compound of the present invention, R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C15] A compound according to Aspect C1, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C16] A compound in Aspect C1, wherein R 3 is group G 51 [Aspect C17] A compound in Aspect C1, wherein R 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C18] A compound according to Aspect C1, wherein R 3is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C19] A compound according to Aspect C1, wherein R 3 is group G 51 [Aspect C20] A compound in Aspect C1, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C21] A compound according to Aspect C2, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C22] In Aspect C2, R 3 is group G 51 [Aspect C23] A compound in Aspect C2, wherein R 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C24] A compound according to Aspect C2, wherein R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C25] A compound according to Aspect C2, wherein R 3 is group G 51 [Aspect C26] A compound in Aspect C2, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C27] A compound according to Aspect C3, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C28] A compound in Aspect C3, wherein R 3 is group G 51 [Aspect C29] A compound in Aspect C3, wherein R is a phenyl group optionally substituted with one or two substituents selected from the following: 3is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C30] A compound according to Aspect C3, wherein R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C31] A compound according to Aspect C3, wherein R 3 is group G 51 [Aspect C32] A compound in Aspect C3, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C33] A compound according to Aspect C4, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C34] In Aspect C4, R 3 is group G 51 [Aspect C35] A compound in Aspect C4, wherein R is a phenyl group optionally substituted with one or two substituents selected from the following: 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C36] A compound according to Aspect C4, wherein R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C37] A compound according to Aspect C4, wherein R 3 is group G 51 [Aspect C38] A compound in Aspect C4, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C39] A compound according to Aspect C5, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C40] In Aspect C5, R 3 is group G 51[Aspect C41] A compound in Aspect C5, wherein R is a phenyl group optionally substituted with one or two substituents selected from the following: 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C42] In Aspect C5, R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C43] In Aspect C5, R 3 is group G 51 [Aspect C44] A compound in Aspect C5, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C45] A compound according to Aspect C6, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 A compound in which R is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following. 3 is group G 51 [Aspect C47] A compound in Aspect C6, wherein R is a phenyl group optionally substituted with one or two substituents selected from the following: 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C48] A compound according to Aspect C6, wherein R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C49] A compound according to Aspect C6, wherein R 3 is group G 51 [Aspect C50] A compound in Aspect C6, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C51] A compound according to Aspect C7, wherein R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C52] In Aspect C7, R3 is group G 51 [Aspect C53] In Aspect C7, R 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C54] In Aspect C7, R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C55] In Aspect C7, R 3 is group G 51 [Aspect C56] A compound in Aspect C7, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C57] In Aspect C8, R 3 is group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 [Aspect C58] In Aspect C8, R 3 is group G 51 [Aspect C59] A compound in Aspect C8, wherein R is a phenyl group optionally substituted with one or two substituents selected from the following: 3 is a phenyl group optionally substituted with one or more halogen atoms. [Aspect C60] A compound according to Aspect C8, wherein R 3 is a phenyl group optionally substituted with one or two halogen atoms. [Aspect C61] A compound according to Aspect C8, wherein R 3 is group G 51 [Aspect C62] A compound in Aspect C8, wherein R 3 is a 6-membered aromatic heterocyclic group optionally substituted with 1 or 2 halogen atoms. [Aspect C63] In the compound of the present invention, X 1 is an oxygen atom. [Aspect C64] In the compound of the present invention, X 1 and X 2 is an oxygen atom. [Aspect C65] In the compound of the present invention, X 1and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C66] A compound of the present invention, wherein X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C67] In Aspect C1, X 1 is an oxygen atom. [Aspect C68] In Aspect C1, X 1 and X 2 is an oxygen atom. [Aspect C69] In Aspect C1, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C70] In Aspect C1, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C71] In Aspect C2, X 1 is an oxygen atom. [Aspect C72] In Aspect C2, X 1 and X 2 is an oxygen atom. [Aspect C73] In Aspect C2, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C74] In Aspect C2, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C75] In Aspect C3, X 1 is an oxygen atom. [Aspect C76] In Aspect C3, X1 and X 2 is an oxygen atom. [Aspect C77] In Aspect C3, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C78] In Aspect C3, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C79] In Aspect C4, X 1 is an oxygen atom. [Aspect C80] In Aspect C4, X 1 and X 2 is an oxygen atom. [Aspect C81] A compound according to Aspect C4, wherein X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C82] In Aspect C4, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C83] In Aspect C5, X 1 is an oxygen atom. [Aspect C84] In Aspect C5, X 1 and X 2 is an oxygen atom. [Aspect C85] In Aspect C5, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C86] In Aspect C5, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C87] In Aspect C6, X 1 is an oxygen atom. [Aspect C88] In Aspect C6, X 1 and X 2 is an oxygen atom. [Aspect C89] In Aspect C6, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C90] In Aspect C6, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C91] In Aspect C7, X 1 is an oxygen atom. [Aspect C92] In Aspect C7, X 1 and X 2 is an oxygen atom. [Aspect C93] In Aspect C7, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C94] In Aspect C7, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C95] In Aspect C8, X 1 is an oxygen atom. [Aspect C96] In Aspect C8, X 1 and X 2 is an oxygen atom. [Aspect C97] In Aspect C8, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C98] In Aspect C8, X 1 and X2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C99] In Aspect C9, X 1 is an oxygen atom. [Aspect C100] In Aspect C9, X 1 and X 2 is an oxygen atom. [Aspect C101] In Aspect C9, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C102] In Aspect C9, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C103] In Aspect C10, X 1 is an oxygen atom. [Aspect C104] In Aspect C10, X 1 and X 2 is an oxygen atom. [Aspect C105] In Aspect C10, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C106] In Aspect C10, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C107] In Aspect C11, X 1 is an oxygen atom. [Aspect C108] In Aspect C11, X 1 and X 2 is an oxygen atom. [Aspect C109] In aspect C11, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C110] In Aspect C11, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C111] In aspect C12, X 1 is an oxygen atom. [Aspect C112] In Aspect C12, X 1 and X 2 is an oxygen atom. [Aspect C113] In Aspect C12, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C114] In Aspect C12, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C115] In Aspect C13, X 1 is an oxygen atom. [Aspect C116] In Aspect C13, X 1 and X 2 is an oxygen atom. [Aspect C117] In Aspect C13, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C118] In Aspect C13, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C119] In Aspect C14, X 1 is an oxygen atom. [Aspect C120] In Aspect C14, X 1 and X 2is an oxygen atom. [Aspect C121] In Aspect C14, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C122] In Aspect C14, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C123] In Aspect C15, X 1 is an oxygen atom. [Aspect C124] In Aspect C15, X 1 and X 2 is an oxygen atom. [Aspect C125] In Aspect C15, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C126] In Aspect C15, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C127] In Aspect C16, X 1 is an oxygen atom. [Aspect C128] In Aspect C16, X 1 and X 2 is an oxygen atom. [Aspect C129] In Aspect C16, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C130] In Aspect C16, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C131] In Aspect C17, X 1 is an oxygen atom. [Aspect C132] In Aspect C17, X 1 and X 2 is an oxygen atom. [Aspect C133] In Aspect C17, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C134] In Aspect C17, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C135] In Aspect C18, X 1 is an oxygen atom. [Aspect C136] In Aspect C18, X 1 and X 2 is an oxygen atom. [Aspect C137] In Aspect C18, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C138] In Aspect C18, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C139] In Aspect C19, X 1 is an oxygen atom. [Aspect C140] In Aspect C19, X 1 and X 2 is an oxygen atom. [Aspect C141] In Aspect C19, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C142] In Aspect C19, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C143] In Aspect C20, X 1 is an oxygen atom. [Aspect C144] In Aspect C20, X 1 and X 2 is an oxygen atom. [Aspect C145] A compound according to Aspect C20, wherein X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C146] In Aspect C20, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C147] In Aspect C21, X 1 is an oxygen atom. [Aspect C148] In Aspect C21, X 1 and X 2 is an oxygen atom. [Aspect C149] In Aspect C21, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C150] In Aspect C21, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C151] In Aspect C22, X 1 is an oxygen atom. [Aspect C152] In Aspect C22, X 1 and X 2is an oxygen atom. [Aspect C153] In Aspect C22, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C154] In Aspect C22, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C155] In Aspect C23, X 1 is an oxygen atom. [Aspect C156] In Aspect C23, X 1 and X 2 is an oxygen atom. [Aspect C157] In Aspect C23, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C158] In Aspect C23, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C159] In Aspect C24, X 1 is an oxygen atom. [Aspect C160] In Aspect C24, X 1 and X 2 is an oxygen atom. [Aspect C161] A compound according to Aspect C24, wherein X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C162] In Aspect C24, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C163] In Aspect C25, X 1 is an oxygen atom. [Aspect C164] In Aspect C25, X 1 and X 2 is an oxygen atom. [Aspect C165] In Aspect C25, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C166] In Aspect C25, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C167] In Aspect C26, X 1 is an oxygen atom. [Aspect C168] In Aspect C26, X 1 and X 2 is an oxygen atom. [Aspect C169] In Aspect C26, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C170] In Aspect C26, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C171] In Aspect C27, X 1 is an oxygen atom. [Aspect C172] In Aspect C27, X 1 and X 2 is an oxygen atom. [Aspect C173] In Aspect C27, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C174] In Aspect C27, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C175] In Aspect C28, X 1 is an oxygen atom. [Aspect C176] In Aspect C28, X 1 and X 2 is an oxygen atom. [Aspect C177] In Aspect C28, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C178] In Aspect C28, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C179] In Aspect C29, X 1 is an oxygen atom. [Aspect C180] In Aspect C29, X 1 and X 2 is an oxygen atom. [Aspect C181] In Aspect C29, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C182] In Aspect C29, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C183] In Aspect C30, X 1 is an oxygen atom. [Aspect C184] In Aspect C30, X 1 and X 2is an oxygen atom. [Aspect C185] In Aspect C30, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C186] In Aspect C30, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C187] In Aspect C31, X 1 is an oxygen atom. [Aspect C188] In Aspect C31, X 1 and X 2 is an oxygen atom. [Aspect C189] In Aspect C31, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C190] In Aspect C31, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C191] In Aspect C32, X 1 is an oxygen atom. [Aspect C192] In Aspect C32, X 1 and X 2 is an oxygen atom. [Aspect C193] In Aspect C32, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C194] In Aspect C32, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C195] In Aspect C33, X 1 is an oxygen atom. [Aspect C196] In Aspect C33, X 1 and X 2 is an oxygen atom. [Aspect C197] In Aspect C33, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C198] In Aspect C33, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C199] In Aspect C34, X 1 is an oxygen atom. [Aspect C200] In Aspect C34, X 1 and X 2 is an oxygen atom. [Aspect C201] In Aspect C34, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C202] In Aspect C34, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C203] In Aspect C35, X 1 is an oxygen atom. [Aspect C204] In Aspect C35, X 1 and X 2 is an oxygen atom. [Aspect C205] In Aspect C35, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C206] In Aspect C35, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C207] In Aspect C36, X 1 is an oxygen atom. [Aspect C208] In Aspect C36, X 1 and X 2 is an oxygen atom. [Aspect C209] In Aspect C36, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C210] In Aspect C36, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C211] In Aspect C37, X 1 is an oxygen atom. [Aspect C212] In Aspect C37, X 1 and X 2 is an oxygen atom. [Aspect C213] In Aspect C37, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C214] In Aspect C37, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C215] In Aspect C38, X 1 is an oxygen atom. [Aspect C216] In Aspect C38, X 1 and X 2is an oxygen atom. [Aspect C217] In Aspect C38, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C218] In Aspect C38, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C219] In Aspect C39, X 1 is an oxygen atom. [Aspect C220] In Aspect C39, X 1 and X 2 is an oxygen atom. [Aspect C221] In Aspect C39, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C222] In Aspect C39, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C223] In Aspect C40, X 1 is an oxygen atom. [Aspect C224] In Aspect C40, X 1 and X 2 is an oxygen atom. [Aspect C225] In Aspect C40, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C226] In Aspect C40, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C227] In Aspect C41, X 1 is an oxygen atom. [Aspect C228] In Aspect C41, X 1 and X 2 is an oxygen atom. [Aspect C229] In Aspect C41, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C230] In Aspect C41, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C231] In Aspect C42, X 1 is an oxygen atom. [Aspect C232] In Aspect C42, X 1 and X 2 is an oxygen atom. [Aspect C233] In Aspect C42, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C234] In Aspect C42, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C235] In Aspect C43, X 1 is an oxygen atom. [Aspect C236] In Aspect C43, X 1 and X 2 is an oxygen atom. [Aspect C237] In Aspect C43, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C238] In Aspect C43, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C239] In Aspect C44, X 1 is an oxygen atom. [Aspect C240] In Aspect C44, X 1 and X 2 is an oxygen atom. [Aspect C241] In Aspect C44, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C242] In Aspect C44, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C243] In Aspect C45, X 1 is an oxygen atom. [Aspect C244] In Aspect C45, X 1 and X 2 is an oxygen atom. [Aspect C245] In Aspect C45, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C246] In Aspect C45, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C247] In Aspect C46, ​​X 1 is an oxygen atom. [Aspect C248] In Aspect C46, ​​X 1 and X 2is an oxygen atom. [Aspect C249] In Aspect C46, ​​X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C250] In Aspect C46, ​​X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C251] In Aspect C47, X 1 is an oxygen atom. [Aspect C252] In Aspect C47, X 1 and X 2 is an oxygen atom. [Aspect C253] In Aspect C47, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C254] In Aspect C47, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C255] In Aspect C48, X 1 is an oxygen atom. [Aspect C256] In Aspect C48, X 1 and X 2 is an oxygen atom. [Aspect C257] In Aspect C48, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C258] In Aspect C48, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C259] In Aspect C49, X 1 is an oxygen atom. [Aspect C260] In Aspect C49, X 1 and X 2 is an oxygen atom. [Aspect C261] In Aspect C49, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C262] In Aspect C49, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C263] In Aspect C50, X 1 is an oxygen atom. [Aspect C264] In Aspect C50, X 1 and X 2 is an oxygen atom. [Aspect C265] In Aspect C50, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C266] In Aspect C50, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C267] In Aspect C51, X 1 is an oxygen atom. [Aspect C268] In Aspect C51, X 1 and X 2 is an oxygen atom. [Aspect C269] In Aspect C51, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C270] In Aspect C51, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C271] In Aspect C52, X 1 is an oxygen atom. [Aspect C272] In Aspect C52, X 1 and X 2 is an oxygen atom. [Aspect C273] In Aspect C52, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C274] In Aspect C52, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C275] In Aspect C53, X 1 is an oxygen atom. [Aspect C276] In Aspect C53, X 1 and X 2 is an oxygen atom. [Aspect C277] In Aspect C53, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C278] In Aspect C53, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C279] In Aspect C54, X 1 is an oxygen atom. [Aspect C280] In Aspect C54, X 1 and X 2is an oxygen atom. [Aspect C281] In Aspect C54, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C282] In Aspect C54, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C283] In Aspect C55, X 1 is an oxygen atom. [Aspect C284] In Aspect C55, X 1 and X 2 is an oxygen atom. [Aspect C285] In Aspect C55, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C286] In Aspect C55, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C287] In Aspect C56, X 1 is an oxygen atom. [Aspect C288] In Aspect C56, X 1 and X 2 is an oxygen atom. [Aspect C289] In Aspect C56, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C290] In Aspect C56, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a hydrogen atom. [Aspect C291] In Aspect C57, X 1 is an oxygen atom. [Aspect C292] In Aspect C57, X 1 and X 2 is an oxygen atom. [Aspect C293] In Aspect C57, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C294] In Aspect C57, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C295] In Aspect C58, X 1 is an oxygen atom. [Aspect C296] In Aspect C58, X 1 and X 2 is an oxygen atom. [Aspect C297] In Aspect C58, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C298] In Aspect C58, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C299] In Aspect C59, X 1 is an oxygen atom. [Aspect C300] A compound according to Aspect C59, wherein X 1 and X 2 is an oxygen atom. [Aspect C301] In Aspect C59, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C302] In Aspect C59, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C303] In Aspect C60, X 1 is an oxygen atom. [Aspect C304] In Aspect C60, X 1 and X 2 is an oxygen atom. [Aspect C305] A compound according to Aspect C60, wherein X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C306] In Aspect C60, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C307] In Aspect C61, X 1 is an oxygen atom. [Aspect C308] In Aspect C61, X 1 and X 2 is an oxygen atom. [Aspect C309] In Aspect C61, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C310] In Aspect C61, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C311] In Aspect C62, X 1 is an oxygen atom. [Aspect C312] In Aspect C62, X 1 and X 2is an oxygen atom. [Aspect C313] In Aspect C62, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a C1-C10 chain hydrocarbon group, a benzyl group, or a hydrogen atom. [Aspect C314] In Aspect C62, X 1 and X 2 is an oxygen atom, and Y 1 is OR 15 and R 15 is a hydrogen atom. [Aspect C315] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 1 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 2 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C316] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C317] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a butyl group optionally substituted with one or more substituents selected from the group G 1 an ethyl group substituted with one or more substituents selected from the group G 1 an n-propyl group substituted with one or more substituents selected from the group G 2 [Aspect C318] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a butyl group optionally substituted with one or more substituents selected from the group G 1 an ethyl group substituted with one or more substituents selected from the group G 1 [Aspect C319] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one substituent selected from the group G 1 a butyl group optionally substituted with one substituent selected from the group G 1 an ethyl group substituted with one substituent selected from the group G 1[Aspect C320] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 1 an isopropyl group optionally substituted with one substituent selected from the group G 1 [Aspect C321] A compound in which R is a butyl group or a C5-C6 cycloalkyl group optionally substituted with one substituent selected from the group consisting of: 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 11 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 21 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C322] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 11 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C323] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C324] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11 an ethyl group substituted with one or more substituents selected from the group G 11 an n-propyl group substituted with one or more substituents selected from the group G 21[Aspect C325] A compound of any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11 an ethyl group substituted with one or more substituents selected from the group G 11 [Aspect C326] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one substituent selected from the group G 11 a butyl group optionally substituted with one substituent selected from the group G 11 an ethyl group substituted with one substituent selected from the group G 11 [Aspect C327] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one substituent selected from the group G 11 [Aspect C328] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 21 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C329] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C330] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 [Aspect C331] In the compounds of Aspects C1 to C314 or the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a butyl group optionally substituted with one or more substituents selected from the group G 12 an ethyl group substituted with one or more substituents selected from the group G 12 an n-propyl group substituted with one or more substituents selected from the group G 2 [Aspect C332] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a butyl group optionally substituted with one or more substituents selected from the group G 12 an ethyl group substituted with one or more substituents selected from the group G 12 [Aspect C333] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one substituent selected from the group G 12 a butyl group optionally substituted with one substituent selected from the group G 12 an ethyl group substituted with one substituent selected from the group G 12[Aspect C334] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one substituent selected from the group G 12 [Aspect C335] A compound in which R is a butyl group or a C5-C6 cycloalkyl group optionally substituted with one substituent selected from the group consisting of: 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C336] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 1 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 2 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C337] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C338] In any of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 11a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 11 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 21 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C339] In any of Aspects C1 to C314 or the compounds of the present invention, R 1 is group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C340] In Aspects C1 to C314 or the compound of the present invention, R 1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 12 a C2-C6 alkenyl group optionally substituted with one or more substituents selected from group G 12 a C2-C6 alkynyl group optionally substituted by one or more substituents selected from group G 21 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C341] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R1 is group G 12 an isopropyl group optionally substituted with one or more substituents selected from the group G 12 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2 a 3- to 6-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the heteroatom(s) constituting the 3- to 6-membered non-aromatic heterocyclic group being an oxygen atom or a sulfur atom; 12 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C342] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is an isopropyl group, a tert-butyl group, or a sec-butyl group. [Aspect C343] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is an isopropyl group or a tert-butyl group. [Aspect C344] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1 is an isopropyl group. [Aspect C345] In the compounds of Aspects C1 to C314 or the present invention, R 1 is a tert-butyl group. [Aspect C346] A compound according to any one of Aspects C1 to C314 or the compound of the present invention, wherein R 1 is a cyclopentyl group. [Aspect C347] In the compounds of Aspects C1 to C314 or the compounds of the present invention, R 1is a cyclohexyl group. [Embodiment C348] In Embodiments C1 to C314 or the compound of the present invention, R 1 is OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, and R 19 is a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom. [Aspect C349] In any of Aspects C1 to C314 or the compound of the present invention, R 1 is OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group or a C3-C6 cycloalkyl group, and R 19 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a hydrogen atom. 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C352] In Aspect C316, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C353] In Aspect C317, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C354] In Aspect C318, R 1is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C355] In Aspect C319, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C356] In Aspect C320, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C357] In Aspect C321, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C358] In Aspect C322, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C359] In Aspect C323, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C360] In Aspect C324, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C361] In Aspect C325, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C362] In Aspect C326, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C363] In Aspect C327, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C364] In Aspect C328, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C365] In Aspect C329, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C366] In Aspect C330, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C367] In Aspect C331, R 1is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C368] In Aspect C332, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C369] In Aspect C333, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C370] In Aspect C334, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C371] In Aspect C335, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C372] In Aspect C336, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C373] In Aspect C337, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C374] In Aspect C338, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C375] In Aspect C339, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C376] In Aspect C340, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C377] In Aspect C341, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C378] In Aspect C348, R 1 is a group to which R is attached at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom. [Aspect C379] In Aspect C349, R 1 is bonded at a carbon atom, and the carbon atom is a di- or tri-substituted carbon atom.

[0014] Next, the method for producing the compound of the present invention will be described.

[0015] Production Method A The compound represented by formula (I-1) (hereinafter referred to as compound (I-1)) can be produced by reacting a compound represented by formula (A1) (hereinafter referred to as compound (A1)) with a compound represented by formula (M1) (hereinafter referred to as compound (M1)) in the presence of a catalyst and a base. [During the ceremony, W 1 represents a chlorine atom, a bromine atom, or an iodine atom; M 1 is an alkoxyboranyl group such as B(OH)2, 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, or a trifluoroborate salt (BF3 - K + ) and R 1a is the group G 1 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 2 a C3-C8 cycloalkenyl group optionally substituted with one or more substituents selected from group G 2 a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of an oxygen atom or a sulfur atom; 2 R represents a cyclopropyl group optionally substituted with one or more substituents selected from the group consisting of 15a represents a C1-C10 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a group G 6The other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include hydrocarbons such as toluene, xylene, and hexane (hereinafter referred to as hydrocarbons); ethers such as methyl tert-butyl ether (hereinafter referred to as MTBE), tetrahydrofuran (hereinafter referred to as THF), and 1,4-dioxane (hereinafter referred to as ethers); halogenated hydrocarbons such as dichloromethane, chloroform, and chlorobenzene (hereinafter referred to as halogenated hydrocarbons); amides such as N,N-dimethylformamide (hereinafter referred to as DMF) (hereinafter referred to as amides); esters such as ethyl acetate (hereinafter referred to as esters); nitriles such as acetonitrile (hereinafter referred to as nitriles); water; and mixtures of two or more of these. Examples of catalysts used in the reaction include palladium catalysts such as tetrakistriphenylphosphinepalladium(0), palladium(II) acetate, tris(dibenzylideneacetone)dipalladium, and [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride. Examples of bases used in the reaction include organic bases such as triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), pyridine, and 4-(dimethylamino)pyridine (hereinafter referred to as organic bases); alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkali metal bicarbonates such as potassium bicarbonate (hereinafter referred to as alkali metal bicarbonates); alkaline earth metal carbonates such as magnesium carbonate and calcium carbonate (hereinafter referred to as alkaline earth metal carbonates); sodium fluoride and tripotassium phosphate. In the reaction, compound (M1) is usually used in a ratio of 1 to 10 moles, catalyst usually in a ratio of 0.01 to 1 mole, and base usually in a ratio of 1 to 10 moles, relative to 1 mole of compound (A1). The reaction temperature is usually within the range of 0 to 150°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-1) can be isolated by post-treatment operations such as mixing the reaction mixture with water, extracting with an organic solvent, and drying and concentrating the organic layer.Compound (M1) is a commercially available compound, or can be produced by the method described in Chemical Reviews, Vol. 95, pp. 2457-2483 (1995), or a method analogous thereto. Alternatively, a boronic acid derivative can be produced by hydrolyzing a commercially available boronic acid ester obtained by such a method, if necessary. Furthermore, a trifluoroborate salt (BF3) can be obtained by fluorinating the boronic acid ester according to the method described in Accounts of Chemical Research, Vol. 40, pp. 275-286 (2007), or the like. - K + ) can also be obtained.

[0016] Production Method B The compound represented by formula (I-2) (hereinafter referred to as compound (I-2)) can be produced by reacting compound (A1) with a compound represented by formula (M2) (hereinafter referred to as compound (M2)) in the presence of a catalyst and a base. [In the formula, R 1b is the group G 1and represents a C1-C6 alkyl group optionally substituted by one or more substituents selected from the group consisting of , and the other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; water; and mixtures of two or more thereof. Examples of catalysts used in the reaction include palladium catalysts such as tetrakistriphenylphosphinepalladium(0), palladium(II) acetate, tris(dibenzylideneacetone)dipalladium, and [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride; and copper catalysts such as copper(I) iodide and copper(I) chloride. Examples of the base used in the reaction include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrogencarbonates; metal carboxylates such as sodium acetate, potassium acetate, calcium acetate, and magnesium acetate (hereinafter referred to as metal carboxylates); metal alkoxides such as sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium methoxide, and potassium tert-butoxide (hereinafter referred to as metal alkoxides); metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide (hereinafter referred to as metal hydroxides); and metal hydrides such as lithium hydride, sodium hydride, potassium hydride, and calcium hydride (hereinafter referred to as metal hydrides). In the reaction, compound (M2) is typically used in a ratio of 1 to 10 moles, a catalyst is typically used in a ratio of 0.01 to 1 mole, and a base is typically used in a ratio of 1 to 10 moles, relative to 1 mole of compound (A1). A ligand can also be used in the reaction, if necessary. Examples of the ligand include triphenylphosphine, xantphos, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, etc. When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 1 mole per mole of compound (A1).The reaction temperature is usually within the range of -20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After the reaction is completed, the reaction mixture is mixed with water, extracted with an organic solvent, and the organic layer is dried, concentrated, or other post-treatment procedures are carried out to isolate compound (I-2) of the present invention. Compound (M2) is either a commercially available compound or can be prepared according to the methods described in Tetrahedron Lett. 1972, 13, 3769, Synlett 1996, 521, etc.

[0017] Production Method C The compound represented by formula (I-4) (hereinafter referred to as compound (I-4)) can be produced by reacting a compound represented by formula (I-3) (hereinafter referred to as compound (I-3)) with hydrogen in the presence of a hydrogenation catalyst. [In the formula, R 1c is the group G 1 a 1-propen-2-yl group optionally substituted by one or more substituents selected from the group G 1 a C4-C8 alkenyl group optionally substituted with one or more substituents selected from group G 2 a C4-C8 cycloalkenyl group optionally substituted with one or more substituents selected from group G 2 a 4- to 8-membered unsaturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (wherein the heteroatom constituting the 4- to 8-membered unsaturated non-aromatic heterocyclic group is an oxygen atom or a sulfur atom); 1 a vinyl group substituted with one or more substituents selected from the group G 1 R represents a 1-propen-1-yl group substituted with one or more substituents selected from 1d is the group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 2 a C4-C8 cycloalkyl group optionally substituted with one or more substituents selected from the group G 2a 4- to 8-membered saturated non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 4- to 8-membered saturated non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 an ethyl group substituted with one or more substituents selected from the group G 1 The other symbols have the same meanings as above.] The reaction is usually carried out in a solvent under a hydrogen atmosphere at 1 to 100 atmospheres. Examples of the solvent used in the reaction include alcohols such as methanol and ethanol (hereinafter referred to as alcohols); esters; halogenated hydrocarbons; ethers; hydrocarbons; water; and mixtures of two or more of these. Examples of the hydrogenation catalyst used in the reaction include transition metal catalysts such as palladium on carbon (Pd / C), platinum on carbon (Pt / C), rhodium on carbon (Rh / C), Raney nickel, and palladium hydroxide. The reaction can also be carried out by adding an acid or a base, if necessary. Examples of the acid include acetic acid and hydrochloric acid, and examples of the base include tertiary amines such as triethylamine and magnesium oxide. In the reaction, a hydrogenation catalyst is typically used in a ratio of 0.001 to 1 mole, and hydrogen is typically 1 mole or more, relative to 1 mole of compound (1-3). When an acid or base is used, the acid is typically used in a ratio of 0.001 to 10 moles, and the base is typically used in a ratio of 1 to 10 moles, relative to 1 mole of compound (1-3). The reaction temperature is typically within the range of -20 to 150°C. The reaction time is typically within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-4) can be isolated by performing a post-treatment operation, such as filtering the reaction mixture and concentrating the filtrate.

[0018] Production Method D The compound represented by formula (I-5) (hereinafter referred to as compound (I-5)) can be produced by reacting a compound represented by formula (A2) (hereinafter referred to as compound (A2)) with a reducing agent. [In the formula, R 1e is the group G 1The other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; water; and mixtures of two or more thereof. Examples of reducing agents used in the reaction include borohydride salts such as sodium borohydride and potassium borohydride (hereinafter referred to as borohydride salts). The reducing agent is usually used in a ratio of 0.3 to 1.5 moles per mole of compound (A2) in the reaction. The reaction temperature is usually within the range of −20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-5) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatments such as drying and concentrating the organic layer.

[0019] Production Method E The compound represented by formula (I-6) (hereinafter referred to as compound (I-6)) can be produced by reacting compound (I-5) with a compound represented by formula (M3) (hereinafter referred to as compound (M3)) in the presence of an acid. [In the ceremony, G 1a represents a C1-C3 alkyl group optionally substituted with one or more halogen atoms, Z 4represents an oxygen atom or a sulfur atom, and other symbols have the same meanings as above. The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; water; and mixtures of two or more of these. Examples of acids used in the reaction include sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid (hereinafter referred to as sulfonic acids); and inorganic acids such as hydrochloric acid and sulfuric acid (hereinafter referred to as inorganic acids). Relative to 1 mole of compound (I-5), compound (M3) can usually be used in an amount ranging from 1 mole to the solvent, and the acid can usually be used in an amount ranging from 0.01 mole to 10 moles. The reaction temperature is usually within the range of −20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-6) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatments such as drying and concentrating the organic layer. The compound (M3) is a commercially available compound, or can be produced according to a known method.

[0020] Production Method F Compound (I-6) can also be produced by reacting a compound represented by formula (A3) (hereinafter referred to as compound (A3)) with compound (M3) or a compound represented by formula (M5) (hereinafter referred to as compound (M5)). [wherein Q represents a paratoluenesulfonyl group, a methanesulfonyl group, or a trifluoromethanesulfonyl group; M 2represents an alkali metal such as lithium, sodium, or potassium, and other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones (hereinafter referred to as ketones) such as acetone and methyl isobutyl ketone (hereinafter referred to as MIBK); water; and mixtures of two or more of these. In the reaction, compound (M3) or compound (M5) is usually used in a ratio of 1 to 10 moles per mole of compound (A3). A base can also be used in the reaction, if necessary. Examples of bases include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogencarbonates, metal carboxylates, metal hydroxides, and metal hydrides. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (A3). The reaction temperature is usually within the range of −20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, the reaction mixture is mixed with water, extracted with an organic solvent, and the organic layer is dried, concentrated, and other post-treatment procedures are carried out to isolate compound (I-6). Compound (M5) is a commercially available compound, or can be produced according to known methods.

[0021] Production Method G The compound represented by formula (I-8) (hereinafter referred to as compound (I-8)) can be produced by reacting a compound represented by formula (I-6-1) (hereinafter referred to as compound (I-6-1)) with an oxidizing agent. [In the formula, r represents 1 or 2, and the other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include halogenated hydrocarbons; nitriles; alcohols; water; and mixtures of two or more of these. Examples of oxidizing agents used in the reaction include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide. In the reaction, the oxidizing agent is usually used in a ratio of 0.5 to 3 moles per mole of compound (I-6-1). When hydrogen peroxide is used as the oxidizing agent, a base or catalyst may be added as necessary. Examples of bases used in the reaction include sodium carbonate. When a base is used in the reaction, the base is usually used in a ratio of 0.01 to 1 mole per mole of compound (I-6-1). Examples of catalysts used in the reaction include sodium tungstate. When a catalyst is used in the reaction, the catalyst is typically used in a ratio of 0.01 to 0.5 moles per mole of compound (I-6-1). The reaction temperature is typically within the range of -20 to 100°C. The reaction time is typically within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-8) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

[0022] Production Method H The compound represented by formula (I-9) (hereinafter referred to as compound (I-9)) can be produced by reacting compound (A3) with a compound represented by formula (M6) (hereinafter referred to as compound (M6)). [In the ceremony, G 1drepresents a halogen atom, a cyano group, or a mercapto group, and other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones; water; and mixtures of two or more thereof. In the reaction, compound (M6) is usually used in a ratio of 1 to 10 moles per mole of compound (A3). The reaction temperature is usually within the range of -20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-9) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatment such as drying and concentrating the organic layer. Compound (M6) is a commercially available compound or can be produced according to known methods.

[0023] Production Method I The compound represented by formula (I-10) (hereinafter referred to as compound (I-10)) can be produced by reacting a compound represented by formula (A2-1) (hereinafter referred to as compound (A2-1)) with a compound represented by formula (M7) (hereinafter referred to as compound (M7)). [In the formula, R 1f is the group G 1 The other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; and mixtures of two or more of these. The reaction is usually carried out in a ratio of 1 to 10 moles of compound (M7) per mole of compound (A2-1). The reaction temperature is usually within the range of -20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After the reaction is complete, compound (I-10) can be isolated by mixing the reaction mixture with an acidic aqueous solution (dilute hydrochloric acid, etc.), extracting with an organic solvent, and performing post-treatment such as drying and concentrating the organic layer. Compound (A2-1) can be produced in accordance with Production Methods K-1, K-2, or K-3 using compound (A2) instead of the compound represented by formula (I-12).

[0024] Production Method J The compound represented by formula (I-11) (hereinafter referred to as compound (I-11)) can be produced by reacting compound (I-10) with a compound represented by formula (M8) (hereinafter referred to as compound (M8)) in the presence of a base. [In the formula, L 2 represents a halogen atom such as a chlorine atom, a bromine atom, or an iodine atom; a leaving group such as a methanesulfonyloxy group, a trifluoromethylsulfonyloxy group, a 4-methylphenylsulfonyloxy group, or a phenylsulfonyloxy group; R 1g represents a C1-C3 alkyl group optionally substituted with one or more halogen atoms, and the other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; alcohols; ketones; water; and mixtures of two or more thereof. Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogencarbonates, metal carboxylates, metal hydroxides, and metal hydrides. In the reaction, compound (M8) is usually used in a ratio of 1 to 10 moles, and the base is usually used in a ratio of 1 to 10 moles, per mole of compound (I-10). The reaction temperature is usually within the range of −20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-11) can be isolated by post-treatment such as mixing the reaction mixture with water, extracting with an organic solvent, and drying and concentrating the organic layer. The compound (M8) is a commercially available compound, or can be produced according to a known method.

[0025] Production Method K-1 The compound represented by formula (I-13) (hereinafter referred to as compound (I-13)) can be produced by reacting a compound represented by formula (I-12) (hereinafter referred to as compound (I-12)) in the presence of water and a base. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a mixed solvent of water and an organic solvent. Examples of organic solvents used in the reaction include ethers; alcohols; and mixtures of two or more of these. Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogencarbonates, metal carboxylates, and metal hydroxides. The base is usually used in a ratio of 1 to 10 moles per mole of compound (I-12) in the reaction. The reaction temperature is usually within the range of −20 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-13) can be isolated by adding an inorganic acid to the reaction mixture to make it acidic, extracting it with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer.

[0026] Production Method K-2 The compound (I-13) can also be produced by reacting the compound (I-12) in the presence of a lithium salt and an amine. [wherein the symbols have the same meanings as defined above.] The reaction can be carried out according to the method described in Tetrahedron Letters 2007, 48, 2497-2499.

[0027] Production Method K-3 The compound (I-13) can also be produced by reacting the compound (I-12) in the presence of an acid. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; water; and mixtures of two or more of these. Examples of acids used in the reaction include sulfones; inorganic acids; and carboxylic acids such as acetic acid and trifluoroacetic acid (hereinafter referred to as carboxylic acids). The acid is usually used in a ratio of 0.001 to 10 moles per mole of compound (I-12). The reaction temperature is usually within the range of −20 to 150°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-13) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatments such as drying and concentrating the organic layer.

[0028] Production Method L Compound (I-12) can be produced by reacting compound (I-13) with a compound represented by formula (M9) (hereinafter referred to as compound (M9)) in the presence of a base. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; imidazolinones such as 1,3-dimethyl-2-imidazolinone; sulfoxides (hereinafter referred to as sulfoxides) such as dimethyl sulfoxide (hereinafter referred to as DMSO); nitriles; water; and mixtures of two or more thereof. Examples of bases used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogencarbonates, metal carboxylates, metal alkoxides, metal hydroxides, and metal hydrides. In the reaction, compound (M9) is usually used in a ratio of 1 to 10 moles, and a base is usually used in a ratio of 1 to 10 moles, relative to 1 mole of compound (I-13). The reaction temperature is usually within the range of −20 to 200° C. The reaction time is usually within the range of 0.1 to 120 hours. After the reaction is complete, the reaction mixture is mixed with water, extracted with an organic solvent, and the organic layer is dried, concentrated, and other post-treatment procedures are carried out to isolate compound (I-12). Compound (M9) is commercially available or can be produced according to known methods.

[0029] Production Method M The compound represented by formula (I-15) (hereinafter referred to as compound (I-15)) can be produced by a step (step M-1) of reacting compound (I-13) with a chlorinating agent to obtain a compound represented by formula (IM-14) (hereinafter referred to as compound (IM-14)), and a step (step M-2) of reacting compound (IM-14) obtained in step M-1 with a compound represented by formula (M11) (hereinafter referred to as compound (M11)) in the presence of a base to obtain compound (I-15). (wherein the symbols have the same meanings as defined above.)

[0030] First, step M-1 will be described. The reaction is typically carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, esters, and mixtures of two or more of these. Examples of chlorinating agents used in the reaction include thionyl chloride, oxalyl chloride, and phosphorus oxychloride. Such chlorinating agents are typically used in a ratio of 1 to 10 moles per mole of compound (I-13). The reaction may be carried out in the presence of a catalyst. Examples of catalysts include DMF. When the reaction is carried out in the presence of a catalyst, the catalyst is typically used in a ratio of 0.01 to 1 mole per mole of compound (I-13). The reaction temperature is typically within the range of −80 to 150°C. The reaction time is typically within the range of 0.1 to 120 hours. After completion of the reaction, compound (IM-14) can be isolated by post-treatment. Alternatively, the reaction mixture after completion of the reaction may be directly subjected to step M-2, or a mixture obtained by concentrating the reaction mixture may be subjected to step M-2.

[0031] Next, step M-2 will be described. The reaction is typically carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; esters; and mixtures of two or more of these. Examples of bases used in the reaction include organic bases; alkaline earth metal carbonates; alkali metal carbonates; alkali metal hydrogencarbonates; metal carboxylates; and metal hydroxides. For the reaction, compound (M11) is typically used in a ratio of 1 to 10 moles and a base is typically used in a ratio of 1 to 10 moles per mole of compound (I-13) used in step M-1. The reaction temperature is typically within the range of −80 to 150°C. The reaction time is typically within the range of 0.1 to 120 hours. After completion of the reaction, compound (I-15) can be isolated by mixing the reaction mixture with water, extracting it with an organic solvent, and performing post-treatments such as washing, drying, and concentrating the organic layer. The reaction conditions (solvent, reaction temperature, reaction time, etc.) in steps M-1 and M-2 may be the same or different. Steps M-1 and M-2 may be carried out simultaneously by mixing compound (I-13), a chlorinating agent, a base, and compound (M11), or step M-1 may be carried out first and then step M-2. Step M-2 may also be started between the start and end of step M-1.

[0032] Production Method N The compound represented by formula (I-16) (hereinafter referred to as compound (I-16)), the compound represented by formula (I-17) (hereinafter referred to as compound (I-17)), and the compound represented by formula (I-18) (hereinafter referred to as compound (I-18)) can be produced by reacting compound (I-12) with a sulfating agent. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons, ethers, halogenated hydrocarbons, and mixtures of two or more thereof. Examples of sulfurizing agents used in the reaction include diphosphorus pentasulfide and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulfide (hereinafter referred to as Lawesson's reagent). The reaction may be carried out in the presence of a base. Examples of the base include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogencarbonates, metal carboxylates, metal alkoxides, metal hydroxides, and metal hydrides. When the reaction is carried out in the presence of a base, the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-12). In the reaction, the sulfurizing agent is usually used in a ratio of 1 to 10 moles per mole of compound (I-12). The reaction temperature is usually within the range of −20 to 150° C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, the reaction mixture is mixed with water, extracted with an organic solvent, and the organic layer is dried, concentrated, or other post-treatment procedures are carried out to isolate compound (I-16), compound (I-17), or compound (I-18). The proportions of compound (I-16), compound (I-17), and compound (I-18) produced can be increased or decreased by adjusting the type of solvent and sulfurizing agent, the equivalent amount of the sulfurizing agent, the reaction temperature, and the reaction time.

[0033] Production Method O The compound represented by formula (I-13) (hereinafter referred to as compound (I-13)) can be produced by reacting compound (I-19) with a diazonium salt represented by formula (A8) (hereinafter referred to as compound (A8)) in the presence of a base. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; water; and mixtures of two or more thereof. Examples of bases used in the reaction include organic bases; alkali metal carbonates; alkaline earth metal carbonates; alkali metal hydrogencarbonates; metal carboxylates such as sodium acetate, potassium acetate, calcium acetate, and magnesium acetate (hereinafter referred to as metal carboxylates); metal alkoxides such as sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium methoxide, and potassium tert-butoxide (hereinafter referred to as metal alkoxides); metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide (hereinafter referred to as metal hydroxides); and metal hydrides such as lithium hydride, sodium hydride, potassium hydride, and calcium hydride (hereinafter referred to as metal hydrides). The reaction may be carried out using two or more of the above-mentioned bases. In the reaction, compound (A6) is typically used in a ratio of 1 to 10 moles, and base is typically used in a ratio of 1 to 10 moles, per mole of compound (I-19). The reaction temperature is typically within the range of -80 to 50°C. The reaction time is typically within the range of 0.01 to 120 hours. After completion of the reaction, the reaction mixture can be neutralized with an acid, extracted with an organic solvent, and subjected to post-treatment procedures such as drying and concentrating the organic layer, thereby isolating compound (I-13) of the present invention. Examples of acids used for neutralization include inorganic acids such as acetic acid, hydrochloric acid, and sulfuric acid (hereinafter referred to as inorganic acids). The reaction for synthesizing (A8) from (A6) in the above scheme can be carried out in accordance with the method described in U.S. Pat. No. 2,454,742.

[0034] Reference Production Method 1 Compound (A1) can be produced by reacting a compound represented by formula (A4) (hereinafter referred to as compound (A4)) in the presence of a halogenating agent. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; nitriles; imidazolinones; sulfoxides; and mixtures of two or more thereof. Examples of halogenating agents used in the reaction include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dibromo-5,5-dimethylhydantoin, and dibromoisocyanuric acid. The halogenating agent is usually used in a ratio of 1 to 10 moles per mole of compound (A4). The reaction temperature is usually within the range of −100 to 200°C. The reaction time is usually within the range of 0.1 to 120 hours. After completion of the reaction, compound (A1) can be isolated by post-treatment such as mixing the reaction mixture with water, extracting it with an organic solvent, and drying and concentrating the organic layer.

[0035] Reference Production Method 2 Compound (A4) can be produced by reacting a compound represented by formula (A5) (hereinafter referred to as compound (A5)) with compound (M9) in the presence of a base. [wherein the symbols have the same meanings as defined above.] The reaction can be carried out according to Production Method L, except that compound (A5) is used in place of compound (I-13).

[0036] Reference Production Method 3 Compound (A3) can be produced by reacting compound (I-5) with a compound represented by formula (M10) (hereinafter referred to as compound (M10)). [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of solvents used in the reaction include hydrocarbons; ethers; halogenated hydrocarbons; amides; esters; imidazolinones; sulfoxides; nitriles; water; and mixtures of two or more thereof. In the reaction, compound (M10) is usually used in a ratio of 1 to 10 moles per mole of compound (I-5). A base can also be used in the reaction, if necessary. Examples of bases include organic bases, alkali metal carbonates, alkaline earth metal carbonates, and alkali metal hydrogencarbonates. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-5). In the reaction, compound (M10) is usually used in a ratio of 1 to 10 moles per mole of compound (I-5). The reaction temperature is usually within the range of −20 to 200° C. The reaction time is usually within the range of 0.1 to 120 hours. After the reaction is complete, the reaction mixture is mixed with water, extracted with an organic solvent, and the organic layer is dried, concentrated, and other post-treatment procedures are carried out to isolate compound (A3). Compound (M10) is a commercially available compound, or can be produced according to known methods.

[0037] Reference Production Method 4 Compound (A5) can be produced using a compound represented by formula (A6) (hereinafter referred to as compound (A6)) and a compound represented by formula (A7) (hereinafter referred to as compound (A7)) according to the following scheme. [In the formula, the symbols have the same meanings as defined above.] Each reaction in the above scheme can be carried out according to the method described in U.S. Pat. No. 2,454,742. Compound (A6) is a commercially available compound or can be produced according to a known method. Compound (A7) is a commercially available compound or can be produced according to a known method.

[0038] Reference Production Method 5 Compound (A2) can be produced by reacting compound (A2-1) with compound (M9) in the presence of a base. [wherein the symbols have the same meanings as defined above.] The reaction can be carried out according to Production Method L, except that compound (A2-1) is used in place of compound (I-13).

[0039] Reference Production Method 6 Compound (A2-1) can be produced using compound (A6) and a compound represented by formula (A10) (hereinafter referred to as compound (A10)) according to the following scheme. [In the formula, the symbols have the same meanings as defined above.] Each reaction in the above scheme can be carried out according to the method described in U.S. Pat. No. 2,454,742. Compound (A10) is a commercially available compound, or can be produced according to the method described in Journal of the Chemical Society, 1963, 4483-4489, etc.

[0040] Reference Production Method 7 Compound (A5) can be produced from compound (A3) and compound (A4) according to the following scheme. [wherein the symbols have the same meanings as defined above.] Each reaction in the above scheme can be carried out according to the method described in The Journal of Organic Chemistry, 1969, 1425-1429, etc.

[0041] Reference Production Method 8 Compound (I-19) can be produced using compound (A5) and compound (M12) according to the following scheme. [In the formula, the symbols have the same meanings as defined above.] Each reaction in the above scheme can be produced according to the method described in Chemistry, a European Journal, 2009, pp. 2826-2845, etc. Compound (M12) is a commercially available compound, or can be produced according to the method described in Journal of the American Chemical Society, 1962, pp. 4899-4904, etc. Compound (I-19) may exist as a keto-enol tautomer. Compound (I-19) includes each keto-enol tautomer and a mixture of keto-enol tautomers in any ratio.

[0042] The compound of the present invention can be mixed or used in combination with one or more components selected from the group consisting of Group (a), Group (b), Group (c), Group (d), Group (e), and Group (f) below (hereinafter referred to as the present component). The term "mixed or used in combination" means that the compound of the present invention and the present component are used simultaneously, separately, or with a time interval between them. When the compound of the present invention and the present component are used simultaneously, the compound of the present invention and the present component may be contained in separate preparations or in a single preparation. One aspect of the present invention is a composition (hereinafter referred to as Composition A) containing one or more components selected from the group consisting of Group (d) and Group (f) (i.e., the present component) and the compound of the present invention.

[0043] Group (a) includes acetylcholinesterase inhibitors (e.g., carbamate insecticides, organophosphate insecticides), GABAergic chloride channel blockers (e.g., phenylpyrazole insecticides), sodium channel modulators (e.g., pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (e.g., neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamate-gated chloride channel allosteric modulators (e.g., macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, microbial insect midgut membrane disruptors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation uncouplers, nicotinic acetylcholine receptor channel blockers (e.g., nereistoxin insecticides), chitin biosynthesis inhibitors, molting inhibitors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial electron transport chain complexes I and II, The group consisting of inhibitors of classes III and IV, voltage-dependent sodium channel blockers, acetyl-CoA carboxylase inhibitors, ryanodine receptor modulators (e.g., diamide insecticides), chordotonal organ modulators, microbial insecticides, and other insecticidal, acaricidal, and nematicidal active ingredients, which are described in the IRAC mechanism-based classification.

[0044] Group (b) consists of nucleic acid synthesis inhibitors (e.g., phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (e.g., MBC fungicides), respiratory inhibitors (e.g., QoI fungicides, QiI fungicides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (e.g., DMI fungicides such as triazoles), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multisite contact-active fungicides, microbial fungicides, and other fungicidal active ingredients. These are listed in the FRAC classification based on the mechanism of action.

[0045] Group (c) is a group of plant growth regulators (including mycorrhizal fungi and rhizobia).

[0046] Group (d) is a group of safening ingredients.

[0047] Group (e) is a group of synergists that enhance the efficacy of other drugs when used in combination with them.

[0048] Group (f) consists of acetyl-CoA carboxylase (ACCase) inhibitors, acetolactate synthase (ALS) inhibitors, photosynthesis (photosystem II) inhibitors, photosystem I electron converters, protoporphyrinogen oxidase (PPO) inhibitors, phytoene desaturase system (PDS) inhibitors, 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) inhibitors, carotenoid biosynthesis inhibitors, EPSP synthase inhibitors, glutamine synthase inhibitors, dihydropteroic acid (DHP) synthase inhibitors, microtubule polymerization inhibitors, mitosis / microtubule formation inhibitors, very long-chain fatty acid (VLCFA) inhibitors, cellulose synthesis inhibitors, uncoupling agents, lipid synthesis inhibitors, indoleacetic acid-like active agents, auxin transport inhibitors, and other herbicidal active ingredients. These are listed in the HRAC classification based on the mechanism of action.

[0049] Examples of combinations of the present component and the compound of the present invention are described below. For example, alanycarb + SX refers to a combination of alanycarb and SX. The abbreviation SX refers to any one of the present compounds selected from the compound groups SX1 to SX12 and present compounds 1 to 314. The present components described below are all known and can be obtained from commercially available preparations or produced by known methods. When the present component is a microorganism, it can also be obtained from a bacterial depository. The number in parentheses indicates the CAS RN (registered trademark).

[0050] Combinations of the present ingredient of the above group (a) with the compound of the present invention: abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetoprole + SX, acrinathrin + SX, acinonapyr + SX, afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha-endosulfan + SX, aluminum phosphide + SX, Amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, Celastrus angulatus bark + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, bentiofluormin + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX,Bioallethrin + SX, bioresmethrin + SX, bistrifluron + SX, bisulfufen + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, Cartap hydrochloride + SX, cartap + SX, chinomethionate + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chloropicrin + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite + SX,Cyanophos + SX, cyantraniliprole + SX, cybenzoxasulfyl + SX, cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, Cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dichloromezotiaz + SX, dicofol + SX, dicrotophos + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, Dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX, dinotefuran + SX, disodium octaborate + SX,Disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, doramectin + SX, dried leaves of Dryopteris filix (mas) + SX, emamectin benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O-(4-nitrophenyl) phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiofencarb + SX, ethion + SX, Ethiprole + SX, ethoprophos + SX, etofenprox + SX, etoxazole + SX, Artemisia absinthium extract + SX, Azadirachta indica extract + SX, Cassia nigricans extract + SX, Clitoria ternatea extract + SX, Symphytum officinale extract + SX, Chenopodium ambrosioides extract + SX, Tansy extract + SX, Urtica dioica extract + SX, Mistletoe extract (extract of Viscum album) + SX,Famphur + SX, fenamiphos + SX, fenazaquin + SX, fenbutatin oxide + SX, fenitrothion + SX, fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, Fluacrypyrim + SX, fluazaindolizine + SX, fluazuron + SX, flubendiamide + SX, fluchlordiniliprole + SX, flucycloxuron + SX, flucythrinate + SX, fluensulfone + SX, flufenprox + SX, flufenoxuron + SX, flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone + SX, flupyrimin + SX, flupyroxystrobin + SX, fluralaner + SX, fluvalinate + SX, fluxametamide + SX,Formetanate + SX, fosthiazate + SX, furamethrin + SX, furathiocarb + SX, gamma-cyhalothrin + SX, GS-omega / kappa HXTX-Hv1a peptide + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, isocycloseram + SX, isofenphos + SX, isoflualanam + SX, isoprocarb + SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate + SX, Isoxathion + SX, Ivermectin + SX, Kadethrin + SX, Kappa-tefluthrin + SX, Kappa-bifenthrin + SX,Kinoprene + SX, lambda-cyhalothrin + SX, ledprona + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, methamidophos + SX, methidathion + SX, Methiocarb + SX, methomyl + SX, methoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, mivorilaner + SX, modoflaner + SX, momfluorothrin + SX, monocrotophos + SX, Moxidectin + SX, Naled + SX, Nicofluprole + SX, Nicotine + SX, Nicotine sulfate + SX, Nitenpyram + SX,Novaluron + SX, Noviflumuron + SX, Chenopodium anthelminticum seed oil + SX, Omethoate + SX, Oxamyl + SX, Oxazosulfyl + SX, Oxydemeton-methyl + SX, Parathion + SX, Parathion-methyl + SX, Permethrin + SX, Phenothrin + SX, Phenthoate + SX, Phorate + SX, Phosalone + SX, Phosmet + SX, Phosphamidon + SX Phosphine + SX, phoxim + SX, pioxaniliprole + SX, piperflanilide + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pymetrozine + SX, Pyraclofos + SX, pyrethrins + SX, pyridaben + SX, pyridalyl + SX,Pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX, ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX, silafluofen + SX, sodium borate + SX, sodium metaborate metaborate + SX, spidoxamat + SX, spinetoram + SX, spinosad + SX, spirobudifen + SX, spirodiclofen + SX, spiromesifen + SX, spiropidione + SX, spirotetramat + SX, sulfiflumin + SX, sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, teflubenzuron + SX,Tefluthrin + SX, Temephos + SX, Terbufos + SX, Terpene constituents of the extract of Chenopodium ambrosioides near ambrosioides + SX, Tetrachlorantraniliprole + SX, Tetrachlorvinphos + SX, Tetradifon + SX, Tetramethrin + SX, Tetramethylfluthrin + SX, Tetraniliprole + SX, Theta-cypermethrin + SX, Thiacloprid + SX, Thiamethoxam + SX Thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap disodium + SX, thiosultap monosodium + SX, tiapyrachlor + SX, tigolaner + SX, thioantraniliprole + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate + SX, triazophos + SX, Trichlorfon + SX, Trifluenfuronate + SX,Triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, tyclopyrazoflor + SX, umifoxolaner + SX, vadescana + SX, vamidothion + SX, Quassia amara wood extract + SX, 3,5-dimethylphenyl N-methylcarbamate (XMC) + SX, xylylcarb + SX, zeta-cypermethrin + SX, zinc phosphide + SX, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5) + SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2) + SX, N-[4-chloro-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-N-ethyl-3-(methanesulfonyl)propanamide + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0) + SX, N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepin-10-one (2607927-97-7) + SX, Bacillus thuringiensis-derived Cry1Ab protein + SX,Cry1Ac protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1Ac protein) + SX, Cry1Fa protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1Fa protein) + SX, Cry1A.105 protein from Bacillus thuringiensis (Bacillus thuringiensis Cry1A.105 protein) + SX, Cry2Ab protein from Bacillus thuringiensis (Bacillus thuringiensis Cry2Ab protein) + SX, Vip3A protein from Bacillus thuringiensis (Bacillus thuringiensis Vip3A protein) + SX, mCry3A protein from Bacillus thuringiensis (Bacillus thuringiensis mCry3A protein) + SX, Cry3Ab protein from Bacillus thuringiensis (Bacillus thuringiensis thuringiensis Cry3Ab protein + SX, Bacillus thuringiensis Cry3Bb protein + SX, Bacillus thuringiensis Cry34Ab1 / Cry35Ab1 protein + SX, Adoxophyes orana GV (granulovirus) strain BV-0001 + SX, Anticarsia gemmatalis MNPV (multiple nucleocapsid nucleopolyhedrovirus) + SX,Autographa californica MNPV + SX, Cydia pomonella GV strain V15 + SX, Cydia pomonella GV strain V22 + SX, Cryptophlebia leucotreta GV + SX, Dendrolimus punctatus cypovirus + SX, Helicoverpa armigera nucleopolyhedrovirus BV-0003 + SX, Helicoverpa zea ... NPV) + SX, Lymantria dispar NPV + SX, Mamestra brassicae NPV + SX, Mamestra configurata NPV + SX, Neodiprion abietis NPV + SX, Neodiprion lecontei NPV + SX, Neodiprion sertifer NPV + SX, Nosema locustae NPV + SX, Orgyia pseudotsugata NPV + SX, Pieris rapae granulosis virus (GV) + SX, Plodia interpunctella granulosis virus (GV) + SX, Spodoptera exigua MNPV + SX,Spodoptera littoralis MNPV + SX, Spinach squid (Spodoptera litura NPV) + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR-371 + SX, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX,Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX, Bacillus thuringiensis var. darmstadiensis strain 24-91 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX,Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216 + SX, Bacillus thuringiensis var. aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinogensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX, Dactylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX, Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium strain Ve6 + SX,Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5 / F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX。,

[0051] Combinations of the present ingredient of the above group (b) with the compound of the present invention: acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, Benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, bifemetstrobin + SX, binapacryl + SX, biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin S + SX, Bordeaux mixture + SX, boscalid + SX, bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, Carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionate + SX, chitin + SX, chloroinconazide + SX,Chloroneb + ​​SX, chlorothalonil + SX, chlozolinate + SX, colletochlorin B + SX, copper(II) acetate + SX, copper(II) hydroxide + SX, copper oxychloride + SX, copper(II) sulfate + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, Dichlobentiazox + SX, dichlofluanid + SX, diclocymet + SX, diclomezine + SX, dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diniconazole-M + SX, dinocap + SX, Dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX,Dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt + SX, dodemorph + SX, dodine + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, garlic extract (Allium sativum) + SX, extract of the cotyledons of lupine plantlets (BLAD) + SX, horsetail extract (Equisetum arvense) + SX SX, tea tree extract (Melaleuca alternifolia) + SX, giant knotweed extract (Reynoutria sachalinensis) + SX, nasturtium extract (Tropaeolus majus) + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, feneptamidoquin + SX, fenfuram + SX, fenhexamid + SX, fenopyramide + SX, fenoxanil + SX Fenpiclonil + SX, fenpicoxamid + SX,Fenpropidin + SX, fenpropimorph + SX, fenpyrazamine + SX, triphenyltin acetate + SX, triphenyltin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluoxytioconazole + SX, fluquinconazole + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, flutriafol + SX, Fluxapyroxad + SX, Folpet + SX, Fosetyl + SX, Fosetyl-aluminum + SX,Fuberidazole + SX, furalaxyl + SX, furametpyr + SX, galquin + SX, guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, imibenconazole + SX, iminoctadine + SX, iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentrifluconazole + SX Ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX, isofetamide + SX, isofleucine + SX, isoflucipram + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX, kresoxim-methyl + SX, laminarin + SX, oak leaves and bark of quercus + SX, mancozeb + SX, mandestrobin + SX, Mandipropamid + SX, maneb + ​​SX, mefentrifluconazole + SX, mepanipyrim + SX, mepronil + SX,Meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metarylpicoxamid + SX, metconazole + SX, methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX Orysastrobin + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphorous acid + SX, Phthalide + SX, picarbutrazox + SX, picoxystrobin + SX, piperalin + SX,Polyoxins + SX, potassium hydrogencarbonate + SX, potassium dihydrogenphosphite + SX, probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propineb + ​​SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, pyrametostrobin + SX, Pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridaclomethyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriophenone + SX, pyrisoxazole + SX, pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, Quinofumelin + SX, quinoxyfen + SX, quintozene + SX,Quinoa saponins (Chenopodiaceae) + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, tetraconazole + SX Thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, thymol + SX, tiadinil + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyricarb + SX, tricyclazole + SX, Tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX,トリチコナゾール(triticonazole) + SX, バリダマイシン(validamycin) + SX, バリフェナレート(valifenalate) + SX, ビンクロゾリン(vinclozolin) + SX, マスタードパウダー(yellow mustard powder) + SX, zinc thiazole + SX, ジネブ(zineb) + SX, ジラム(ziram) + SX, ゾキサミド(zoxamide) + SX, N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N'-[5-chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX,N'-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5) + SX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5) + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S,5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5) + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX,2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1) + SX, methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4) + SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2) + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8) + SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX, 3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX,3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX,4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)morpholin-3-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine + SX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX,1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxetan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxolan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxan-4-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)ethyl]pyrimidin-2-amine + SX,5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX,3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2,2-dimethylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-(2-cyanoethoxy)ethyl]-5-[1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, methyl ({5-[1-(2,6-difluoro-4-isopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-cyclopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-methoxyphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-[(3-isopropyl-1H-pyrazol-1-yl)-2-methylphenoxy]-3-methoxyprop-2-enoate + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-6-fluoro-3,3-dimethylisoquinolin-4(3H)-one + SX, methyl (2Z)-3-methoxy-2-[(4-methyl[1,1'-biphenyl]-3-yl)oxy]prop-2-enoate + SX, N-[2-(pyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-cyanopyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[(2S)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[(2R)-2-(6-chloro-4-methoxypyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide ,N-[2-{6-[(1E)-(methoxyimino)ethyl]pyridin-2-yl}-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(5-methylpyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-dichlorophenyl)isoxazole-3-carboxamide + SX, Methyl 6-[2-{[5-(2,4-dichlorophenyl)isoxazole-3-carbonyl]amino}-1-methyl-1-(1-methylpyrazol-4-yl)ethyl]pyridine-3-carboxylate + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(3,5-difluoropyridin-2-yl)isoxazole-3-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-3-(2,4-difluorophenyl)-1,2,4-oxadiazole-5-carboxamide + SX, N-[2-(6-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)-1,3,4-thiadiazole-2-carboxamide + SX, N-[2-(5-chloropyridin-2-yl)-2-(1-methylpyrazol-4-yl)propyl]-5-(2,4-difluorophenyl)-1,3,4-thiadiazole-2-carboxamide + SX,N-[2-(6-氯吡啶-2-基)-2-(1-甲基吡唑-4-基)丙基]-5-(3,5-二氟吡啶-2-基)-1,3,4-噻二唑-2-甲酰胺 + SX,N-[2-(6-氰基吡啶-2-基)-2-(1-甲基吡唑-4-基)丙基]-5-(3,5-二氟吡啶-2-基)-1,3,4-噻二唑-2-甲酰胺 + SX,N-[2-(6-氯吡啶-2-基)-2-(1-甲基吡唑-4-基)丙基]-5-(2,6-二氟吡啶-3-基)-1,3,4-噻二唑-2-甲酰胺,[4-(二氟甲氧基)苯基]甲基 4-[(N-乙基-N-甲氨基)亚甲基]氨基-2,5-二甲基苯甲酸酯,放射形土壤杆菌菌株K1026 + SX,放射形土壤杆菌菌株K84 + SX,解淀粉芽孢杆菌菌株PTA-4838(Aveo(商标) EZ杀线虫剂) + SX,解淀粉芽孢杆菌菌株AT332 + SX,解淀粉芽孢杆菌菌株B3 + SX,解淀粉芽孢杆菌菌株D747 + SX,解淀粉芽孢杆菌菌株DB101 + SX,解淀粉芽孢杆菌菌株DB102 + SX,解淀粉芽孢杆菌菌株GB03 + SX,解淀粉芽孢杆菌菌株FZB24 + SX,Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246 + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis strain HB-2 + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB / BS03 + SX, Bacillus subtilis strain MBI600 + SX,Bacillus subtilis strain QST30002 / AQ30002 + SX, Bacillus subtilis strain QST30004 / AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX, Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + SX, Clonostachys rosea + SX, Coniothyrium minitans strain CGMCC8325 + SX, Coniothyrium minitans strain CON / M / 91-8 + SX, cryptococcus albidus + SX, Erwinia carotovora subsp. carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX,Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX, Pseudomonas fluorescens strain A506 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX,Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX, Trichoderma atroviride strain SKT-1 + SX, Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX,Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX。,

[0052] Combinations of the present ingredient in group (c) above with the compound of the present invention: 1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, (1H-indol-3-yl)acetic acid (IAA) + SX, 4-(1H-indol-3-yl)butyric acid (IBA) + SX, 2-(4-chloro-2-methylphenoxy)acetic acid (MCPA) + SX, 4-(4-chloro-2-methylphenoxy)butyric acid (MCPB) + SX, 4-chlorophenoxyacetic acid (4-CPA) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat chloride + SX, chlorpropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, Cyclanilide + SX,Daminozide + SX, decan-1-ol + SX, dichlorprop + SX, dikegulac + SX, dimethipin + SX, diquat + SX, ethephon + SX, ethychlozate + SX, flumetralin + SX, flurprimidol + SX, forchlorfenuron + SX, formononetin + SX, gibberellin A + SX, gibberellin A3 + SX, inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintophen + SX, sodium 1-naphthaleneacetate + SX, sodium cyanate + SX, Thidiazuron + SX, triapenthenol + SX, tribufos + SX, trinexapac-ethyl + SX,Uniconazole-P + SX, 2-(naphthalen-1-yl)acetamide + SX, [4-oxo-4-(2-phenylethyl)amino]butyric acid + SX, Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]propan-1-ol + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX,Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX。,

[0053] Combinations of the present ingredient of the above group (d) with the compound of the present invention: allidochlor + SX, benoxacor + SX, cloquintocet + SX, cloquintocet-mexyl + SX, cyometrinil + SX, cyprosulfamide + SX, dichlormid + SX, dicyclonone + SX, dimepiperate + SX, disulfoton + SX, dymron + SX, fenchlorazole + SX, fenchlorazole-ethyl + SX, fenclorim + SX, Flurazole + SX, Furilazole + SX, Fluxofenim + SX, Hexim + SX, Isoxadifen + SX, Isoxadifen-ethyl + SX, Jiecaowan + SX, Jiecaoxi + SX, Mecoprop + SX, Mefenpyr + SX, Mefenpyr-ethyl + SX, Mefenpyr-diethyl + SX, Mephenate + SX, Metocamifen + SX, Oxabetrinil + SX, 1,8-Naphthalic Anhydride + SX, octane-1,8-diamine + SX, AD-67 (4-(dichloroacetyl)-1-oxa-4-azaspiro [4.5] decane) + SX, CL-304415 (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) + SX, CSB (1-bromo-4-[(chloromethyl)sulfonyl]benzene) + SX, DKA-24 (2,2-dichloro-N-[2-oxo-2-(2-propenylamino)ethyl]-N-(2-propenyl)acetamide) + SX, MG191 (2-(dichloromethyl)-2-methyl-1,3-dioxolane) + SX, MG-838 (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) + SX, PPG-1292 (2,2-dichloro-N-(1,3-dioxan-2-ylmethyl)-N-(2-propenyl)acetamide) + SX, R-28725 (3-(dichloroacetyl)-2,2-dimethyl-1,3-oxazolidine) + SX, R-29148 (3-(dichloroacetyl)-2,2,5-trimethyl-1,3-oxazolidine) + SX, TI-35 (1-(dichloroacetyl)azepane) + SX。.

[0054] Combinations of the present component of the above group (e) with the compound of the present invention: 1-dodecyl-1H-imidazole + SX, N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide + SX, bucarpolate + SX, N,N-dibutyl-4-chlorobenzenesulfonamide + SX, dietholate + SX, diethylmaleate + SX, Jiajizengxiaolin + SX, octachlorodipropyl ether + SX, perbutin + SX, piperonyl butoxide + SX, piperonyl cyclonene + SX, piprotal + SX, propyl isome + SX, safroxan + SX, sesamex + SX, sesamolin + SX, sulfoxide + SX, verbutin + SX, 1,1-bis(4-chlorophenyl)ethanol (DMC) + SX, 1,1-bis(4-chlorophenyl)-2,2,2-trifluoroethanol (FDMC) + SX, 1,2-epoxy-1,2,3,4-tetrahydronaphthalene (ETN) + SX, 1,1,1-trichloro-2,3-expoxypropane (ETP) + SX, PSCP (phenylsaligenin cyclic phosphate) + SX, TBPT (S,S,S-tributyl phosphorotrithioate) + SX,TPP (triphenyl phosphate) + SX。,

[0055] Combinations of the present ingredient in group (f) above with the compound of the present invention: 2,3,6-trichlorobenzoic acid (2,3,6-TBA) + SX, 2,3,6-TBA dimethylammonium + SX, 2,3,6-TBA lithium + SX, 2,3,6-TBA potassium + SX, 2,3,6-TBA sodium + SX, 2,4-D + SX, 2,4-D choline + SX, 2,4-D biproamine + SX, 2,4-D doboxyl + SX, 2,4-D-2-ethylhexyl + SX, 2,4-D-3-butoxypropyl + SX, 2,4-D-ammonium + SX, 2,4-D-butotyl + SX, 2,4-D-butyl + SX, 2,4-D-diethylammonium + SX, 2,4-D-dimethylammonium + SX, 2,4-D-diolamine + SX, 2,4-D-dodecylammonium + SX, 2,4-D-ethyl + SX, 2,4-D-heptylammonium + SX, 2,4-D-isobutyl + SX, 2,4-D-isooctyl + SX, 2,4-D-isopropyl + SX, 2,4-D-isopropylammonium + SX, 2,4-D-lithium + SX, 2,4-D-meptyl + SX,2,4-D-methyl + SX, 2,4-D-octyl + SX, 2,4-D-pentyl + SX, 2,4-D-propyl + SX, 2,4-D-sodium + SX, 2,4-D-tefuryl + SX, 2,4-D-tetradecylammonium + SX, 2,4-D-triethylammonium + SX, 2,4-D-tris(2-hydroxypropyl)ammonium + SX, 2,4-D-trolamine + SX, 2,4-DB + SX, 2,4-DB choline salt + SX, 2,4-DB biproamine + SX, 2,4-DB butyl + SX, 2,4-DB dimethylammonium + SX, 2,4-DB isoctyl + SX, 2,4-DB potassium salt + SX, 2,4-DB sodium salt + SX, acetochlor + SX, acifluorfen + SX, acifluorfen sodium + SX, aclonifen + SX, ACN (2-amino-3-chloronaphthalene-1,4-dione) + SX, alachlor + SX, alloxydim + SX, ametryn + SX, amicarbazone + SX, amidosulfuron + SX, aminocyclopyrachlor + SX,Aminocyclopyrachlor-methyl + SX, aminocyclopyrachlor-potassium + SX, aminopyralid + SX, aminopyralid choline salt + SX, aminopyralid-potassium + SX, aminopyralid-tripromine + SX, amiprophos-methyl + SX, amitrole + SX, anilofos + SX, asulam + SX, atrazine + SX, azafenidin + SX, azimsulfuron + SX, beflubutamid + SX Benazolin-ethyl + SX, bencarbazone + SX, benfluralin + SX, benfuresate + SX, benquitrione + SX, bensulfuron + SX, bensulfuron-methyl + SX, bensulide + SX, bentazon + SX, benthiocarb + SX, benzfendizone + SX, benzobicyclon + SX, benzofenap + SX, benzthiazuron + SX, bialaphos + SX, Bicyclopyrone + SX, Bifenox + SX, Bipyrazone + SX, Bispyribac + SX,Bispyribac-sodium + SX, bixlozone + SX, bromacil + SX, bromobutide + SX, bromofenoxim + SX, bromoxynil + SX, bromoxynil octanoate + SX, butachlor + SX, butafenacil + SX, butamifos + SX, butroxydim + SX, butyrate + SX, cafenstrole + SX, carbetamide + SX, carfentrazone + SX, Carfentrazone-ethyl + SX, chlomethoxyfen + SX, chloramben + SX, chloridazon + SX, chlorimuron + SX, chlorimuron + SX, chlorimuron-ethyl + SX, chlorbromuron + SX, chlorotoluron + SX, chloroxuron + SX, chlorpropham + SX, chlorsulfuron + SX, chlorthal-dimethyl + SX, chlorthiamid + SX, cinflubrolin + SX, cinidon + SX, cinidon-ethyl + SX, Cinmethylin + SX, Cinosulfuron + SX, Clethodim + SX, Clodinafop + SX,Clodinafop-propargyl + SX, clomazone + SX, clomeprop + SX, clopyralid + SX, clopyralid choline salt + SX, clopyralid-methyl + SX, clopyralid-olamine + SX, clopyralid-potassium + SX, clopyralid-tris(2-hydroxypropyl)ammonium + SX, cloransulam + SX, cloransulam-methyl + SX, cumyluron + SX, cyanazine + SX, Cycloate + SX, cyclopyranil + SX, cyclopyrimorate + SX, cyclosulfamuron + SX, cycloxydim + SX, cyhalofop + SX, cyhalofop-butyl + SX, cypyrafluone + SX, dalapon + SX, dazomet + SX, desmedipham + SX, desmetryn + SX, di-allate + SX, dicamba + SX, dicamba choline salt + SX, dicamba-biproamine + SX, Dicambatrolamine + SX, Dicamba-diglycolamine + SX,Dicamba dimethylammonium + SX, dicamba diolamine + SX, dicamba isopropylammonium + SX, dicamba methyl + SX, dicamba olamine + SX, dicamba potassium + SX, dicamba sodium + SX, dichlobenil + SX, dichlorprop choline + SX, dichlorprop biproamine + SX, dichlorprop-2-ethylhexyl + SX, dichlorprop-butotyl + SX, Dichlorprop-dimethylammonium + SX, dichlorprop-ethylammonium + SX, dichlorprop-isoctyl + SX, dichlorprop-methyl + SX, dichlorprop-P + SX, dichlorprop-P choline salt + SX, dichlorprop-P-biproamine + SX, dichlorprop-P-etexyl + SX, dichlorprop-P-dimethylammonium + SX, dichlorprop-potassium + SX, dichlorprop-sodium + SX Diclofop + SX,Diclofop-methyl + SX, diclosulam + SX, difenoxuron + SX, difenzoquat + SX, difenzoquat methylsulfate + SX, diflufenican + SX, diflufenzopyr + SX, diflufenzopyr sodium + SX, dimefuron + SX, dimepiperate + SX, dimepyrolimet + SX, dimesulfazet + SX, dimethachlor + SX Dimethametryn + SX, dimethenamid + SX, dimethenamid P + SX, dinitramine + SX, dinoseb + SX, dinoterb + SX, dioxopyritrione + SX, diphenamid + SX, diquat-dibromide + SX, disodium methylarsonate (DSMA) + SX, dithiopyr + SX, diuron + SX, 2-methyl-4,6-dinitrophenol (DNOC) + SX, epirifenacil + SX, esprocarb + SX SX, ethalfluralin + SX, ethametsulfuron + SX, ethametsulfuron-methyl + SX, ethidimuron + SX, ethofumesate + SX,Ethoxyfen-ethyl + SX, ethoxysulfuron + SX, etobenzanid + SX, fenoxaprop + SX, fenoxaprop-ethyl + SX, fenoxaprop-P + SX, fenoxaprop-P-ethyl + SX, fenoxasulfone + SX, fenpyrazone + SX, fenquinotrione + SX, fentrazamide + SX, fenuron + SX, feproxydim + SX, flamprop-M + SX SX, flazasulfuron + SX, florasulam + SX, florpyrauxifen + SX, florpyrauxifen-benzyl + SX, fluazifop + SX, fluazifop-butyl + SX, fluazifop-P + SX, fluazifop-P-butyl + SX, fluazolate + SX, flucarbazone + SX, flucarbazone-sodium + SX, flucetosulfuron + SX, fluchloraminopyr + SX Fluchloraminopyr-tefuryl + SX, Flufenacet + SX, Flufenauxirim + SX, Flufenauxirim-metotyl + SX,Flufenazopyr + SX, Flufenoximacil + SX, Flufenpyr + SX, Flufenpyr-ethyl + SX, Flumetsulam + SX, Flumetsulam + SX, Flumiclorac + SX, Flumiclorac-pentyl + SX, Flumioxazin + SX, Fluometuron + SX, Fluoroglycofen-ethyl + SX, Flupoxam + SX, Flupropanate + SX, Flupyrsulfuron + SX Flupyrsulfuron-methyl-sodium + SX, flurenol + SX, fluridone + SX, flurochloridone + SX, fluroxypyr + SX, fluroxypyr-butometyl + SX, fluroxypyr-meptyl + SX, flurtamone + SX, flusulfinam + SX, fluthiacet + SX, fluthiacet-methyl + SX, fomesafen + SX, fomesafen-sodium + SX, foramsulfuron + SX Fosamine + SX, glufosinate + SX, glufosinate-ammonium + SX, glufosinate-P + SX,Glufosinate-P-ammonium + SX, glufosinate-P-sodium + SX, glyphosate + SX, glyphosate choline + SX, glyphosate-isopropylammonium + SX, glyphosate-biproamine + SX, glyphosate-ammonium + SX, glyphosate-diammonium + SX, glyphosate-potassium + SX, glyphosate-sodium + SX, glyphosate-trimesium + SX Halauxifen + SX, halauxifen-benzyl + SX, halauxifen-methyl + SX, halosafen + SX, halosulfuron + SX, halosulfuron-methyl + SX, haloxyfop + SX, haloxyfop-ethotyl + SX, haloxyfop-methyl + SX, haloxyfop-P + SX, haloxyfop-P-ethotyl + SX, haloxyfop-P-methyl + SX, hexazinone + SX, icafolin + SX, Icafolin-methyl + SX, Imazamethabenz + SX, Imazamethabenz-methyl + SX,Imazamox + SX, imazamox-ammonium + SX, imazamox-sodium + SX, imazapic + SX, imazapic-ammonium + SX, imazapyr + SX, imazapyr-ammonium + SX, imazapyr-isopropylammonium + SX, imazaquin + SX, imazaquin-ammonium + SX, imazethapyr + SX, imazethapyr-ammonium + SX, imazosulfuron + SX, indanofan + SX Indaziflam + SX, indolauxipyr + SX, indolauxipyr-cyanomethyl + SX, iodosulfuron + SX, iodosulfuron-methyl-sodium + SX, iofensulfuron + SX, iofensulfuron-sodium + SX, ioxynil + SX, ioxynil-octanoate + SX, ipfencarbazone + SX, iptriazopyrid + SX, isoproturon + SX, isouron + SX Isoxaben + SX, Isoxachlortole + SX, Isoxafenacil + SX,Isoxaflutole + SX, lactofen + SX, lenacil + SX, linuron + SX, maleic hydrazide + SX, MCPA choline salt + SX, MCPA-biproamine + SX, MCPA-etexyl + SX, MCPA-butotyl + SX, MCPA-butyl + SX, MCPA-dimethylammonium + SX, MCPA-diolamine + SX, MCPA-ethyl + SX, MCPA-isobutyl + SX, MCPA-isoctyl + SX MCPA-isopropyl + SX, MCPA-methyl + SX, MCPA-olamine + SX, MCPA-sodium + SX, MCPA-trolamine + SX, MCPB (4-(4-chloro-2-methylphenoxy)butanoic acid) + SX, MCPB-choline + SX, MCPB-biproamine + SX, MCPB-ethyl + SX, MCPB-methyl + SX, MCPB-sodium + SX, mecoprop choline + SX, mecoprop-biproamine + SX Mecoprop-2-ethylhexyl + SX, Mecoprop-dimethylammonium + SX,Mecoprop-diolamine + SX, mecoprop-ethadyl + SX, mecoprop-isoctyl + SX, mecoprop-methyl + SX, mecoprop-potassium + SX, mecoprop-sodium + SX, mecoprop-trolamine + SX, mecoprop-P + SX, mecoprop-P choline + SX, mecoprop-P-2-ethylhexyl + SX, mecoprop-P-dimethylammonium + SX Mecoprop-P-isobutyl + SX, mecoprop-P-potassium + SX, mefenacet + SX, mesosulfuron + SX, mesosulfuron-methyl + SX, mesotrione + SX, metam + SX, metamifop + SX, metamitron + SX, metazachlor + SX, metazosulfuron + SX, methabenzthiazuron + SX, methiozolin + SX, methyldymron + SX Metobromuron + SX, metolachlor + SX, metoxuron + SX, metosulam + SX, metproxybicyclone + SX,Metribuzin + SX, metsulfuron + SX, metsulfuron-methyl + SX, molinate + SX, monolinuron + SX, naproanilide + SX, naproxen + SX, naproxen M + SX, naptalam + SX, neburon + SX, nicosulfuron + SX, norflurazon + SX, oleic acid + SX, orbencarb + SX, orthosulfamuron + SX, oryzalin + SX SX, oxadiargyl + SX, oxadiazon + SX, oxasulfuron + SX, oxaziclomefone + SX, oxyfluorfen + SX, paraquat + SX, paraquat-dichloride + SX, pebulate + SX, pelargonic acid + SX, pendimethalin + SX, penoxsulam + SX, pentanochlor + SX, pentoxazone + SX, pethoxamid + SX, phenisopham + SX, Phenmedipham + SX, picloram, picolinafen + SX, picolinafen + SX, pinoxaden + SX, piperophos + SX,Pretilachlor + SX, Primisulfuron + SX, Primisulfuron-methyl + SX, Prochlorosulfone + SX, Prodiamine + SX, Profluazol + SX, Propoxydim + SX, Prometon + SX, Prometryn + SX, Propachlor + SX, Propanil + SX, Propaquizafop + SX, Propazine + SX, Propham + SX, Propisochlor + SX, Propoxycarbazone + SX, Propoxycarbazone-sodium + SX SX, propyrisulfuron + SX, propyzamide + SX, prosulfocarb + SX, prosulfuron + SX, pyraclonil + SX, pyraquinate + SX, pyrasulfotole + SX, pyrazolinate + SX, pyrazosulfuron + SX, pyrazosulfuron-ethyl + SX, pyrazoxyfen + SX, pyribenzoxim + SX, pyributicarb + SX, pyridafol + SX, pyridate + SX Pyriflubenzoxim + SX, pyriftalid + SX, pyriminobac + SX,Pyriminobac-methyl + SX, pyrimisulfan + SX, pyrithiobac + SX, pyrithiobac-sodium + SX, pyroxasulfone + SX, pyroxsulam + SX, quinclorac + SX, quinmerac + SX, quizalofop + SX, quizalofop-ethyl + SX, quizalofop-tefuryl + SX, quizalofop-P + SX, quizalofop-P-ethyl + SX, Quizalofop-P-tefuryl + SX, rimisoxafen + SX, rimsulfuron + SX, saflufenacil + SX, sethoxydim + SX, EPTC (S-ethyl N,N-dipropylcarbamothioate) + SX, siduron + SX, simazine + SX, simetryn + SX, S-metolachlor + SX, MSMA (sodium hydrogen methylarsonate) + SX, sulcotrione + SX, sulfentrazone + SX, sulfometuron + SX, Sulfometuron-methyl + SX, sulfosulfuron + SX, swep + SX, TCA (2,2,2-trichloroacetic acid) + SX, TCA-ammonium + SX,TCA calcium + SX, TCA ethadyl + SX, TCA magnesium + SX, TCA sodium + SX, tebutam + SX, tebuthiuron + SX, tefuryltrione + SX, tembotrione + SX, tepraloxydim + SX, terbacil + SX, terbumeton + SX, terbuthylazine + SX, terbutryn + SX, tetflupyrolimet + SX, thaxtomin A + SX, Thenylchlor + SX, thiazopyr + SX, thidiazimin + SX, thiencarbazone + SX, thiencarbazone-methyl + SX, thifensulfuron + SX, thifensulfuron-methyl + SX, tiafenacil + SX, thiocarbazil + SX, tolpyralate + SX, topramezone + SX, tralkoxydim + SX, triafamone + SX, tri-allate + SX, triasulfuron + SX Triaziflam + SX, tribenuron + SX, tribenuron-methyl + SX, triclopyr + SX, triclopyr-butotyl + SX,Triclopyr-ethyl + SX, triclopyr-triethylammonium + SX, tridiphane + SX, trietazine + SX, trifloxysulfuron + SX, trifloxysulfuron-sodium + SX, trifludimoxazin + SX, trifluralin + SX, triflusulfuron + SX, triflusulfuron-methyl + SX, tripyrasulfone + SX, tritosulfuron + SX, vernolate + SX, 4-(4-fluorophenyl)-6-[(2-hydroxy-6-oxo-1-cyclohexen-1-yl)carbonyl]-2-methyl-1,2,4-triazine-3,5(2H,4H)-dione + SX, 2-chloro-N-(1-methyl-1H-tetrazol-5-yl)-3-(methylthio)-4-(trifluoromethyl)benzamide + SX, 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methanesulfonyl)-4-(trifluoromethyl)benzamide + SX, 1-{2-chloro-6-[(5-chloropyrimidin-2-yl)oxy]phenyl}-4,4,4-trifluorobutan-1-one (2052297-97-7) + SX. ,

[0056] The ratio of the compound of the present invention to the present component is not particularly limited, and examples thereof include a weight ratio (compound of the present invention:present component) of 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, 1:50, and the like.

[0057] Specific examples of targets to be controlled by the compound of the present invention include, but are not limited to, the following: Urticaceae weeds: Dwarf nettle (Urtica urens) Polygonaceae weeds: Bindweed (Polygonum convolvulus), Polygonum lapathifolium, Polygonum pensylvanicum, Polygonum persicaria, Polygonum longisetum, Willow (Polygonum aviculare), Willow (Polygonum arenastrum), Japanese knotweed (Polygonum cuspidatum), Rumex japonicus, Rumex crispus, Rumex obtusifolius, and Rumex acetosa. Portulacaceae weeds: Purslane (Portulaca oleracea) Caryophyllaceae weeds: Chickweed (Stellaria media), Cow chickweed (Stellaria aquatica), Earweed (Cerastium holosteoides), Dutch earweed (Cerastium glomeratum), Common clover (Spergula arvensis), Silene gallica. Molluginaceae weeds: Woodruff (Mollugo verticillata). Chenopodiaceae weeds: Chenopodium album, Common ragwort (Chenopodium ambrosioides), Kochia (Bassia scoparia), Salsola kali, Atriplex spp..

[0058] Amaranthaceae weeds: Amaranthus retroflexus, Amaranthus viridis, Amaranthus lividus, Amaranthus spinosus, Amaranthus hybridus, Amaranthus palmeri, Amaranthus patulus, Waterhemp (Amaranthus tuberculatus = Amaranthus rudis = Amaranthus tamariscinus), American blackweed (Amaranthus blitoides), Amaranthus deflexus, Amaranthus quitensis, Alternant weed (Alternanthera philoxeroides), Alternanthus sessilis, Sanguinaria (Alternanthera tenella) Papaveraceae: Corn poppy (Papaver rhoeas), Long-legged poppy (Papaver dubium), Thistle poppy (Argemone mexicana) Brassicaceae: Wild radish (Raphanus raphanistrum), Radish (Raphanus sativus), Field mustard (Sinapis arvensis), Shepherd's purse (Capsella bursa-pastoris), Common mustard (Brassica juncea), Common oilseed rape (Brassica napus), Descurainia pinnata, Burdock root (Rorippa islandica), Yellow mustard (Rorippa sylvestris), Shepherd's purse (Thlaspi arvense), Mountain mustard (Myagrum rugosum), Lepidium virginicum, Coronopus didymusCapparaceae weed: Cleome affinis

[0059] Legume weeds (Fabaceae): Water hyacinth (Aeschynomene indica), zigzag-jointed vetch (Aeschynomene rudis), American hornbeam (Sesbania exaltata), Slipper grass (Cassia obtusifolia), Boxweed (Cassia occidentalis), Day bush clover (Desmodium tortuosum), Field bush clover (Desmodium adscendens), Illinois bush clover (Desmodium illinoense), White clover (Trifolium repens), Kudzu (Pueraria lobata), Vetch (Vicia angustifolia), Japanese ragwort (Indigofera hirsuta), Indigofera truxillensis, Wild cowpea (Vigna sinensis). Oxalidaceae: Wood sorrel (Oxalis corniculata), Oxalis stricta, Oxalis oxyptera Geraniaceae: American buttercup (Geranium carolinense), Dutch buttercup (Erodium cicutarium) Euphorbiaceae: Spurge (Euphorbia helioscopia), Western jasmine (Euphorbia maculata), Cornus humistrata, Euphorbia esula, Cardamom (Euphorbia heterophylla), Hyssop-leaf sand mat (Euphorbia brasiliensis), Chinese hackberry (Acalypha australis), Tropic croton (Croton glandulosus), Lobed croton (Croton lobatus), Brazilian phyllanthus (Phyllanthus corcovadensis), castor bean (Ricinus communis)

[0060] Malvaceae: Abutilon theophrasti, Sida rhombifolia, Sida cordifolia, Sida spinosa, Sida glaziovii, Sida santaremnensis, Hibiscus trionum, Caladium laurel, Malvastrum coromandelianum. Onagraceae: Ludwigia epilobioides, Ludwigia octovalvis, Ludwigia decurrens, Oenothera biennis, Oenothera laciniata. Sterculiaceae (Sterculiaceae): Waltheria indica (Waltheria indica) Violaceae (Violaceae): Viola arvensis, Viola tricolor (Wild pansy) Cucurbitaceae (Cucurbitaceae): Sicyos angulatus, Echinocystis lobata, Momordica charantia (Wild bitter gourd) Lythraceae (Lythraceae): Ammannia multiflora, Ammannia auriculata, Ammannia coccinea, Lythrum salicaria, Rotala indica (Lythrum weed) Elatinaceae (Elatinaceae): Elatine triandra), California waterwort (Elatine californica)

[0061] Umbelliferae weeds (Apiaceae): Japanese parsley (Oenanthe javanica), wild carrot (Daucus carota), hemlock (Conium maculatum) Araliaceae weeds: Hydrocotyle sibthorpioides, Brazilian hydrocotyle (Hydrocotyle ranunculoides) Ceratophyllaceae weeds: Ceratophyllum demersum Cabombaceae weeds: Cabomba caroliniana Haloragaceae weeds: Water milfoil (Myriophyllum aquaticum), water milfoil (Myriophyllum verticillatum), water milfoil (Myriophyllum spicatum, Myriophyllum heterophyllum, etc.) Sapindaceae (Sapindaceae): Balloon vine (Cardiospermum halicacabum) Primulaceae (Primulaceae): Red-leaf chickweed (Anagallis arvensis) Asclepiadaceae (Asclepiadaceae): Giant milkweed (Asclepias syriaca), honeyvine milkweed (Ampelamus albidus) Rubiaceae (Rubiaceae): Catchweed bedstraw (Galium aparine), cleaver (Galium spurium var. echinospermon), broadleaf weed (Spermacoce latifolia), Brazilian false hawkweed (Richardia brasiliensis), winged phallus buttonweed (Borreria alata)

[0062] Convolvulaceae weeds: Morning glory (Ipomoea nil), American morning glory (Ipomoea hederacea), round morning glory (Ipomoea purpurea), round morning glory (Ipomoea hederacea var. integriuscula), common morning glory (Ipomoea lacunosa), starry morning glory (Ipomoea triloba), common morning glory (Ipomoea acuminata), ivy morning glory (Ipomoea hederifolia), common morning glory (Ipomoea coccinea), morning glory (Ipomoea quamoclit), Ipomoea grandifolia, Ipomoea aristolochiaefolia, sweet bindweed (Ipomoea cairica), and European bindweed (Convolvulus arvensis), Calystegia hederacea, Calystegia japonica, Merremia hederacea, Hairy woodrose (Merremia aegyptia), Roadside woodrose (Merremia cissoides), Morning glory (Jacquemontia tamnifolia) Boraginaceae: Forget-me-not (Myosotis arvensis) Lamiaceae: Lamium purpureum, Lamium amplexicaule, Leonotis nepetaefolia, Hyptis suaveolens, Hyptis lophanta, Leonurus sibiricus), Arvensis arvensis

[0063] Solanaceae weeds: Datura stramonium, Solanum nigrum, Solanum americanum, Solanum ptycanthum, Solanum sarrachoides, Solanum rostratum, Solanum aculeatissimum, Solanum sisymbriifolium, Solanum carolinense, Solanum angulata, Solanum subglabrata, Solanum persica (Nicandra physalodes). Scrophulariaceae weeds: Veronica hederaefolia, Solanum persica (Veronica persica), Veronica arvensis, Lindernia procumbens, Lindernia dubia, Lindernia angustifolia, Bacopa rotundifolia, Dopatrium junceum, Gratiola japonica. Plantaginaceae: Plantain (Plantago asiatica), Plantain lanceolata, Common plantain (Plantago major), Water chickweed (Callitriche palustris).

[0064] Asteraceae weeds: Cocklebur (Xanthium pensylvanicum), Giant cocklebur (Xanthium occidentale), Brimbur (Xanthium italicum), Wild sunflower (Helianthus annuus), Chamomile (Matricaria chamomilla), Chamomile (Matricaria perforata), Corn marigold (Chrysanthemum segetum), Oriental daisy (Matricaria matricarioides), Wormwood (Artemisia princeps), Artemisia vulgaris, Chinese mugwort (Artemisia verlotorum), Goldenrod (Solidago altissima), Dandelion (Taraxacum officinale), Dead daisy (Galinsoga ciliata), Japanese cornflower (Galinsoga parviflora), Groundsweet (Senecio vulgaris, Senecio brasiliensis, Senecio grisebachii, Ragweed (Conyza bonariensis), Ragweed (Conyza smatrensis), Artemisia canadensis, Ragweed (Ambrosia artemisiifolia), Mulberry (Ambrosia trifida), Bidens tripartita, Bidens pilosa, Bidens frondosa, Bidens subalternans, Thorn thistle (Cirsium arvense), American thistle (Cirsium vulgare), Milk thistle (Silybum marianum), Musk thistle (Carduus nutans), Lettuce (Lactuca serriola), common sowweed (Sonchus oleraceus), common sowweed (Sonchus asper), beach creeping oxeye (Wedeliaglauca), Perfoliate Blackfoot (Melampodium perfoliatum), Pale Bitter Gum (Emilia sonchifolia), Chiaroscuro (Tagetes minuta), Paracles (Blainvillea latifolia), Little Daisy (Tridax procumbens), Yerba Polosa (Porophyllum ruderale), Paraguay Starburst (Acanthospermum australe), Bristle Starburst (Acanthospermum hispidum), Balloon Vine (Cardiospermum halicacabum), Ageratum (Ageratum conyzoides), Common Boneset (Eupatorium perfoliatum), Dandlouze (Erechtites hieracifolia), American Everlasting (Gamochaeta spicata), White-legged Weevil (Gnaphalium spicatum), Jaegeria hiera (Jaegeria hirta), Cornflower (Parthenium hysterophorus), Oriental fir (Siegesbeckia orientalis), American snowdrop (Soliva sessilis), Eclipta prostrata, American snowdrop (Eclipta alba), Snowdrop (Centipeda minima)

[0065] Alismataceae weeds: Sagittaria pygmaea, Sagittaria trifolia, Sagittaria sagittifolia, Sagittaria montevidensis, Sagittaria aginashi, Alisma canaliculatum, Alisma plantago-aquatica Limnocharitaceae weeds: Limnocharis flava Hydrocharitaceae weeds: Frogbit (Limnobium spongia), Hydrilla verticillata, Common water nymph (Najas guadalupensis) Araceae weeds: Water duckweed (Pistia stratiotes) Duckweeds (Lemnaceae): Duckweed (Lemna aoukikusa, Lemna paucicostata, Lemna aequinoctialis), duckweed (Spirodela polyrhiza), water flea (Wolffia spp.)) Potamogetonaceae: Potamogeton distinctus, pondweeds (Potamogeton crispus, Potamogeton illinoensis, Stuckenia pectinata, etc.) Liliaceae: Wild onion (Allium canadense), wild garlic (Allium vineale), wild oak (Allium macrostemon) Pontederiaceae: Water hyacinth (Eichhornia crassipes), American boxwood (Heteranthera limosa), Japanese black laurel (Monochoria korsakowii), Japanese boxwood (Monochoria vaginalis) Commelinaceae: Dayflower (Commelina communis), common dayflower (Commelina benghalensis), erect dayflower (Commelina erecta), boxwood (Murdannia keisak).

[0066] Grass weeds (Poaceae): Barnyard grass (Echinochloa crus-galli), Oriental watergrass (Echinochloa oryzicola), Lesser Oriental watergrass (Echinochloa crus-galli var. formosensis), Latewatergrass (Echinochloa oryzoides), Lesser barnyard grass (Echinochloa colona), Gulf cockspur (Echinochloa crus-pavonis), Green foxtail (Setaria viridis), Setaria faberi, Golden foxtail (Setaria glauca), American green foxtail (Setaria geniculata), Large crabgrass (Digitaria ciliaris), Large crabgrass (Digitaria sanguinalis), Jamaican crabgrass (Digitaria horizontalis), Large crabgrass (Digitaria insularis), Common goosegrass (Eleusine indica), Annual bluegrass (Poa annua), Poa trivialis, Poa pratensis, Alopecurus aequalis, Blackgrass (Alopecurus myosuroides), Oat (Avena fatua), Sorghum halepense, Shattercane (Sorghum vulgare), Quackgrass (Agropyron repens), Lolium multiflorum, Lolium perenne, Lolium rigidum, Bromegrass (Bromus catharticus), Bromegrass (Bromus sterilis), Bromegrass (Bromus japonicus), Bromegrass (Bromus secalinus), Bromegrass (Bromus tectorum), Bromegrass (Hordeum jubatum), Goatgrass (Aegilops cylindrica), Reed canary grass (Phalaris arundinacea), Small canary grass (Phalarisminor), Silky bentgrass (Apera spica-venti), Common bentgrass (Panicum dichotomiflorum), Texas panicum (Panicum texanum), Guinea millet (Panicum maximum), American millet (Brachiaria platyphylla), Ruzigrass (Brachiaria ruziziensis), Alexandergrass (Brachiaria plantaginea), Surinamegrass (Brachiaria decumbens), Palisade grass (Brachiaria brizantha), Columbiagrass (Brachiaria humidicola), Sinqueweed moth (Cenchrus echinatus), Small chestnut moth (Cenchrus pauciflorus), Narco barnyard grass (Eriochloa villosa), Pennisetum (Pennisetum setosum), African brown grass (Chloris gayana), African brown grass (Chloris virgata), Eragrostis pilosa), Ruby grass (Rhynchelytrum repens), Seagrass (Dactyloctenium aegyptium), Taiwan grass (Ischaemum rugosum), Japanese bamboo grass (Isachne globosa), Wild rice (Oryza sativa), American paspalum (Paspalum notatum), Coastal sand paspalum (Paspalum maritimum), Knotgrass (Paspalum distichum), Kikuyu grass (Pennisetum clandestinum), Narrow-beaded grass (Pennisetum setosum), Horngrass (Rottboellia cochinchinensis), Japanese maple grass (Leptochloa chinensis), Japanese maple grass (Leptochloa fascicularis), Japanese threadgrass (Leptochloa filiformis), Amazon spangletop (Leptochloa panicoides), Leersia japonica, Leersiasayanuka), Siberian bog grass (Leersia oryzoides), Duckgrass (Glyceria leptorrhiza), Mutsuoregusa (Glyceria acutiflora), Loach grass (Glyceria maxima), Duckgrass (Agrostis gigantea), Siberian bog grass (Agrostis stolonifera), Horsegrass (Cynodon dactylon), Orchard grass (Dactylis glomerata), Centipede grass (Eremochloa ophiuroides), Tall fescue (Festuca arundinacea), Big fescue (Festuca rubra), Imperata cylindrica, Japanese silvergrass (Miscanthus sinensis), Switchgrass (Panicum virgatum), Zoysia japonica

[0067] Cyperaceae weeds: Cyperus microiria, Cyperus iria, Cyperus compressus, Cyperus difformis, Cyperus flaccidus, Cyperus globosus, Cyperus nipponicus, Cyperus odoratus, Cyperus serotinus, Cyperus rotundus, Cyperus esculentus, Kylerius gracillima, Kylerius brevifolia, Fimbristylis miliacea, Fimbristylis japonica dichotoma), Eleocharis acicularis, Eleocharis kuroguwai, Schoenoplectiella hotarui, Schoenoplectiella juncoides, Schoenoplectiella wallichii, Schoenoplectiella mucronatus, Schoenoplectiella triangulatus, Schoenoplectiella nipponicus, Schoenoplectiella triqueter, Bolboschoenus koshevnikovii, Bolboschoenus fluviatilis. Equisetaceae weeds: Horsetail (Equisetum arvense), Horsetail (Equisetum palustre). Salviniaceae weeds: Salvinia natans Azollaceae weeds: Azolla japonica, Azolla pinnataMarsileaceae weeds: Marsilea quadrifolia Others: Filamentous algae (Pithophora, Cladophora), mosses, liverworts, hornworts, cyanobacteria, ferns, suckers of perennial crops (pome fruits, stone fruits, berries, nuts, citrus fruits, hops, grapes, etc.).

[0068] The intraspecific mutations of the above-mentioned weeds are not particularly limited. They also include those with reduced susceptibility (also known as resistance) to certain herbicides. The reduced susceptibility may be due to a mutation at the target site (site mutation) or a factor other than site mutation (non-site mutation). Site mutations include those in the open reading frame (OPF) of a nucleic acid sequence corresponding to the amino acid sequence of a protein, resulting in an amino acid substitution in the target protein, and those resulting in overexpression of the target protein due to mutations such as deletion of a suppressor sequence in the promoter region, amplification of an enhancer sequence, or increased gene copy number. Factors that can cause reduced susceptibility due to non-site mutations include enhanced metabolism, inadequate absorption, inadequate translocation, and excretion from the system. Examples of factors that can cause enhanced metabolism include increased activity of metabolic enzymes such as cytochrome P450 monooxygenase (CYP), aryl acylamidase (AAA), esterase, glutathione S-transferase (GST), and cyanoalanine nitrilase. Examples of excretion include transport to vacuoles by ABC transporters. Examples of herbicide-resistant weeds include: Glyphosate resistance: Examples of reduced susceptibility due to site-of-action mutations include weeds with one or more of the following amino acid substitutions in the EPSPS gene: Thr102Ile, Pro106Ser, Pro106Ala, Pro106Leu, and Pro106Thr. In particular, weeds with both Thr102Ile and Pro106Ser, and those with both Thr102Ile and Pro106Thr, are particularly susceptible. These site-of-action mutations effectively control glyphosate-resistant species such as goosegrass, Lolium multiflorum, Celastrus oryzae, Ryegrass, and Bidens subalternans. A similar example of glyphosate resistance involving the site of action is increased copy number of the EPSPS gene (PNAS, 2018 115 (13) 3332-3337). According to the present invention, glyphosate-resistant plants such as amaryllis, water hemp, and kochia with an increased copy number of the EPSPS gene can be effectively controlled.Examples of weeds with reduced susceptibility due to non-active point mutations include weeds with glyphosate resistance due to ABC transporters, such as Artemisia gracilis, Rattus nigra, and Rattus gracilis, which can be effectively controlled by the present invention. Another non-active point mutation is barnyardgrass, which has reduced susceptibility to glyphosate due to increased expression of aldo-keto reductase (Plant Physiology 181, 1519-1534), and this can be effectively controlled by the present invention. Resistance to ALS-inhibiting herbicides: Examples of weeds with reduced susceptibility due to active point mutations include weeds with mutations in the ALS gene that cause one or more of the following amino acid substitutions: Ala122Thr, Ala122Val, Ala122Tyr, Pro197Ser, Pro197His, Pro197Thr, Pro197Arg, Pro197Leu, Pro197Gln, Pro197Ala, Pro197Ile, Ala205Val, Ala205Phe, Asp376Glu, Asp376Gln, Asp376Asn, Arg377His, Trp574Leu, Trp574Gly, Trp574Met, Ser653Thr, Ser653Asn, Ser635Ile, Gly654Glu, Gly645Asp. The present invention effectively controls ALS inhibitor-resistant plants such as Amaranthus retroflexus, Amaranthus retroflexus, Amaranthus retroflexus, waterhemp, and Kochia japonica, which have these site-of-action mutations. Examples of weeds with reduced susceptibility due to non-active site mutations include weeds that have become resistant to ALS inhibitors due to the involvement of CYP or GST, and these can be effectively controlled by the present invention. Examples include Bomugi (grass) overexpressing CYP81A10 or CYP81A1v1, Echinochloa oryzicola overexpressing CYP81A12 or CYP81A21, and Black-legged foxtail (grass) overexpressing GSTF1 or GSTU2. ACCase inhibitor resistance: Examples of weeds with reduced susceptibility due to active site mutations include weeds with mutations in the ACCase gene that result in one or more of the following amino acid substitutions:Ile1781Ala, Ile1781Leu, Ile1781Val, Ile1781Thr, Leu1818Phe, Trp1999Cys, Trp1999Leu, Trp1999Ser, Ala2004Val, Trp2027Cys, Trp2027Leu, Ile2041Asn, Ile2041Asp, Ile2041Val, Ile2041Thr, Asp2078Gly, Asp2078Glu, Cys2088Arg, Cys2088Phe, Gly2096Ala, Gly2096Ser.According to the present invention, ACCase-resistant weeds having these site-of-action mutations can be effectively controlled. Similarly, an example of ACCase inhibitor resistance involving the site of action is increased expression of the ACCase gene (Pest Manag. Sci. 2017 Nov;73(11):2227-2235). Examples of reduced susceptibility of weeds due to non-site mutations include weeds that have become resistant to ACCase inhibitors due to CYP or GST, and these can be effectively controlled by the present invention. Examples include Bomugi (grass) overexpressing CYP81A10 or CYP81A1v1, barnyardgrass overexpressing CYP81A12, CYP81A21, or CYP709C69, and Black-legged foxtail (Japanese ragweed) overexpressing GSTF1 or GSTU2. PPO inhibitor resistance: Examples of reduced susceptibility of weeds due to site-of-action mutations include weeds with mutations in the PPO gene that result in one or more of the following amino acid substitutions. These mutations are known to confer resistance to carfentrazone-ethyl, fomesafen, or lactofen, or are predicted to confer resistance.Arg128Leu, Arg128Met, Arg128Gly, Arg128His, Arg128Ala, Arg128Cys, Arg128Glu, Arg128Ile, Arg128Lys, Arg128Asn, Arg128Gln, Arg128Ser, Arg128Thr, Arg128Val, Arg128Tyr, Gly210 deletion, Ala210 deletion, Gly210Thr, Ala210Thr, Gly211 deletion, Gly114Glu, Ser149Ile, Val361Ala, Gly399Ala (all amino acid numbers are standardized to the sequence of PPO2 from Amaranthus palmeri). Typically, weeds have two PPO genes: the PPO1 gene and the PPO2 gene. The mutation may be present in either the PPO1 gene, the PPO2 gene, or both. The mutation is preferably present in the PPO2 gene. For example, Arg128Met means that there is a mutation at the 128th amino acid. In the ragweed PPO2 gene, this mutation corresponds to the 98th amino acid (Weed Science 60, 335-344), and is known as Arg98Leu. This Arg98 is synonymous with Arg128 in this specification.In the PPO genes of weeds targeted for control by the present invention, Arg128Met and Arg128Gly are known in Amaranthus retroflexus (Pest Management Science 73, 1559-1563), Arg128Gly is known in the PPO2 of waterhemp (Pest Management Science, 2019; 75: 3235-3244), Arg128Ile and Arg128Lys are known in the PPO2 of waterhemp (Pest Management Science, 2019; 75: 3235-3244), Arg128His is known as Arg132His in the PPO2 of Bouquet (WSSA annual meeting, 2018), and Gly114Glu, Ser149Ile, Val361Ala, and Gly399Ala are known in the PPO2 of Amaranthus retroflexus (Frontiers in Plant Science 10, Article 568 and Plants 2023, 12(9), 1886), and Ala210Thr is known as Ala212Thr in PPO1 of goosegrass (Pest Management Science, doi: 10.1002 / ps.5703). According to the present invention, PPO inhibitor-resistant weeds having these site-of-action mutations can be effectively controlled, but the PPO inhibitor-resistant weeds to be controlled are not limited to these. That is, not only amaryllis plants having the Arg128Leu, Arg128Met, Arg128Gly, Arg128His, Arg128Ala, Arg128Cys, Arg128Glu, Arg128Ile, Arg128Lys, Arg128Asn, Arg128Gln, Arg128Ser, Arg128Thr, Arg128Val, Arg128Tyr, Gly210 deficiency, Ala210 deficiency, Gly210Thr, Ala210Thr, Gly211 deficiency, Gly114Glu, Ser149Ile, or Gly399Ala mutation in PPO1 or PPO2, but also, for example, waterhemp, ragweed, and dayflower having the same mutations can be effectively controlled.Examples of reduced susceptibility of weeds due to non-acting point mutations include waterhemp and amaryllis retroflexus that have become resistant to PPO inhibitors due to CYP or GST, as well as waterhemp that has become resistant to carfentrazone ethyl (PLOS ONE, doi: 10.1371 / journal.pone.0215431). These can be effectively controlled by the present invention. Resistance to auxin-based herbicides: An example of a non-acting point mutation is a mutation that causes Gly-Asn in the degron region of the AUX / IAA gene. This invention effectively controls Kochia, amaryllis retroflexus, and waterhemp that possess this mutation. Examples of non-acting point mutations include dicamba-resistant amaryllis retroflexus and 2,4-D-resistant waterhemp, which are suggested to be CYP-mediated. These can be effectively controlled by the present invention. The same applies to non-acting point mutations involving GST. HPPD inhibitor resistance: An example of HPPD inhibitor resistance involving the site of action is increased expression of the HPPD gene (Frontiers in Plant Science, 2017, 8: 555). Examples of weeds with reduced susceptibility due to non-site mutations include waterhemp and amaryllis, which have become resistant to HPPD inhibitors due to CYP or GST, and these can be effectively controlled by the present invention. Known examples include amaryllis, which overexpresses CYP72A219, CYP81B, and CYP81E8. Photosystem II inhibitor resistance: An example of weeds with reduced susceptibility due to site mutations is weeds with one or more of the following amino acid substitutions in the psbA gene: Val219Ile, Ser264Gly, Ser264Ala, and Phe274Val. The present invention effectively controls Amaranthus retroflexus and waterhemp that have these site-of-action mutations and are resistant to photosystem II inhibitors.Examples of weeds with reduced susceptibility due to non-site-of-action mutations include Amaranthus retroflexus and waterhemp that are resistant to photosystem II inhibitors due to the involvement of CYP, GST, or AAA, and these can be effectively controlled by the present invention.One example of this is known to be boumugi (a kind of weed) with overexpression of CYP71R4. Glutamate synthase inhibitor resistance: An example of reduced susceptibility in weeds due to site-of-action mutations is a weed with a mutation in the glutamine synthase gene that causes an amino acid substitution of Asp171Asn. The present invention effectively controls glutamine synthase inhibitor-resistant weeds such as ambrosia and waterhemp that have this mutation. An example of glutamate synthase inhibitor resistance involving the site of action is an increase in the copy number of the glutamate synthase gene (Weed Science, 2022, 70.4: 370-379). An example of reduced susceptibility in weeds due to non-site-of-action mutations is ambrosia and waterhemp that have become glufosinate-resistant due to CYP or GST, and these weeds are effectively controlled by the present invention. An example of such a resistant weed is ambrosia retroflexus, which overexpresses CYP72A219, CYP81B, or CYP81E8. Even resistant weeds that are "stacked" (combined) with resistance to two or more of the above groups (randomly selected group 2, randomly selected group 3, randomly selected group 4, randomly selected group 5, randomly selected group 6, group 7, or group 8) are effectively controlled. An example of a stacked resistant weed is waterhemp, which is resistant to photosystem II inhibitors, HPPD inhibitors, 2,4-D, PPO inhibitors, ALS inhibitors, and glyphosate, and is also effectively controlled. The stacked weeds may be a combination of active point mutations, a combination of non-active point mutations, or a combination of active and non-active point mutations.

[0069] The compound of the present invention or Composition A is typically formulated into aqueous suspensions, oil suspensions, oil solutions, emulsifiable concentrates, emulsions, microemulsions, microcapsule formulations, wettable powders, water dispersible granules, dusts, granules, tablets, aerosols, resin formulations, etc. by mixing an inert carrier such as a solid carrier, liquid carrier, or gaseous carrier with a surfactant, and optionally adding formulation adjuvants such as binders, dispersants, and stabilizers. In addition to these formulations, the compound of the present invention or Composition A can also be formulated into dosage forms described in the Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271 to 276, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2016, ISSN:0259-2517. These formulations typically contain 0.0001 to 99% by weight of the compound of the present invention or Composition A.

[0070] Examples of solid carriers include clay (pyrophyllite clay, kaolin clay, etc.), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid clay, attapulgite, white carbon, ammonium sulfate, vermiculite, perlite, pumice, silica sand, fine powder and granular chemical fertilizers (ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride, etc.), and resins (polyethylene, polypropylene, polyester, polyurethane, polyamide, polyvinyl chloride, etc.).

[0071] Examples of liquid carriers include water, alcohols (ethanol, cyclohexanol, benzyl alcohol, propylene glycol, polyethylene glycol, etc.), ketones (acetone, cyclohexanone, etc.), aromatic hydrocarbons (xylene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, etc.), esters (ethyl acetate, methyl oleate, propylene carbonate, etc.), nitriles (acetonitrile, etc.), ethers (ethylene glycol dimethyl ether, etc.), amides (N,N-dimethylformamide, N,N-dimethyloctanamide, etc.), sulfoxides (dimethyl sulfoxide, etc.), lactams (N-methylpyrrolidone, N-octylpyrrolidone, etc.), fatty acids (oleic acid, etc.), and vegetable oils (soybean oil, etc.).

[0072] Examples of gaseous carriers include fluorocarbons, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide gas.

[0073] Examples of surfactants include nonionic surfactants (polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyethylene glycol fatty acid esters, etc.) and anionic surfactants (alkyl sulfonates, alkylaryl sulfonates, alkyl sulfates, etc.).

[0074] Other formulation adjuvants include binders, dispersants, colorants, stabilizers, etc., and specific examples include polysaccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), acid isopropyl phosphate, and dibutylhydroxytoluene.

[0075] In addition, adjuvants can be used as components that enhance or support the efficacy of the compound of the present invention. Specific examples include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), Sundance II (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark).

[0076] The compound of the present invention can be used in agricultural land where useful plants are cultivated to control weeds in the agricultural land. Examples of the useful plants include the following.

[0077] Corn (horse-tooth, hard grain, soft grain, explosive, glutinous, sweet, field corn), rice (long grain, short grain, medium grain, japonica, tropical japonica, indica, javanica, paddy rice, upland rice, floating rice, direct-seeded rice, transplanted rice, glutinous rice), wheat (bread wheat (hard, soft, medium, red wheat, white wheat), durum wheat, spelt wheat, club wheat, each winter wheat type, spring wheat type), barley (two-row barley (= beer barley), six-row barley, naked barley, waxy barley, each winter barley type, spring barley type), rye (winter rye type, spring rye type), triticale (winter triticale type, spring triticale type), oats (winter oat type, spring oat type), sorghum, cotton (upland type, pima type), soybean (fully harvested seed varieties, edamame varieties, green-harvested varieties, indeterminate, determinate, semi-determinate types), peanuts, buckwheat, sugar beet (sugar production, animal feed, root vegetable, leafy vegetable, fuel), rapeseed (winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type), sunflower (oil production, food, ornamental), sugarcane, tobacco, tea plant, mulberry, solanaceous vegetables (eggplant, tomato, bell pepper, chili pepper) , potatoes, etc.), Cucurbitaceae vegetables (cucumber, pumpkin, zucchini, watermelon, melon, etc.), Cruciferous vegetables (radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard greens, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, garland chrysanthemum, artichoke, lettuce, etc.), Liliaceae vegetables (leeks, onions, garlic, asparagus, etc.), Umbelliferae vegetables (carrots, parsley, celery, parsley, etc.), Chenopodiaceae vegetables (spinach, Swiss chard, etc.), Lamiaceae vegetables (perilla, mint, basil, etc.), strawberries, sweet potatoes, yams, scallions, Sweet potatoes, pome fruits (apples, European pears, Japanese pears, Chinese pears, quince, quince, etc.), stone fruits (peaches, plums, nectarines, plums, cherries, apricots, prunes, etc.), citrus fruits (Satsuma mandarins, oranges, lemons, limes, grapefruits, etc.), nuts (chestnuts, walnuts, hazelnuts, almonds, pistachios, cashew nuts, macadamia nuts, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, figs, olives, loquats, bananas, coffee, dates, coconuts, ornamental plants, forest plants,Turfgrass, pasture grass,

[0078] The useful plants are not particularly limited as long as they are varieties that are commonly cultivated, and include plants that can be produced by natural crossbreeding, plants that can be generated by mutation, F1 hybrid plants, and genetically modified crops. Examples of genetically modified crops include plants that have been conferred resistance to herbicides such as HPPD (4-hydroxyphenylpyruvate dioxygenase enzyme) inhibitors such as isoxaflutole, ALS (acetolactate synthase) inhibitors such as imazethapyr and thifensulfuron methyl, EPSP (5-enolpyruvylshikimate-3-phosphate synthase) inhibitors, glutamine synthetase inhibitors, PPO (protoporphyrinogen oxidase) inhibitors, bromoxynil, or dicamba; plants that are capable of synthesizing selective toxins known to be found in the genus Bacillus, such as Bacillus thuringiensis; and plants that can be conferred specific insecticidal activity by synthesizing gene fragments that partially match endogenous genes derived from harmful insects and inducing gene silencing (RNAi; RNA interference) in the target harmful insect.

[0079] The weed control method of the present invention comprises the step of applying an effective amount of the compound of the present invention to weeds or to a place where weeds grow or will grow. 2 The compound of the present invention is usually used in an amount of 5 to 5,000 g, preferably 10 to 1,000 g, per acre. When applying the compound of the present invention or Composition A, a spraying device can be used. Examples of devices used for application include a hand-cranked sprayer, a power sprayer, a pancrusher sprayer, a manned aircraft (such as a manned helicopter), an unmanned aircraft (such as a radio-controlled helicopter or drone), a tractor, a planter, and the like. Alternatively, the compound may be applied by hand without using a spraying device.

[0080] In the weed control method of the present invention, the compound of the present invention is usually used in the form of the herbicidal composition of the present invention. Examples of the weed control method of the present invention include a method of foliar application of the herbicidal composition of the present invention to weeds, a method of applying the herbicidal composition of the present invention to the soil surface where weeds grow or are likely to grow, a method of incorporation of the herbicidal composition of the present invention into soil where weeds grow, and a method of applying the herbicidal composition of the present invention to the surface water of a paddy field flooded with water where weeds grow or are likely to grow. Methods of applying the herbicidal composition of the present invention include a uniform area application method and a selective spot application method. Even when the herbicidal composition of the present invention is sprayed in small amounts in an area where weeds do not grow or where there is no risk of weeds growing due to drift, transpiration, etc., it is included in the spot application as long as it is not a uniform area application. Furthermore, spot treatment does not necessarily mean that all areas where weeds grow or are likely to grow in a continuous area where useful plants are cultivated are selectively treated. That is, even if part of the cultivation area is treated over an entire area, or even if some areas where weeds grow or are likely to grow are not treated with the herbicidal composition of the present invention, spot treatment is still considered to be a spot treatment as long as there are areas in the continuous area where useful plants are cultivated that have been spot-treated. Spot treatment may be carried out while avoiding useful plants, or may be carried out based only on the location of weeds, regardless of the location of useful plants.

[0081] Specific examples of spot treatment methods are given below. Spot treatment may be performed by visually spraying the herbicidal composition of the present invention using a handheld nozzle or robotic arm nozzle while an applicator is walking or riding on a ground-based or flying device in a cultivation area of ​​useful plants. Furthermore, spot treatment may be performed by mapping the area where weeds are growing or are likely to grow in advance and spraying the compound of the present invention or the herbicidal composition of the present invention containing the compound of the present invention and one or more compounds selected from the compound of the present invention and the present component based on the map information. In spraying based on map information, in addition to the above-mentioned methods, spot treatment may be performed by automatically or manually opening and closing the boom nozzle or robotic arm nozzle while the sprayer is traveling or flying, based on the sprayer's position information (obtained by GPS, etc.) and the map information. The map information may be created based on image information captured by a manned or unmanned flying object, or may be created visually by an observer walking on the ground, riding on a ground-based or flying device, or by an observer riding on a flying device. Furthermore, a traveling or flying sprayer may be equipped with a function for detecting areas where weeds are growing or are likely to grow, and spot treatment may be performed using the boom or robot arm while performing real-time mapping. Such techniques are described in patent documents (e.g., WO 2018 / 001893, WO 2018 / 036909) and non-patent documents (e.g., Crop Protection 26, 270-277, Weed Technology 17, 711-717, Applied Engineering in Agriculture 30, 143-152). These technologies are a form of emerging agriculture known as precision agriculture, smart agriculture, or digital agriculture, and the uneven application pattern caused by the spot treatment is also referred to as VRA (Variable Rate Application) in the emerging agriculture field. Locations where weeds are likely to grow may be estimated based on the fact that the weeds formed vegetation patches in past growing seasons, or may be estimated from the distribution of buried seeds in the soil.The distribution of seed banks can be investigated by soil sampling or estimated by remote sensing.

[0082] The present invention will be explained in more detail below with reference to Production Examples, Formulation Examples, Test Examples, etc., but the present invention is not limited to these examples. First, production examples of the compounds of the present invention and their production intermediates will be shown.

[0083] When the physical properties of a compound are measured by liquid chromatography / mass spectrometry (hereinafter referred to as LCMS), the measured molecular ion value [M+H] ＋ or [M-H] － and retention time (hereinafter referred to as RT). The conditions for liquid chromatography (hereinafter referred to as LC) are as follows:

[0084] [LC conditions] Column: L-column 2 ODS, inner diameter 4.6 mm, length 30 mm, particle size 3 μm (Chemicals Evaluation and Research Institute, Japan) UV measurement wavelength: 254 nm Mobile phase: Solution A: 0.1% formic acid aqueous solution, Solution B: 0.1% formic acid acetonitrile Flow rate: 2.0 mL / min Gradient conditions: Solution was delivered at the concentration gradient shown in [Table LC1].

[0085]

[0086] Reference manufacturing example 1

[0087] STEP 1: Preparation of 4-trifluoromethoxybenzenediazonium chloride aqueous solution (hereinafter referred to as solution A) 17.7 g of 4-(trifluoromethoxy)aniline, 80 mL of water, and 80 mL of 3N hydrochloric acid were mixed at room temperature and then cooled in an ice bath. To the resulting aqueous solution, an aqueous sodium nitrite solution (6.9 g of sodium nitrite / 50 mL of water) was added dropwise under ice cooling, and the mixture was stirred for 10 minutes to obtain solution A.

[0088] STEP 2: Diazo Coupling 12.6 g of 4-hydroxy-6-methyl-2H-pyran-2-one, 100 mL of water, and 25.4 g of sodium carbonate were mixed at room temperature, and then Solution A was added dropwise with stirring under ice cooling. After the dropwise addition was completed, the resulting slurry was gradually warmed to room temperature, and then an aqueous sodium thiosulfate solution was added and stirred at room temperature for 15 minutes. The target hydrazone compound was obtained by filtering the solid from the resulting slurry.

[0089] STEP 3: Pyridazinone Cyclization The hydrazone compound obtained in STEP 2 and 200 mL of 1N aqueous sodium hydroxide were mixed at room temperature and stirred under reflux for 1 hour. After cooling to room temperature, 3N hydrochloric acid was added. The precipitated solid was collected by filtration to obtain 26.8 g of Intermediate 1 represented by the following formula. Intermediate 1: 1 H-NMR (CDCl3) δ: 7.53-7.41 (4H, m), 6.91 (1H, s), 2.35 (3H, s).

[0090] Reference Production Example 2 25.1 g of Intermediate 1, 80 mL of DMF, 16.6 g of potassium carbonate, and 18.7 g of ethyl iodide were mixed at room temperature and stirred at 50°C for 3 hours. Methyl tert-butyl ether (hereinafter referred to as MTBE) and water were added to the obtained mixture, and the layers were separated. The obtained organic layer was dried over magnesium sulfate and concentrated under reduced pressure to obtain 13.7 g of Intermediate 2 represented by the following formula: Intermediate 2: 1 H-NMR (CDCl3) δ: 7.45-7.37 (4H, m), 6.59 (1H, s), 4.42 (2H, q), 2.18 (3H, s), 1.38 (3H, t).

[0091] Reference Production Example 3: 13.7 g of Intermediate 2, 7.48 g of N-bromosuccinimide, and 80 mL of acetonitrile were mixed at room temperature and stirred at 60°C for 2 hours. After removing the solvent under reduced pressure, ethyl acetate was added to the resulting residue, and the mixture was washed successively with a mixed solution of aqueous sodium thiosulfate and saturated aqueous sodium bicarbonate, water, and saturated brine. The resulting organic layer was dried over magnesium sulfate and concentrated under reduced pressure to obtain 17.3 g of Intermediate 3 represented by the following formula: Intermediate 3: 1 H-NMR (CDCl3) δ: 7.47-7.39 (4H, m), 4.43 (2H, q), 2.44 (3H, s), 1.38 (3H, t).

[0092] Preparation Example 1: 632 mg of Intermediate 3, 336 mg of 1-cyclopentenylboronic acid, 147 mg of [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride, 955 mg of tripotassium phosphate, 3 mL of 1,2-dimethoxyethane, and 1.5 mL of purified water were mixed at room temperature and then stirred at 70°C for 30 minutes. Saturated brine was added to the resulting mixture, and the mixture was extracted with MTBE. The resulting organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain 216 mg of Compound 1 of the present invention, which is represented by the following formula: Compound 1 of the present invention: 1 H-NMR (CDCl3) δ: 7.46-7.35 (4H, m), 5.78-5.76 (1H, m), 4.41 (2H, q), 2.67-2.62 (2H, m), 2.56-2.50 (2H, m), 2.15 (3H, s), 2.07-1.96 (2H, m), 1.37 (3H, t).

[0093] Preparation Example 2: A mixture of 160 mg of compound 1 of the present invention, 80 mg of palladium-carbon (palladium 10%, 55% wet with water), and 20 mL of ethanol was stirred at room temperature under a hydrogen atmosphere for 4 hours. The mixture was filtered, and the obtained filtrate was concentrated under reduced pressure to give 141 mg of compound 2 of the present invention represented by the following formula. Compound 2 of the present invention: 1H-NMR (CDCl3) δ: 7.43-7.36 (4H, m), 4.41 (2H, q), 3.15-3.05 (1H, m), 2.21 (3H, s), 2.17-2.09 (2H, m), 2.02-1.93 (2H, m), 1.77-1.58 (4H, m), 1.37 (3H, t).

[0094] Preparation Example 3: 4 mL of 1 M aqueous sodium hydroxide solution and 4 mL of ethanol were added to 100 mg of compound 2 of the present invention, and the mixture was stirred at room temperature for 30 minutes. After removing the ethanol under reduced pressure, 4 mL of 3 M hydrochloric acid was added. The precipitated solid was collected by filtration to obtain 67 mg of compound 3 of the present invention. Compound 3 of the present invention: 1 H-NMR (CDCl3) δ: 7.45-7.40 (4H, m), 3.22-3.13 (1H, m), 2.36 (3H, s), 2.16-1.97 (4H, m), 1.85-1.67 (4H, m).

[0095] Reference Preparation Example 4: 3.07 g of 5-acetyl-1-(4-chlorophenyl)-1,4-dihydro-6-methyl-4-oxo-3-pyridazinecarboxylic acid prepared by the method described in European Patent Application Publication No. 0089137, 10 mL of DMF, 1.87 g of ethyl iodide, and 1.66 g of potassium carbonate were mixed at room temperature and stirred for 3 hours. MTBE was added to the resulting mixture, which was then washed successively with water and saturated brine. The resulting organic layer was concentrated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=1:1) to give 603 mg of intermediate 4 represented by the following formula: Intermediate 4: 1 H-NMR (CDCl3) δ: 7.56-7.51 (2H, m), 7.33-7.28 (2H, m), 4.43 (2H, q), 2.64 (3H, s), 2.21 (3H, s), 1.38 (3H, t).

[0096] Reference Production Example 5: To 1.67 g of Intermediate 4, 10 mL of ethanol and 189 mg of sodium borohydride were added sequentially under ice cooling. The mixture was warmed to room temperature and stirred for 1 hour. 3 M hydrochloric acid was then slowly added to the resulting mixture, followed by extraction with ethyl acetate. The resulting organic layer was concentrated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=1:2) to obtain 603 mg of Intermediate 5 represented by the following formula: Intermediate 5: 1 H-NMR (CDCl3) δ: 7.44-7.37 (4H, m), 5.56 (1H, d), 4.90-4.81 (1H, m), 4.43 (2H, q), 2.19 (3H, s), 1.59 (3H, d), 1.38 (3H, t).

[0097] Preparation Example 4: 337 mg of Intermediate 5, 1 g of concentrated sulfuric acid, and 5 mL of methanol were mixed at room temperature and then stirred at 50°C for 30 minutes. The resulting mixture was poured into a mixture of MTBE and water and extracted with MTBE. The resulting organic layer was washed successively with saturated aqueous sodium bicarbonate and saturated brine, and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain 279 mg of the present compound 4 represented by the following formula. Compound 4 of the present invention: 1 H-NMR (CDCl3) δ: 7.54-7.49 (2H, m), 7.32-7.28 (2H, m), 5.17 (1H, q), 3.94 (3H, s), 3.28 (3H, s), 2.32 (3H, s), 1.43 (3H, d).

[0098] Preparation Example 5 A mixture of 100 mg of the present compound 21, 22.6 mg of potassium carbonate, 0.7 mL of methanol and 0.7 mL of water was stirred at room temperature for 1 hour, and the resulting mixture was concentrated under reduced pressure to give 100 mg of the present compound 22. Compound 22 of the present invention: 1H-NMR (DMSO-D6) δ: 7.74-7.70 (2H, m), 7.68-7.64 (2H, m), 3.25-3.18 (1H, m), 2.29 (3H, s), 1.35 (6H, d).

[0099] Preparation Example 6: A mixture of 100 mg of the present compound 21, 0.06 mL of isopropylamine, and 0.7 mL of THF was stirred at room temperature for 1 hour. The resulting mixture was concentrated under reduced pressure, and the resulting solid was washed with ethyl acetate to give 109 mg of the present compound 23. Compound 23 of the present invention: 1 H-NMR (DMSO-D6) δ: 7.63-7.59 (2H, m), 7.49-7.45 (2H, m), 3.27-3.20 (1H, m), 3.11-3.04 (1H, m), 2.12 (3H, s), 1.28 (6H, d), 1.15 (6H, d).

[0100] Reference Production Example 6: 107 g of methyl isobutyl ketone, 163 g of acetic anhydride, and 200 mL of boron trifluoride diethyl ether complex were mixed at room temperature and stirred at 50°C for 12 hours. Aqueous sodium acetate solution (262 g of sodium acetate / 800 mL of water) was added to the resulting mixture and stirred at 70°C for 6 hours. MTBE was added, and the mixture was separated. The resulting organic layer was washed with aqueous sodium hydroxide solution, dried over magnesium sulfate, and concentrated under reduced pressure. The resulting mixture was distilled under reduced pressure to obtain 15.1 g of Intermediate 6. Intermediate 6: 1 H-NMR (CDCl3) δ: 3.42 (1H, d), 2.53-2.45 (1H, m), 2.17 (6H, s), 0.90 (6H, d).

[0101] Reference Preparation Example 7: To 308 mL of a 1.9 M sodium bis(trimethylsilyl)amide / THF solution, a solution of Intermediate 6 (27.7 g) in THF (200 mL) was added dropwise over 1 hour at 0-5°C. The resulting mixture was stirred under ice-cooling for 1 hour, and then a solution of dimethyl carbonate (17.6 g) in THF (100 mL) was added dropwise over 1 hour at 0-5°C, followed by stirring at room temperature for 2 hours. MTBE and 10% hydrochloric acid were added to the resulting mixture, and the layers were separated. The resulting organic layer was washed with saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=4:1) to obtain 14.2 g of Intermediate 7. Intermediate 7: 1 H-NMR (CDCl3) δ: 3.76-3.70 (3H, m), 3.56-3.48 (2H, m), 2.55-2.35 (1H, m), 2.23-2.17 (3H, m), 0.97-0.88 (6H, m).

[0102] Reference Preparation Example 8: 10 g of methyl isobutyl ketone, 20 g of propionic anhydride, and 20 mL of boron trifluoride diethyl ether complex were mixed at room temperature and stirred at 70°C for 6 hours. A sodium acetate aqueous solution (25 g of sodium acetate / 80 mL of water) was added to the resulting mixture and stirred at 70°C for 2 hours. MTBE was added, and the mixture was separated. The resulting organic layer was washed with a sodium hydroxide aqueous solution, dried over magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=4:1) to obtain 4.10 g of Intermediate 8. Intermediate 8: 1 H-NMR (CDCl3) δ: 3.41 (1H, d), 2.57-2.38 (3H, m), 2.16 (3H, s), 1.03 (3H, t), 0.91-0.88 (6H, m).

[0103] Reference Preparation Example 9: To 449 mL of a 1.9 M sodium bis(trimethylsilyl)amide / THF solution, a solution of intermediate 8 (44.5 g) in THF (285 mL) was added dropwise over 1 hour at 0-5°C. The resulting mixture was stirred for 1 hour under ice-cooling, and then a solution of dimethyl carbonate (25.6 g) in THF (142 mL) was added dropwise over 1 hour at 0-5°C, followed by stirring at room temperature for 1 hour. MTBE and 10% hydrochloric acid were added to the resulting mixture, and the layers were separated. The resulting organic layer was washed with saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (hexane:ethyl acetate=8:1) to obtain 35.3 g of intermediate 9. Intermediate 9: 1 H-NMR (CDCl3) δ: 3.76-3.69 (3H, m), 3.59-3.44 (2H, m), 2.67-2.36 (3H, m), 1.07-1.01 (3H, m), 0.95-0.88 (6H, m).

[0104] Production Example 7

[0105] STEP 1: Preparation of Solution B 80 mg of 1,2-dimethyl-1H-benzimidazol-5-amine, 1 mL of methanol, 3 mL of water, and 0.4 mL of 3N hydrochloric acid were mixed at room temperature and then cooled in an ice bath. To the resulting aqueous solution, an aqueous solution of sodium nitrite (37 mg of sodium nitrite / 2 mL of water) was added dropwise under ice cooling, and the mixture was stirred for 10 minutes under ice cooling to obtain Solution B.

[0106] STEP 2: Diazo Coupling 100 mg of Intermediate 7, 5 mL of water, 3 mL of methanol, and 127 mg of sodium carbonate were mixed at room temperature, and then Solution B was added dropwise with stirring under ice cooling. After the addition was complete, the resulting mixture was gradually warmed to room temperature, and 3 mL of 1N aqueous sodium hydroxide was added and stirred at room temperature for 3 hours. The reaction mixture was neutralized with hydrochloric acid and extracted with ethyl acetate. The resulting residue was subjected to reverse-phase column chromatography (water:acetonitrile = 1:1) to obtain 137 mg of the present invention compound 252 represented by the following formula. Compound 252 of the present invention 1H-NMR (CDCl3) δ: 7.99 (1H, d), 7.74 (1H, d), 7.34 (1H, dd), 3.96 (3H, s), 3.29-3.15 (1H, m), 2.88 (3H, s), 2.30 (3H, s), 1.44 (6H, d).

[0107] Production Example 7 The production method and the methods described in the Production Examples are accurate to the production of the compounds and their physical properties are shown below.

[0108] Compound 5 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.53–7.48 (2H, m), 7.30–7.27 (2H, m), 4.40 (2H, q), 2.30 (3H, s), 1.56–1.48 (1H, m), 1.37 (3H, t), 1.01–0.95 (4H, m). Compound 6 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.52 (2H, m), 7.34–7.29 (2H, m), 2.45 (3H, s), 1.67–1.59 (1H, m), 1.15–1.04 (4H, m). Compound 7 of this invention: 1 H-NMR (CDCl3) δ: 7.43-7.35 (4H, m), 4.40 (2H, q), 2.31 (3H, s), 1.55-1.50 (1H, m), 1.37 (3H, t), 1.03-0.96 (4H, m).

[0109] This compound 8: 1 ¹H-NMR (CDCl₃) δ: 7.46–7.39 (4H, m), 2.46 (3H, s), 1.68–1.59 (1H, m), 1.15–1.06 (4H, m). Compound 9 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.47–7.39 (4H, m), 3.27–3.17 (1H, m), 2.36 (3H, s), 1.44 (6H, d). Compound 10 of this invention: 1H-NMR (CDCl3) δ: 7.43-7.35 (4H, m), 4.41 (2H, q), 3.16 (1H, dq), 2.20 (3H, s), 1.41-1.35 (9H, m).

[0110] Compound 11 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.44–7.37 (4H, m), 7.24–7.17 (1H, m), 6.25–6.20 (1H, m), 4.42 (2H, q), 2.26 (3H, s), 1.94 (3H, dd), 1.38 (3H, t). Compound 12 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.59–7.53 (2H, m), 7.37–7.33 (2H, m), 5.52–5.50 (1H, m), 5.03 (1H, s), 2.30 (3H, s), 2.07 (3H, s). Compound 13 of this invention: 1 H-NMR (CDCl3) δ: 7.49-7.40 (4H, m), 5.91 (1H, t), 2.70-2.58 (4H, m), 2.30 (3H, s), 2.13-2.05 (2H, m).

[0111] This compound 14: 1 ¹H-NMR (CDCl₃) δ: 7.52–7.49 (2H, m), 7.31–7.28 (2H, m), 3.93 (3H, s), 3.18–3.11 (1H, m), 2.19 (3H, s), 1.38 (6H, d). Compound 15 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.55–7.47 (3H, m), 7.35–7.32 (2H, m), 4.41 (2H, q), 3.23–3.12 (1H, m), 2.18 (3H, s), 1.44–1.34 (9H, m). Compound 16 of this invention: 1 H-NMR (CDCl3) δ: 7.44-7.37 (4H, m), 5.18 (1H, q), 3.95 (3H, s), 3.29 (3H, s), 2.34 (3H, s), 1.44 (3H, d).

[0112] This compound 17: 1 ¹H-NMR (CDCl₃) δ: 7.44–7.37 (4H, m), 5.29 (1H, q), 4.42 (2H, q), 3.52–3.36 (2H, m), 2.36 (3H, s), 1.43 (3H, d), 1.38 (3H, t), 1.18 (3H, dd). Compound 18 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.46–7.41 (4H, m), 5.29 (1H, q), 3.58–3.37 (2H, m), 2.51 (3H, s), 1.48 (3H, d), 1.22 (3H, dd). Compound 19 of this invention: 1 H-NMR (CDCl3) δ: 7.65 (1H, d), 7.53 (1H, d), 7.26-7.22 (1H, m), 2.47 (3H, s), 1.65-1.58 (1H, m), 1.15-1.05 (4H, m).

[0113] This compound 20: 1 ¹H-NMR (CDCl₃) δ: 7.36–7.31 (2H, m), 7.24–7.19 (2H, m), 4.40 (2H, q), 2.29 (3H, s), 1.53 (1H, ddd), 1.37 (3H, t), 1.03–0.94 (4H, m). Compound 21 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.52 (2H, m), 7.35–7.31 (2H, m), 3.25–3.18 (1H, m), 2.34 (3H, s), 1.43 (6H, d). Compound 24 of this invention: 1 H-NMR (CDCl3) δ: 7.46-7.41 (4H, m), 5.18 (1H, q), 3.34 (3H, s), 2.48 (3H, s), 1.49 (3H, d).

[0114] This compound 25: 1¹H-NMR (CDCl₃) δ: 7.53 (¹H, d), 7.29 (¹H, d), 7.16 (¹H, dd), 5.50 (¹H, t), 5.03 (¹H, s), 2.46 (³H, s), 2.31 (³H, s), 2.07 (³H, s). Compound 26 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.60 (¹H, d), 7.46 (¹H, dd), 7.41 (¹H, d), 5.38 (¹H, t), 4.93 (¹H, s), 4.41 (2H, q), 2.10 (3H, s), 2.03 (3H, s), 1.38 (3H, t). Compound 27 of this invention: 1 H-NMR (CDCl3) δ: 7.61 (1H, t), 7.51-7.44 (2H, m), 3.29-3.17 (1H, m), 2.29 (3H, s), 1.43 (6H, dd).

[0115] This compound 28: 1 ¹H-NMR (CDCl₃) δ: 7.41–7.36 (2H, m), 7.26–7.20 (2H, m), 2.44 (3H, s), 1.67–1.61 (1H, m), 1.14–1.03 (4H, m). Compound 29 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.65 (¹H, d), 7.55 (¹H, d), 7.26 (¹H, dd), 3.25–3.18 (¹H, m), 2.37 (³H, s), 1.42 (⁶H, d). Compound 30 of this invention: 1 H-NMR (CDCl3) δ: 7.58 (1H, d), 7.44 (1H, dd), 7.39 (1H, d), 4.40 (2H, q), 3.22-3.12 (1H, m), 2.13 (3H, s), 1.40-1.36 (9H, m).

[0116] This compound 31: 1¹H-NMR (CDCl₃) δ: 7.61 (¹H, d), 7.50 (¹H, d), 7.22 (¹H, dd), 4.40 (2H, q), 2.33 (3H, s), 1.56–1.48 (¹H, m), 1.37 (3H, t), 1.02–0.97 (4H, m). Compound 32 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.61 (¹H, d), 7.50 (¹H, d), 7.22 (¹H, dd), 4.41 (2H, q), 3.20–3.10 (¹H, m), 2.21 (3H, s), 1.40–1.36 (9H, m). Compound 33 of this invention: 1 H-NMR (CDCl3) δ: 7.41-7.37 (2H, m), 7.26-7.20 (2H, m), 3.29-3.16 (1H, m), 2.34 (3H, s), 1.43 (6H, d).

[0117] This compound 34: 1 ¹H-NMR (CDCl₃) δ: 7.57 (¹H, dd), 7.21 (¹H, dd), 7.12 (¹H, ddd), 4.40 (2H, q), 2.33 (3H, s), 1.56–1.49 (¹H, m), 1.37 (3H, t), 1.02–0.95 (4H, m). Compound 35 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.57 (¹H, t), 7.21 (¹H, dd), 7.13 (¹H, ddd), 4.41 (2H, q), 3.18–3.11 (¹H, m), 2.21 (3H, s), 1.39–1.36 (9H, m). Compound 36 of this invention: 1 H-NMR (CDCl3) δ: 7.61 (1H, t), 7.27 (1H, dd), 7.17 (1H, ddd), 3.25-3.17 (1H, m), 2.37 (3H, s), 1.43 (6H, d).

[0118] This compound 37: 1¹H-NMR (CDCl₃) δ: 7.46–7.33 (3H, m), 3.26–3.18 (1H, m), 2.34 (3H, d), 1.46–1.40 (6H, m). Compound 38 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.39 (¹H, t), 7.34–7.29 (²H, m), 4.41 (²H, q), 3.19–3.12 (¹H, m), 2.19 (³H, d), 1.40–1.36 (⁹H, m). Compound 39 of this invention: 1 H-NMR (CDCl3) δ: 7.61 (1H, dd), 7.26 (1H, dd), 7.16 (1H, ddd), 2.47 (3H, s), 1.66-1.60 (1H, m), 1.15-1.05 (4H, m).

[0119] This compound 40: 1 ¹H-NMR (CDCl₃) δ: 7.52–7.48 (2H, m), 7.31–7.28 (2H, m), 4.40 (2H, q), 2.86 (1H, s), 2.18 (3H, s), 2.10–1.96 (1H, m), 1.81–1.71 (1H, m), 1.39–1.35 (6H, m), 0.87 (3H, t). Compound 41 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.46 (¹H, t), 7.40–7.36 (²H, m), 7.22 (¹H, d), 3.28–3.21 (¹H, m), 2.26 (³H, s), 2.07 (³H, s), 1.44 (⁶H, d). Compound 42 of this invention: 1 H-NMR (CDCl3) δ: 7.56-7.52 (2H, m), 7.35-7.33 (2H, m), 3.09-3.02 (1H, m), 2.65 (2H, q), 1.47 (6H, d), 1.13 (3H, t).

[0120] This compound 43: 1¹H-NMR (CDCl₃) δ: 7.51 (¹H, d), 7.27 (¹H, d), 7.13 (¹H, dd), 3.25–3.18 (¹H, m), 2.45 (³H, s), 2.35 (³H, s), 1.42 (⁶H, d). Compound 44 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.57–7.52 (2H, m), 7.34–7.30 (2H, m), 3.00–2.90 (1H, m), 2.33 (3H, s), 2.05–1.97 (1H, m), 1.88–1.77 (1H, m), 1.40 (3H, d), 0.89 (3H, t). Compound 45 of this invention: 1 H-NMR (CDCl3) δ: 7.40 (1H, d), 7.37 (1H, dd), 7.19 (1H, d), 3.26-3.19 (1H, m), 2.25 (3H, s), 2.06 (3H, s), 1.43 (6H, d).

[0121] This compound 46: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.52 (2H, m), 7.30–7.26 (2H, m), 3.29–3.22 (1H, m), 3.07–3.00 (1H, m), 1.48 (6H, d), 1.35 (6H, d). Compound 47 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.35–7.32 (2H, m), 7.23–7.19 (2H, m), 4.41 (2H, q), 3.20–3.13 (1H, m), 2.18 (3H, s), 1.39 (9H, dd). Compound 48 of this invention: 1 H-NMR (CDCl3) δ: 7.54-7.49 (2H, m), 7.34-7.30 (2H, m), 5.77-5.75 (1H, m), 4.41 (2H, q), 2.67-2.62 (2H, m), 2.55-2.50 (2H, m), 2.14 (3H, s), 2.06-1.97 (2H, m), 1.37 (3H, t).

[0122] This compound 49: 1 ¹H-NMR (CDCl₃) δ: 7.44 (2H, d), 7.39–7.31 (5H, m), 7.23–7.18 (2H, m), 5.38 (2H, s), 3.21–3.15 (1H, m), 2.17 (3H, s), 1.38 (6H, d). Compound 50 of this invention: 1 H-NMR (CDCl3) δ: 7.52-7.48 (2H, m), 7.31-7.27 (2H, m), 4.33 (2H, t), 3.20-3.13 (1H, m), 2.19 (3H, s), 1.78-1.73 (2H, m), 1.39-1.33 (10H, m), 0.89 (3H, t).

[0123] This compound 51: 1 ¹H-NMR (CDCl₃) δ: 7.52–7.47 (2H, m), 7.46–7.42 (2H, m), 7.38–7.28 (5H, m), 5.38 (2H, s), 3.21–3.14 (1H, m), 2.18 (3H, s), 1.38 (6H, d). Compound 52 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.60 (¹H, d), 7.48 (¹H, d), 7.44 (2H, dd), 7.36–7.31 (3H, m), 7.20 (¹H, dd), 5.38 (2H, s), 3.20–3.13 (¹H, m), 2.20 (3H, s), 1.37 (6H, d). Compound 53 of this invention: 1 H-NMR (CDCl3) δ: 7.54 (2H, d), 7.33 (2H, d), 3.21-3.12 (1H, m), 2.35 (3H, s), 2.16-2.08 (2H, m), 2.04-1.96 (2H, m), 1.83-1.75 (2H, m), 1.74-1.66 (2H, m).

[0124] This compound 54: 1¹H-NMR (CDCl₃) δ: 7.48 (¹H, d), 7.23 (¹H, d), 7.11 (¹H, dd), 4.40 (2H, q), 3.19–3.12 (¹H, m), 2.44 (3H, s), 2.19 (3H, s), 1.40–1.35 (9H, m). Compound 55 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.53–7.48 (2H, m), 7.31–7.29 (2H, m), 4.40 (2H, q), 3.13–3.04 (1H, m), 2.20 (3H, s), 2.18–2.09 (2H, m), 2.01–1.93 (2H, m), 1.75–1.61 (4H, m), 1.37 (3H, t). Compound 56 of this invention: 1 H-NMR (CDCl3) δ: 7.46-7.43 (2H, m), 7.39-7.28 (6H, m), 5.38 (2H, s), 3.20-3.13 (1H, m), 2.18 (3H, d), 1.40-1.35 (6H, m).

[0125] This compound 57: 1 ¹H-NMR (CDCl₃) δ: 7.51–7.48 (2H, m), 7.31–7.27 (2H, m), 5.31–5.21 (1H, m), 3.22–3.15 (1H, m), 2.18 (3H, s), 1.38–1.35 (12H, m). Compound 58 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.57–7.53 (2H, m), 7.34–7.30 (2H, m), 5.17 (1H, q), 3.33 (3H, s), 2.47 (3H, s), 1.48 (3H, d). Compound 59 of this invention: 1 H-NMR (CDCl3) δ: 7.54-7.49 (2H, m), 7.32-7.28 (2H, m), 7.23-7.15 (1H, m), 6.22 (1H, dq), 4.42 (2H, q), 2.25 (3H, s), 1.94 (3H, dd), 1.38 (3H, t).

[0126] This compound 60: 1 ¹H-NMR (CDCl₃) δ: 7.53–7.49 (2H, m), 7.33–7.30 (2H, m), 5.92–5.89 (1H, m), 4.41 (2H, q), 2.08 (3H, s), 1.93 (3H, dd), 1.60 (3H, d), 1.37 (3H, t). Compound 61 of this invention: 1 H-NMR (CDCl3) δ: 7.55 (2H, d), 7.34 (2H, d), 5.92 (1H, s), 2.24 (3H, s), 2.01 (3H, s), 1.64 (3H, s).

[0127] This compound 62: 1 ¹H-NMR (CDCl₃) δ: 7.51 (2H, d), 7.30 (2H, d), 4.41 (2H, q), 2.61 (2H, t), 2.17 (3H, s), 1.53–1.35 (7H, m), 0.94 (3H, t). Compound 63 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.54 (2H, d), 7.32 (2H, d), 2.44 (3H, s), 1.34 (3H, s), 0.97 (2H, s), 0.80 (2H, s). Compound 64 of this invention: 1 H-NMR (CDCl3) δ: 7.55-7.52 (2H, m), 7.35-7.30 (2H, m), 2.70 (2H, t), 2.32 (3H, s), 1.55-1.41 (4H, m), 0.98 (3H, t).

[0128] This compound 65: 1 ¹H-NMR (CDCl₃) δ: 7.28–7.24 (2H, m), 7.03–7.01 (2H, m), 3.88 (3H, s), 3.26–3.19 (1H, m), 2.35 (3H, s), 1.43 (6H, d). Compound 66 of this invention: 1¹H-NMR (CDCl₃) δ: 7.26–7.23 (2H, m), 7.02–6.97 (2H, m), 4.40 (2H, q), 3.86 (3H, s), 3.18 (1H, dt), 2.17 (3H, s), 1.39–1.35 (9H, m). Compound 67 of this invention: 1 H-NMR (CDCl3) δ: 7.53-7.48 (2H, m), 7.31-7.28 (2H, m), 4.41 (2H, q), 3.20-3.12 (1H, m), 2.19 (3H, s), 1.39-1.35 (9H, m).

[0129] This compound 68: 1 ¹H-NMR (CDCl₃) δ: 7.54–7.48 (¹H, m), 7.43 (¹H, td), 7.34–7.24 (²H, m), 4.41 (²H, q), 3.21–3.14 (¹H, m), 2.19 (³H, d), 1.41–1.36 (⁹H, m). Compound 69 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.53 (2H, dd), 7.33 (2H, dd), 6.00–5.98 (¹H, m), 4.94–4.91 (2H, m), 4.85–4.82 (2H, m), 4.41 (2H, q), 2.22 (3H, s), 1.38 (3H, t). Compound 70 of this invention: 1 H-NMR (CDCl3) δ: 7.52-7.48 (2H, m), 7.31-7.27 (2H, m), 4.30 (2H, t), 3.21-3.14 (1H, m), 2.19 (3H, s), 1.82-1.73 (2H, m), 1.38 (6H, d), 0.98 (3H, t).

[0130] This compound 71: 1¹H-NMR (CDCl₃) δ: 7.53–7.49 (2H, m), 7.32–7.28 (2H, m), 7.24–7.19 (1H, m), 6.20 (1H, dt), 4.42 (2H, q), 2.31–2.23 (5H, m), 1.38 (3H, t), 1.09 (3H, t). Compound 72 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.50 (2H, d), 7.29 (2H, d), 4.41 (2H, q), 2.29 (3H, s), 1.38 (3H, t), 1.29 (3H, s), 0.85 (2H, s), 0.72 (2H, s). Compound 73 of this invention: 1 H-NMR (CDCl3) δ: 7.61 (1H, d), 7.50 (1H, d), 7.22 (1H, dd), 3.93 (3H, s), 3.18-3.09 (1H, m), 2.22 (3H, s), 1.38 (6H, d).

[0131] This compound 74: 1 ¹H-NMR (CDCl₃) δ: 7.60 (¹H, d), 7.50 (¹H, d), 7.21 (¹H, dd), 5.30–5.23 (¹H, m), 3.21–3.14 (¹H, m), 2.20 (³H, s), 1.39–1.36 (¹²H, m). Compound 75 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.55–7.51 (2H, m), 7.33–7.29 (2H, m), 2.44 (3H, s), 1.56 (9H, s). Compound 76 of this invention: 1 H-NMR (CDCl3) δ: 7.57-7.48 (2H, m), 7.41 (1H, t), 7.30-7.27 (1H, m), 3.26-3.19 (1H, m), 2.36 (3H, s), 1.43 (6H, d).

[0132] This compound 77: 1¹H-NMR (CDCl₃) δ: 7.71–7.69 (2H, m), 7.25–7.24 (2H, m), 3.25–3.18 (1H, m), 2.34 (3H, s), 1.43 (6H, d). Compound 78 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.67–7.65 (2H, m), 7.24–7.21 (2H, m), 4.40 (2H, q), 3.18–3.13 (1H, m), 2.19 (3H, s), 1.39–1.35 (9H, m). Compound 79 of this invention: 1 H-NMR (CDCl3) δ: 7.92-7.89 (2H, m), 7.13-7.10 (2H, m), 3.25-3.18 (1H, m), 2.34 (3H, s), 1.42 (6H, d).

[0133] This compound 80: 1 ¹H-NMR (CDCl₃) δ: 7.87–7.85 (2H, m), 7.10–7.08 (2H, m), 4.40 (2H, q), 3.19–3.12 (1H, m), 2.19 (3H, s), 1.39–1.35 (9H, m). Compound 81 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.85 (2H, d), 7.54 (2H, d), 3.26–3.19 (1H, m), 2.35 (3H, s), 1.44 (6H, d). Compound 82 of this invention: 1 H-NMR (CDCl3) δ: 8.43-8.39 (2H, m), 7.59-7.55 (2H, m), 4.41 (2H, q), 3.21-3.11 (1H, m), 2.23 (3H, t), 1.42-1.38 (9H, m).

[0134] This compound 83: 1 ¹H-NMR (CDCl₃) δ: 7.51–7.47 (2H, m), 7.30–7.26 (2H, m), 4.39 (2H, q), 2.28 (3H, s), 1.51 (9H, s), 1.36 (3H, s). Compound 84 of this invention: 1¹H-NMR (CDCl₃) δ: 7.52–7.49 (2H, m), 7.33–7.31 (2H, m), 4.40 (2H, q), 2.98–2.92 (1H, m), 2.52 (2H, q), 1.43 (6H, d), 1.37 (3H, t), 1.06 (3H, t). Compound 85 of this invention: 1 H-NMR (CDCl3) δ: 7.81 (2H, d), 7.50 (2H, d), 4.41 (2H, q), 3.22-3.11 (1H, m), 2.21 (3H, s), 1.40-1.36 (9H, m).

[0135] This compound 86: 1 ¹H-NMR (CDCl₃) δ: 8.46–8.43 (2H, m), 7.64–7.60 (2H, m), 3.25–3.20 (1H, m), 2.37 (3H, s), 1.44 (6H, d). Compound 87 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.47–7.44 (2H, m), 7.35–7.32 (2H, m), 4.41 (2H, q), 3.49–3.42 (1H, m), 1.75–1.71 (1H, m), 1.42 (6H, d), 1.38 (3H, t), 0.87 (2H, dt), 0.47 (2H, q). Compound 88 of this invention: 1 H-NMR (CDCl3) δ: 7.52-7.49 (2H, m), 7.41-7.38 (2H, m), 3.61-3.54 (1H, m), 1.88-1.80 (1H, m), 1.46 (6H, d), 0.99-0.96 (2H, m), 0.57-0.54 (2H, m).

[0136] This compound 89: 1¹H-NMR (CDCl₃) δ: 7.54–7.51 (2H, m), 7.32–7.28 (2H, m), 6.22 (1H, t), 5.93 (1H, q), 4.42 (2H, q), 2.31 (3H, s), 1.58 (3H, d), 1.39 (3H, dd). Compound 90 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.54–7.49 (2H, m), 7.37–7.33 (2H, m), 6.29 (1H, t), 5.97 (1H, q), 2.45 (3H, s), 1.64 (3H, d). Compound 91 of this invention: 1 H-NMR (CDCl3) δ: 7.39-7.35 (2H, m), 7.27-7.24 (2H, m), 3.26-3.18 (1H, m), 2.54 (3H, s), 2.35 (3H, s), 1.43 (6H, d).

[0137] This compound 92: 1 ¹H-NMR (CDCl₃) δ: 8.81 (¹H, dd), 8.69 (¹H, d), 7.78 (¹H, ddd), 7.55 (¹H, ddd), 3.27–3.20 (¹H, m), 2.36 (³H, s), 1.44 (⁶H, d). Compound 93 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.37–7.32 (2H, m), 7.25–7.22 (2H, m), 4.40 (2H, q), 3.22–3.11 (1H, m), 2.53 (3H, s), 2.19 (3H, s), 1.39–1.35 (9H, m). Compound 94 of this invention: 1 H-NMR (CDCl3) δ: 7.35-7.28 (2H, m), 7.23-7.20 (2H, m), 4.40 (2H, q), 3.22-3.12 (1H, m), 2.45 (3H, s), 2.17 (3H, s), 1.42-1.37 (9H, m).

[0138] This compound 95: 1¹H-NMR (CDCl₃) δ: 7.35–7.33 (2H, m), 7.24–7.21 (2H, m), 3.26–3.19 (1H, m), 2.45 (3H, s), 2.33 (3H, s), 1.43 (6H, d). Compound 96 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.54 (¹H, m), 7.30–7.28 (¹H, m), 7.19–7.12 (²H, m), 3.26–3.19 (¹H, m), 2.36 (³H, s), 1.43 (⁶H, d). Compound 97 of this invention: 1 H-NMR (CDCl3) δ: 7.56-7.47 (1H, m), 7.27-7.20 (1H, m), 7.16-7.11 (2H, m), 4.46-4.38 (2H, m), 3.22-3.11 (1H, m), 2.21 (3H, s), 1.38-1.37 (9H, m).

[0139] This compound 98: 1 ¹H-NMR (CDCl₃) δ: 7.51 (¹H, dd), 7.36–7.27 (²H, m), 3.25–3.18 (¹H, m), 2.35 (³H, s), 1.42 (⁶H, d). Compound 99 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.85 (¹H, d), 7.74 (¹H, t), 7.66 (¹H, s), 7.60 (¹H, d), 3.26–3.19 (¹H, m), 2.34 (³H, s), 1.44 (⁶H, d). Compound 100 of this invention: 1 H-NMR (CDCl3) δ: 7.46 (1H, dd), 7.32-7.23 (2H, m), 4.41 (2H, q), 3.21-3.10 (1H, m), 2.20 (3H, s), 1.40-1.36 (9H, m).

[0140] This compound 101: 1¹H-NMR (CDCl₃) δ: 8.78–8.74 (¹H, m), 8.66 (¹H, d), 7.75–7.72 (¹H, m), 7.53–7.49 (¹H, m), 4.41 (2H, q), 3.22–3.12 (¹H, m), 2.21 (3H, s), 1.41–1.35 (9H, m). Compound 102 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.78 (¹H, d), 7.73–7.64 (²H, m), 7.57 (¹H, d), 4.43 (²H, q), 3.22–3.12 (¹H, m), 2.20 (³H, s), 1.40–1.35 (⁹H, m). Compound 103 of this invention: 1 H-NMR (CDCl3) δ: 8.78 (1H, d), 8.57 (1H, d), 7.83 (1H, t), 3.26-3.19 (1H, m), 2.38 (3H, s), 1.43 (6H, d).

[0141] This compound 104: 1 ¹H-NMR (CDCl₃) δ: 7.87–7.85 (2H, m), 7.47–7.44 (2H, m), 3.26–3.19 (1H, m), 2.35 (3H, s), 1.44 (6H, d). Compound 105 of this invention: 1 ¹H-NMR (CDCl₃) δ: 8.71 (¹H, d), 8.55 (¹H, d), 7.75 (¹H, t), 4.42 (²H, q), 3.19–3.12 (¹H, m), 2.24 (³H, s), 1.40–1.36 (⁹H, m). Compound 106 of this invention: 1 H-NMR (CDCl3) δ: 7.63 (1H, t), 7.45-7.43 (1H, m), 7.36-7.34 (1H, m), 7.28-7.26 (1H, m), 3.26-3.19 (1H, m), 2.35 (3H, s), 1.43 (6H, d).

[0142] This compound 107: 1¹H-NMR (CDCl₃) δ: 7.91–7.89 (¹H, m), 7.74 (¹H, t), 7.36–7.34 (¹H, m), 7.31–7.27 (¹H, m), 3.25–3.18 (¹H, m), 2.35 (³H, s), 1.43 (⁶H, d). Compound 108 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.57–7.52 (2H, m), 7.33–7.31 (2H, m), 2.62 (2H, d), 2.32 (3H, s), 2.06–1.96 (1H, m), 1.00 (6H, d). Compound 109 of this invention: 1 H-NMR (CDCl3) δ: 7.68-7.66 (2H, m), 7.35-7.32 (2H, m), 3.26-3.19 (2H, m), 2.34 (3H, s), 1.43 (6H, q).

[0143] This compound 110: 1 ¹H-NMR (CDCl₃) δ: 7.61–7.53 (2H, m), 7.37–7.30 (2H, m), 3.68–3.49 (1H, m), 2.40 (3H, s), 1.64–1.49 (3H, m). Compound 111 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.89–7.79 (¹H, m), 7.74–7.70 (¹H, m), 7.34–7.24 (²H, m), 4.40 (²H, q), 3.21–3.10 (¹H, m), 2.19 (³H, s), 1.40–1.35 (⁹H, m). Compound 112 of this invention: 1 H-NMR (CDCl3) δ: 7.83-7.81 (2H, m), 7.56-7.52 (2H, m), 4.41 (2H, q), 3.20-3.13 (1H, m), 2.79 (3H, s), 2.21 (3H, s), 1.40-1.36 (9H, m).

[0144] This compound 113: 1¹H-NMR (CDCl₃) δ: 7.40–7.37 (2H, m), 7.33–7.28 (2H, m), 6.59 (1H, t), 3.26–3.19 (1H, m), 2.35 (3H, s), 1.43 (6H, d). Compound 114 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.84–7.81 (2H, m), 7.44–7.39 (2H, m), 4.41 (2H, q), 3.22–3.11 (1H, m), 2.21 (3H, s), 1.43–1.36 (9H, m). Compound 115 of this invention: 1 H-NMR (CDCl3) δ: 7.57 (1H, t), 7.39-7.36 (1H, m), 7.33-7.31 (1H, m), 7.25-7.25 (1H, m), 4.41 (2H, q), 3.21-3.11 (1H, m), 2.20 (3H, s), 1.39-1.37 (9H, m).

[0145] This compound 116: 1 ¹H-NMR (CDCl₃) δ: 7.52–7.45 (¹H, m), 7.13–7.04 (²H, m), 3.26–3.19 (¹H, m), 2.34 (³H, d), 1.43 (⁶H, dd). Compound 117 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.37–7.35 (2H, m), 7.29–7.26 (2H, m), 6.58 (1H, t), 4.41 (2H, q), 3.19–3.13 (1H, m), 2.19 (3H, s), 1.39–1.36 (9H, m). Compound 118 of this invention: 1 H-NMR (CDCl3) δ: 7.66-7.61 (2H, m), 7.33-7.29 (2H, m), 4.42 (2H, q), 3.21-3.13 (2H, m), 2.20 (3H, s), 1.43-1.36 (9H, m).

[0146] This compound 119: 1¹H-NMR (CDCl₃) δ: 9.04 (¹H, dd), 8.28–8.20 (²H, m), 7.87 (¹H, d), 7.66 (¹H, dd), 7.54 (¹H, dd), 4.41 (²H, q), 3.24–3.17 (¹H, m), 2.25 (³H, s), 1.43–1.35 (⁹H, m). Compound 120 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.44–7.39 (¹H, m), 7.06–7.01 (¹H, m), 6.91–6.89 (¹H, m), 6.86 (¹H, t), 4.40 (2H, q), 3.85 (3H, s), 3.22–3.12 (¹H, m), 2.20 (3H, s), 1.40–1.35 (9H, m). Compound 121 of this invention: 1 H-NMR (CDCl3) δ: 7.47-7.40 (1H, m), 7.09-7.00 (2H, m), 4.41 (2H, q), 3.22-3.11 (1H, m), 2.18 (3H, d), 1.40-1.36 (9H, m).

[0147] This compound 122: 1 ¹H-NMR (CDCl₃) δ: 7.52–7.48 (2H, m), 7.28–7.24 (2H, m), 4.39 (2H, q), 3.16–3.09 (1H, m), 2.89–2.82 (1H, m), 1.45 (6H, d), 1.37 (3H, t), 1.29 (6H, d). Compound 123 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.55-7.50 (2H, m), 7.39-7.31 (2H, m), 4.26-4.18 (1H, m), 4.06-3.92 (3H, m), 3.71-3.60 (1H, m), 2.44-2.34 (4H, m), 2.22-2.12 (1H, m). Compound 124 of this invention: 1H-NMR (CDCl3) δ: 7.53-7.48 (2H, m), 7.34-7.28 (2H, m), 4.41 (2H, q), 2.22-2.14 (4H, m), 1.42 (3H, d), 1.38 (3H, t), 1.28-1.19 (1H, m), 0.61-0.54 (1H, m), 0.43-0.35 (1H, m), 0.21-0.14 (1H, m), 0.04-0.02 (1H, m).

[0148] This compound 125: 1 ¹H-NMR (CDCl₃) δ: 8.18 (2H, d), 7.63 (2H, d), 3.27–3.19 (1H, m), 3.12 (3H, s), 2.37 (3H, s), 1.44 (6H, d). Compound 126 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.57-7.52 (2H, m), 7.36-7.31 (2H, m), 2.32-2.17 (4H, m), 1.67-1.58 (1H, m), 1.47 (3H, d), 0.70-0.60 (1H, m), 0.49-0.40 (1H, m), 0.28-0.19 (1H, m), 0.08-0.02 (1H, m). Compound 127 of this invention: 1 H-NMR (CDCl3) δ: 8.15-8.11 (2H, m), 7.61-7.57 (2H, m), 4.44-4.39 (2H, m), 3.21-3.09 (4H, m), 2.23-2.22 (3H, m), 1.40-1.36 (9H, m).

[0149] This compound 128: 1 ¹H-NMR (CDCl₃) δ: 7.08–6.97 (3H, m), 3.25–3.18 (1H, m), 2.38 (3H, d), 1.43 (6H, d). Compound 129 of this invention: 1¹H-NMR (CDCl₃) δ: 7.02–6.93 (3H, m), 4.41 (2H, q), 3.19–3.11 (1H, m), 2.23 (3H, s), 1.40–1.36 (9H, m). Compound 130 of this invention: 1 H-NMR (CDCl3) δ: 7.88-7.86 (2H, m), 7.58-7.56 (2H, m), 3.25-3.21 (1H, m), 2.80 (3H, s), 2.36 (3H, s), 1.45-1.43 (6H, m).

[0150] This compound 131: 1 ¹H-NMR (CDCl₃) δ: 7.61 (¹H, d), 7.52 (¹H, d), 7.26–7.24 (¹H, m), 4.40 (2H, q), 2.98–2.91 (¹H, m), 2.53 (2H, q), 1.43 (6H, d), 1.37 (3H, t), 1.08 (3H, t). Compound 132 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.51 (2H, m), 7.39–7.35 (2H, m), 6.46 (1H, t), 4.45–4.38 (2H, m), 3.40–3.32 (1H, m), 1.46–1.42 (6H, m), 1.41–1.35 (3H, m). Compound 133 of this invention: 1 H-NMR (CDCl3) δ: 7.71 (1H, s), 7.59 (1H, s), 3.98 (3H, s), 3.27-3.19 (1H, m), 2.47 (3H, s), 1.41 (6H, d).

[0151] This compound 134: 1 ¹H-NMR (CDCl₃) δ: 7.49 (¹H, d), 6.43 (¹H, d), 3.95 (³H, s), 3.27–3.18 (¹H, m), 2.42 (³H, s), 1.40 (⁶H, d). Compound 135 of this invention: 1¹H-NMR (CDCl₃) δ: 7.60 (¹H, s), 7.56 (¹H, s), 4.41 (2H, q), 3.96 (3H, s), 3.23–3.13 (¹H, m), 2.28 (3H, s), 1.41–1.33 (9H, m). Compound 136 of this invention: 1 H-NMR (CDCl3) δ: 7.65 (1H, d), 7.55 (1H, d), 7.29-7.25 (1H, m), 3.08-3.01 (1H, m), 2.67 (2H, q), 1.47 (6H, d), 1.16 (3H, t).

[0152] This compound 137: 1 ¹H-NMR (CDCl₃) δ: 7.44 (¹H, d), 6.36–6.35 (¹H, m), 4.40 (2H, q), 3.94 (3H, s), 3.22–3.15 (¹H, m), 2.26 (3H, s), 1.40–1.33 (9H, m). Compound 138 of this invention: 1 ¹H-NMR (CDCl₃) δ: 8.01–7.98 (¹H, m), 7.45–7.38 (¹H, m), 7.25–7.19 (¹H, m), 6.59–6.52 (¹H, m), 3.25–3.15 (¹H, m), 2.25 (³H, s), 1.43 (⁶H, d). Compound 139 of this invention: 1 H-NMR (CDCl3) δ: 7.72-7.69 (1H, m), 7.56 (1H, t), 7.44 (1H, t), 7.34-7.30 (1H, m), 3.25-3.18 (1H, m), 2.35 (3H, s), 1.43 (6H, d).

[0153] This compound 140: 1 ¹H-NMR (CDCl₃) δ: 7.94–7.92 (¹H, m), 7.32–7.26 (²H, m), 6.85–6.79 (¹H, m), 3.27–3.17 (¹H, m), 2.27 (³H, s), 1.44 (⁶H, d). Compound 141 of this invention: 1¹H-NMR (CDCl₃) δ: 7.54–7.49 (2H, m), 7.39–7.34 (1H, m), 3.25–3.18 (1H, m), 2.34 (3H, d), 1.45–1.40 (6H, m). Compound 142 of this invention: 1 H-NMR (CDCl3) δ: 7.77 (1H, t), 7.25-7.20 (1H, m), 7.13-7.08 (1H, m), 3.25-3.17 (1H, m), 2.37 (3H, s), 1.42 (6H, d).

[0154] This compound 143: 1 ¹H-NMR (CDCl₃) δ: 7.82 (¹H, d), 7.55–7.52 (¹H, m), 7.19–7.15 (¹H, m), 3.24–3.17 (¹H, m), 2.36 (³H, s), 1.42 (⁶H, d). Compound 144 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.65 (¹H, d), 7.54 (¹H, d), 7.26–7.24 (¹H, m), 2.99–2.90 (¹H, m), 2.36 (³H, s), 1.84 (2H, dq), 1.39 (3H, d), 0.89 (3H, t). Compound 145 of this invention: 1 H-NMR (DMSO-D6) δ: 8.15 (1H, d), 7.95 (1H, d), 7.75 (1H, dd), 2.77 (2H, q), 1.79-1.76 (1H, m), 1.32-1.29 (2H, m), 1.06 (3H, t), 0.97-0.95 (2H, m).

[0155] This compound 146: 1 ¹H-NMR (CDCl₃) δ: 7.56–7.53 (2H, m), 7.33–7.31 (2H, m), 6.19 (¹H, ddd), 5.17–5.12 (2H, m), 4.09–4.06 (¹H, m), 2.32 (³H, s), 1.46 (³H, dd). Compound 147 of this invention: 1¹H-NMR (CDCl₃) δ: 7.54 (2H, d), 7.33 (2H, d), 2.85 (2H, q), 1.67–1.62 (1H, m), 1.41–1.38 (2H, m), 1.15 (3H, t), 1.08–1.05 (2H, m). Compound 148 of this invention: 1 H-NMR (CDCl3) δ: 7.50 (2H, d), 7.31 (2H, d), 4.39 (2H, q), 2.72 (2H, q), 1.54-1.50 (1H, m), 1.36 (3H, t), 1.32-1.27 (2H, m), 1.07 (3H, t), 0.97-0.91 (2H, m).

[0156] This compound 149: 1 ¹H-NMR (CDCl₃) δ: 7.47 (2H, d), 7.34 (2H, d), 4.39 (2H, q), 1.90–1.83 (1H, m), 1.82–1.74 (1H, m), 1.41–1.34 (5H, m), 0.96–0.90 (2H, m), 0.90–0.85 (2H, m), 0.60–0.54 (2H, m). Compound 150 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.69 (¹H, d), 7.58 (¹H, d), 7.33 (¹H, dd), 5.13 (¹H, q), 3.33 (³H, s), 2.49 (³H, s), 1.48 (³H, d). Compound 151 of this invention: 1 H-NMR (CDCl3) δ: 7.63 (1H, d), 7.51 (1H, d), 7.23 (1H, dd), 5.16 (1H, q), 3.94 (3H, s), 3.29 (3H, s), 2.35 (3H, s), 1.43 (3H, d).

[0157] This compound 152: 1¹H-NMR (CDCl₃) δ: 7.62 (¹H, d), 7.52 (¹H, d), 7.23 (¹H, dd), 5.16 (¹H, q), 4.42 (2H, q), 2.35 (3H, s), 1.43 (3H, d), 1.38 (3H, t), 1.25 (3H, q). Compound 153 of this invention: 1 ¹H-NMR (CDCl₃) δ: 7.66–7.63 (¹H, m), 7.55–7.53 (¹H, m), 7.40 (¹H, t), 7.31–7.28 (¹H, m), 4.41 (2H, q), 3.18–3.14 (¹H, m), 2.20 (3H, s), 1.39–1.37 (9H, m). Compound 154 of this invention: 1 H-NMR (CDCl3) δ: 7.35-7.32 (2H, m), 7.22-7.19 (2H, m), 4.41 (2H, q), 2.92-2.84 (1H, m), 2.17 (3H, s), 2.06-1.99 (1H, m), 1.8...

Claims

1. Formula (I) [In the formula, R 1 is the group G 1 an isopropyl group optionally substituted with one or more substituents selected from the group G 1 a C4-C8 alkyl group optionally substituted with one or more substituents selected from the group G 1 a C2-C8 alkenyl group optionally substituted with one or more substituents selected from group G 1 a C2-C8 alkynyl group optionally substituted with one or more substituents selected from group G 2 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from group G 2 a 3- to 8-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 8-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 1 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 represents R 2 is the group G 3 a C1-C8 chain hydrocarbon group optionally substituted with one or more substituents selected from the group G 4 a C3-C8 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , C (= Z 1 ) R 11 , C (= Z 1 ) OR 12 , C (= Z 1 ) NR 11 R 12 , S(O) p R 13 , or NR 11 R 14 represents R 3 is the group G 5 a phenyl group optionally substituted with one or more substituents selected from the group G 5 a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from the group G 5 or a group represented by any one of the following formulae: (● indicates the bonding site with the nitrogen atom) G 7a , G 7b and G 7c The combination of 7a is C=O or CR 26a R 27a and G 7b is C=O or CR 26b R 27b and G 7c is C=O or CR 26c R 27c A combination where 7a is C=O or CR 26a R 27a and G 7b is C=O or CR 26b R 27b and G 7c is NR 28c , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7a is C=O or CR 26a R 27a and G 7b is NR 28b , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7c is C=O or CR 26c R 27c A combination where 7a is NR 28a , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7b is C=O or CR 26b R 27b and G 7c is C=O or CR 26c R 27c or a combination in which 7a is NR 28a , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7b is C=O or CR 26b R 27b and G 7c is NR 28c , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2; 7d , G 7e , G 7f and G 7g The combination of 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7d is C=O or CR 26d R 27d and G 7e is C=O or CR 26e R 27e and G 7f is NR 28f , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is NR 28e , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is C=O or CR 26d R 27d and G 7e is NR 28e , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7f is C=O or CR 26f R 27f and G 7g is NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, G 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is C=O or CR 26g R 27g A combination where 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7e is C=O or CR 26e R 27e and G 7f is C=O or CR 26f R 27f and G 7g is NR 28g , an oxygen atom, a sulfur atom, S=O, or a combination of S=O2, or 7d is NR 28d , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7e is C=O or CR 26e R 27e and G 7f is NR 28f , an oxygen atom, a sulfur atom, S=O, or S=O2, and G 7g is C=O or CR 26g R 27g A combination where X 1 and X 2 are the same or different and represent an oxygen atom or a sulfur atom; Y 1 is OR 15 or SR 15 represents Z 1 and Z 2 are the same or different and represent an oxygen atom or a sulfur atom; m, p, and q each independently represent 0, 1, or 2; R 10 , R 13 and R 23 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a group G 6 R represents a phenyl group which may be substituted with one or more substituents selected from the group consisting of 11 and R 21 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a group G 6 R represents a phenyl group which may be substituted with one or more substituents selected from the group consisting of: 12 , R 16 , R 19 , R 20 and R 22 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 14 , R 17 , R 18 and R 24 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, R 15 represents a C1-C10 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a group G 6 R represents a benzyl group optionally substituted with one or more substituents selected from the group consisting of 25 is the group G 56 R represents a C1-C6 alkyl group optionally substituted with one or more substituents selected from 26a , R 26b , R 26c , R 26d , R 26e , R 26f , R 26g , R 27a , R 27b , R 27c , R 27d , R 27e , R 27f , and R 27g are the same or different and represent a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 28a , R 28b , R 28c , R 28d , R 28e , R 28f , and R 28g are the same or different and represent a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a (C1-C3 alkyl)carbonyl group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 29a , R 29b , R 29c , R 29d , R 29e , and R 29f are the same or different and represent a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 57 is the group G 571 a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 58 is the group G 571 Group G represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. 1 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 2 Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 3 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 4 Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, an oxo group, a thioxo group, a halogen atom, a cyano group, a hydroxy group, and a mercapto group. 5 :Group G 54 a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group G 52 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of OR 20 Group, OR 25 Group, C (=Z 2 ) R 21 , C (= Z 2 ) OR 22 , C (= Z 2 ) NR 21 R 22 , C(R 57 ) = N-OR 58 , S(O) q R 23 , N.R. 20 R 24 , group G 52 a phenyl group optionally substituted with one or more substituents selected from the group G 52 a 3- to 10-membered heterocyclic group optionally substituted with one or more substituents selected from the group consisting of a nitro group, a halogen atom, SF ５ Group G consisting of a cyano group and a phenyl group. 6 Group G: a group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, a cyano group, a nitro group, a hydroxy group, and a mercapto group. 52 : a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms Group G consists of a methyl group, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group. 54 : a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms, a Group G consists of a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, and a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group. 56 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, C(R 561 ) = N-OR 562 , a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, and an SF5 group. 561 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, an aromatic heterocyclic group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 562 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. 571 a C3-C6 alicyclic hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, a 5- or 6-membered heterocyclic group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkylthio group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkyl)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkoxy)carbonyl group optionally substituted with one or more halogen atoms, a (C1-C a (C1-C6 alkylamino)carbonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)carbonyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, a (C1-C6 alkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a (C2-C8 dialkylamino)sulfonyl group optionally substituted with one or more halogen atoms, a cyano group, a nitro group, a hydroxy group, an amino group, a formyl group, a halogen atom, and an SF5 group.

2. R 3 But the group G 5 a phenyl group optionally substituted with one or more substituents selected from the group G 5 a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from the group G 5 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, OR 20 Group, C (=Z 2 ) R 21 , C (= Z 2 ) OR 22 , C (= Z 2 ) NR 21 R 22 , S(O) q R 23 , N.R. 20 R 24 2. The compound or salt thereof according to claim 1, wherein the aryl group is a nitro group, a halogen atom, and a cyano group.

3. X 1 and X 2 The compound or salt thereof according to claim 1 or 2, wherein is an oxygen atom.

4. Y 1 is OR 15 The compound or salt thereof according to any one of claims 1 to 3, wherein the compound is a group.

5. R 2 But the group G 3 a C1-C4 alkyl group optionally substituted with one or more substituents selected from the group G 4 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a cyano group, OR 10 , or S(O) p R 13 and R 10 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, and R 13 The compound or salt thereof according to any one of claims 1 to 4, wherein is a C1-C3 alkyl group optionally substituted with one or more halogen atoms.

6. R 2 The compound or salt thereof according to claim 5, wherein is a C1-C3 alkyl group optionally substituted with one or more halogen atoms.

7. R 1 But the group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a C4-C6 alkyl group optionally substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 a 3- to 6-membered non-aromatic heterocyclic group optionally substituted with one or more substituents selected from the group consisting of the following (heteroatoms constituting the 3- to 6-membered non-aromatic heterocyclic group are oxygen atoms or sulfur atoms); 11 a linear C1-C3 alkyl group substituted with one or more substituents selected from the group consisting of OR 16 , S(O) m R 17 , or NR 18 R 19 and R 16 , R 17 and R 18 are the same or different and are a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, R 19 is a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom, or a salt thereof. 11 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; 21 The group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group.

8. R 1 But the group G 11 an isopropyl group optionally substituted with one or more substituents selected from the group G 11 a butyl group optionally substituted with one or more substituents selected from the group G 11 an ethyl group substituted with one or more substituents selected from the group G 11 an n-propyl group substituted with one or more substituents selected from the group G 21 a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group G 21 The compound or salt thereof according to claim 7, wherein the heteroatom constituting the 3- to 6-membered saturated heterocyclic group is an oxygen atom, and the heteroatom is optionally substituted with one or more substituents selected from the following: 11 Group G: a group consisting of a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group; 21 The group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a C1-C3 alkylthio group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfinyl group optionally substituted with one or more halogen atoms, a C1-C3 alkylsulfonyl group optionally substituted with one or more halogen atoms, a halogen atom, and a cyano group.

9. R 1 The compound or salt thereof according to claim 8, wherein is an isopropyl group or a sec-butyl group.

10. R 3 But the group G 5 a phenyl group optionally substituted with 1 to 3 substituents selected from the group G 5 The compound or salt thereof according to any one of claims 1 to 9, which is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following:

11. R 3、 But the group G 5 a phenyl group substituted with 1 to 3 substituents selected from the group G 5 The compound or salt thereof according to any one of claims 1 to 9, which is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents selected from the following:

12. R 3 But the group G 5 10. The compound or salt thereof according to any one of claims 1 to 9, wherein the phenyl group is optionally substituted with 1 to 3 substituents selected from the following:

13. R 3 But the group G 5 The compound or salt thereof according to any one of claims 1 to 9, wherein the phenyl group is substituted with 1 to 3 substituents selected from the following:

14. R 3 But the group G 5 The compound or salt thereof according to claim 13, wherein the phenyl group is substituted with 1 or 2 substituents selected from the group consisting of:

15. R 3 is a phenyl group substituted by 1 to 2 substituents selected from the group consisting of a cyano group, a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof.

16. R 3 But the group G 5 The compound or salt thereof according to any one of claims 1 to 9, which is a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 2 substituents selected from the following:

17. R 3 is a 5-membered aromatic heterocyclic group optionally substituted by 1 to 2 substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof.

18. R 3 is a 6-membered aromatic heterocyclic group optionally substituted with one substituent selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof.

19. R 3 The compound or salt thereof according to any one of claims 1 and 3 to 9, wherein is a group represented by any of the following formulas:

20. R 3 The compound or salt thereof according to claim 19, wherein is a group represented by any of the following formulas:

21. R 3 The compound or salt thereof according to claim 19, wherein is a group represented by the following formula:

22. R 3 The compound or salt thereof according to claim 19, wherein is a group represented by the following formula:

23. R 3 But the group G ５ 10. The compound or salt thereof according to claim 1, wherein the aromatic fused heterocyclic group is an aromatic fused heterocyclic group optionally substituted with one or more substituents selected from the group consisting of:

24. R 3 is an 8- to 10-membered aromatic fused heterocyclic group optionally substituted by 1 to 2 substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group, a C1-C3 haloalkyl group, and a C3-C6 cycloalkyl group, or a salt thereof.

25. A herbicidal composition comprising the compound or salt thereof according to any one of claims 1 to 24 and an inert carrier.

26. A method for controlling weeds, comprising the step of applying the compound or salt thereof according to any one of claims 1 to 24 to weeds or soil in which weeds grow.

27. Use of the compound or salt thereof according to any one of claims 1 to 24 for controlling weeds.

28. A composition comprising one or more components selected from the group consisting of group (d) and group (f), and the compound or salt thereof according to any one of claims 1 to 24: Group (d): phytotoxicity-reducing component; Group (f): herbicidal active component.

Images